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Major depression and anxiety disorders are debilitating and prevalent conditions, yet 
current methods for tailoring treatments and predicting treatment response are 
suboptimal, in part due to a lack of understanding of the biological and behavioural bases 
of these disorders. Neuroimaging has provided some insights, but this area lacks a well-
defined battery of trans-diagnostic psychological measures, and most neuroimaging 
studies have focused on pharmacological, rather than psychological therapies. 
This thesis firstly details meta-analyses of the changes in brain activation and neural 
predictors of treatment response with psychological therapies to determine whether 
robust correlates exist currently. Further chapters aimed to pilot novel fMRI and 
behavioural methods in patients with anxiety and depression. Firstly, a human translation 
of a rodent task to measure fear and anxiety, which had yet to be piloted in patients with 
affective disorders, despite the relevance of threat-avoidance to these conditions. 
Secondly, a novel task to measure self-reflection more directly than currently available 
methods. Thirdly, a new and underutilised method of analysing resting-state data to 
reveal temporal variability in connectivity.  
We were able to demonstrate consistent changes in brain activation associated with 
psychological therapies across depression and anxiety, though the meta-analyses 
highlight how far we are from utilising neuroimaging in clinical practice. We did not find 
significant differences in brain activation on the novel tasks between patients and 
controls; however, the task relating to self-reflection showed promise as a behavioural 
measure. We found increased fluctuations in connectivity between default mode network 
regions considered crucial for the generation of self-reflective thoughts in patients versus 
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controls. We were able to replicate this finding in an independent sample, suggesting the 
finding is robust.  
These results contribute to an understanding of threat sensitivity and self-reflection in 
affective disorders and provide ideas for future research in to neural biomarkers and 
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Overview and statement of the candidate’s contribution 
to the work presented in this thesis 
This thesis has been written having regard to the King’s College London university 
guidelines that allow published work to be included and a modified thesis structure to be 
used. The thesis is therefore written with a general introduction and aims (Chapter 1), a 
meta-analysis (Chapter 2) and description of the main methods used (Chapter 3). There 
then follows three experimental chapters in which the three components of the thesis are 
described, with specific methods, results and a discussion of the results presented for each 
aspect of the study. These correspond to already published work where indicated, or 
planned publications. Finally, a full discussion bringing together all aspects of the work 
is presented in Chapter 7. 
An outline of each chapter is given below along with a statement of contribution: 
Chapter 1 
This chapter provides a background to the thesis. I wrote all parts of this section, with 
guidance from Professor Anthony Cleare and Dr Adam Perkins. 
Chapter 2 
I independently conducted literature searches and performed statistical analyses for these 
meta-analyses of the neural correlates of psychological therapy. The chapter was written 




This chapter details the methodology of the fMRI (Study 1) and behavioural experiments 
(Study 2) in this thesis. I applied for ethics and funding for these projects, and solely 
recruited and conducted all participant visits (consulting Professor Anthony Cleare for 
clinical advice as required and receiving training on administering the clinical 
assessments). I also adapted a behavioural task, originally designed by Dr Adam Perkins 
for measuring self-reflection (the “Fake IQ test”), so as to be suitable as an fMRI paradigm, 
with the help of a programmer and advice of experts in the field of neuroimaging (Dr 
Owen O’Daly, Dr Roland Zahn, David Gasston and Alexandru Popescu). I wrote all parts 
of this chapter, with guidance from Professor Anthony Cleare and Dr Adam Perkins. A 
paper has been published about the utility of various recruitment methods used in this 
and other fMRI studies of patients with major depression (Wise et al., 2016).  
Chapter 4 
 This chapter reports results from the Fake IQ test, a novel measure of self-reflection 
created by Dr Adam Perkins. I adapted this task to be suitable as an fMRI paradigm, with 
the help of a programmer (Alexandru Popescu) and advice of experts in the field of 
neuroimaging (Dr Owen O’Daly, Dr Roland Zahn and David Gasston). All data was 
collected independently by me and analysis conducted with advice from Dr Toby Wise 
due to his expertise with the analysis methodology. I wrote all parts of this chapter, with 
guidance from Professor Anthony Cleare and Dr Adam Perkins. 
Chapter 5  
This chapter analysed resting-state data using a recently developed analysis technique 
looking at dynamic functional connectivity in participants recruited in this thesis project 
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(Study 1) and in an independent sample of patients with major depression. Data for this 
additional sample was collected by Dr Toby Wise, Dr Danilo Arnone, Dr Andres Herane-
Vives and me. The analysis scripts were created and analysis conducted by Dr Toby Wise. 
I contributed towards the pre-processing of fMRI data and behavioural analyses and 
jointly in the writing and theoretical analysis of the results. This work has been published 
in Translational Psychiatry where I am joint first author (Wise et al., 2017). The figures 
presented in this chapter are edited versions of the images in the published manuscript. 
The manuscript was reviewed by all named authors on the published paper, as well as 
anonymous reviewers. 
Chapter 6  
This chapter presents results on the Joystick Operational Runway Task, a measure of 
threat avoidance behaviour in patients from Study 1 and Study 2. I collected all data 
reported in this chapter. Scripts for fMRI data analysis were primarily written by Dr Toby 
Wise with whom I conducted data pre-processing and analysis and problem solved issues 
with the analysis script. The chapter was written by myself with guidance from Dr Adam 
Perkins, Dr Toby Wise and Professor Cleare. Figures 6-a and 6-b were kindly provided by 
Dr Perkins. The task was programmed by Robert Davis with technical support from David 
Gasston. 
Chapter 7  
This chapter provides an overall discussion of the work discussed in this thesis. It was 
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Chapter 1: Introduction  
 
1.1 General introduction and rationale 
Major depression and anxiety disorders are highly prevalent and greatly impact a person’s 
quality of life, affecting a wide range of functioning such as mood, physical health, social 
and cognitive ability (Olatunji et al., 2007; Wells et al., 1989; Wittchen et al., 2011). 
Comorbidity is common between the two conditions (Kaufman & Charney, 2000) and 
both respond to similar treatments (Ressler & Mayberg, 2007). Although there are many 
effective therapies for these disorders, a large proportion, around 40-60%, of patients do 
not respond to first-line recommended treatments which include evidence-based 
psychological therapies and antidepressant or anxiolytic medications (Baldwin et al., 
2014; Cleare et al., 2015). Poor response rates and residual symptoms remaining post-
treatment have significant individual and societal costs such as continued distress and 
increased probability of relapse, suicide risk, loss of productivity and wasted resources of 
inefficient treatment (Dunlop et al., 2011; Kennedy & Foy, 2005; Kessler et al., 2006). 
Currently, psychiatric assessments are principally based on patient self-report and 
observation of patient behaviours without parallel measurement of the underlying 
biological mechanisms. Decisions regarding treatment are therefore based on clinical 
characteristics such as symptom severity, subtype, comorbidity and previous psychiatric 
history (Fava et al., 1997; Thase et al., 1997; Trivedi et al., 2006). These assessments are 
aided by the Diagnostic and Statistical Manual (American Psychiatric Association, 2013) 




However, patients vary widely in the pattern of symptoms they display suggesting there 
are multiple underlying causes and disease processes. A lack of understanding of the 
biological mechanisms underlying these heterogeneous disorders hampers the 
development of improved treatments or personalised medicine. Recent evidence from 
neuroscientific research has shown that existing clinical diagnostic categories, as outlined 
in the DSM and ICD, may lack accurate prediction of treatment response (Insel et al., 
2010). This is potentially due to a failure to capture important pathophysiological 
mechanisms of these heterogeneous diseases in existing classification systems. Indeed, 
neuroimaging studies have shown evidence of new neurophysiological-based subtypes of 
disorders being better able to predict treatment response and symptoms (Clementz et al., 
2015; Drysdale et al., 2017). A major goal in psychiatry is therefore the development of 
pathophysiological systems of diagnosis and predictors of response with the hope that 
they will lead to a more personalised treatment approach and better response rates by 
reducing the current trial-and-error approach to identifying the right treatment for 
patients (Insel et al., 2010). 
One promising method of approaching this objective of a more biological approach in 
psychiatry is through identifying quantitatively measurable and specific dysfunctions in 
psychological or behavioural processes that are related to distinct brain structures and/or 
functions (Hyman, 2007). In recent years there has been a rapidly growing body of 
evidence to show that brain activation and morphology differs in emotional and cognitive 
domains in patients with depression and anxiety compared to healthy individuals (Etkin, 
2010; Wise, Cleare, Vives, Young, & Arnone, 2014). There is also evidence to suggest that 
neural activation normalises over the course of therapy and that pre-treatment brain 
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activity can predict subsequent response to both pharmacological and psychological 
therapies (Fu et al., 2013; Ma, 2015; Messina et al., 2013; Shin et al., 2013). 
Most functional imaging studies in affective disorders have studied response to emotional 
stimuli, for example, responses to both explicit and implicit presentations of emotional 
stimuli or the effect of emotional stimuli on ability to perform tasks of working memory 
or attention i.e. ability to gate out affective distractors (Etkin & Wager, 2007; Fonzo & 
Etkin, 2017; Treadway & Pizzagalli, 2014). Functional neuroimaging studies typically 
demonstrate an imbalance in neural activation in patients with anxiety and depression 
compared to healthy controls whereby abnormally elevated limbic activation is not 
adequately controlled by prefrontal regions (Etkin, 2010; Hariri et al., 2000; Rauch et al., 
2000; Whalen et al., 2002). These findings align with a dual process model of emotion 
regulation with top-down prefrontal controlled processes and bottom-up, automatic 
limbic activation (Barrett et al., 2004). Prefrontal activation is involved in executive 
control (Owen et al., 2005) and emotional regulation processes (Ochsner & Gross, 2005), 
and has an inhibitory effect on limbic brain regions such as the amygdala, insula, 
hippocampus and anterior cingulate cortex (ACC), which are associated with intrinsic 
emotional reactivity (Drevets & Raichle, 1998; Phillips et al., 2003). 
Patients with affective disorders who remit have been found to show recovery in the 
imbalance between these two systems (DeRubeis et al., 2008; Etkin et al., 2005; Siegle et 
al., 2007). DeRubeis et al. proposed that psychological therapies act to regulate emotional 
control processes by increasing activation in prefrontal emotional regulation systems 
which in turn have a top-down effect on limbic activation for depression (DeRubeis et al., 
2008). An equivalent model in anxiety disorders has been proposed (Etkin et al., 2005). 
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Evidence for and against the dual-process model will be discussed in more depth in 
Chapter 2.  
This field lacks a well-defined battery of performance-based, clinical measures which 
could aid the linking of psychiatric and neuroscientific findings (Insel et al., 2010). The 
development of robust neuropsychological measures of affective functioning – linking key 
personality dimensions of mental health to their underlying neural circuitry – could be a 
key step in achieving a more evidence-based approach to psychiatric treatment. It is 
important to understand the causes of response and non-response in patients to better 
target treatments and to also aid the development of improved or novel treatments. This 
is critical due to poor response rates in these conditions and many of the present 
pharmacological treatments for affective disorders, almost all of which target the 
monoaminergic system, being discovered by chance without a clear knowledge of the 
exact biological mechanisms of these disorders and treatment response. 
Threat avoidance (an innate defensive reaction to fear and anxiety provoking situations) 
and self-reflection (inner consideration on personal thoughts, feelings and actions) are 
two such measurable neuropsychological domains of functioning relevant to both 
depression and anxiety disorders and for which there can be performance-based and well-
defined tasks alongside validated measures of self-report. Both can be considered as 
dimensional constructs spanning several psychopathologies, which is encouraged in this 
line of biomarker research due to symptom overlap and communalities between structural 
and functional abnormalities between conditions (Cuthbert & Insel, 2013; Goodkind et 
al., 2015; McTeague et al., 2017). These psychological constructs are also associated with 
the activity of specific neural systems. Self-reflection is linked to the default mode network 
(DMN), two key areas being the medial prefrontal cortex (mPFC) and posterior cingulate 
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cortex (PCC) (Philippi & Koenigs, 2014). Threat avoidance is associated with midbrain 
regions such as the periaqueductal gray (PAG) and the hippocampus (Bach et al., 2014; 
Mobbs et al., 2009, 2007), along with amygdala-striatal and prefrontal cortex interactions 
(Collins et al., 2014; Delgado et al., 2009). 
This thesis will pilot the ability of novel tasks, for measuring threat avoidance and self-
reflection, to discriminate between patients and controls. The neural activity relating to 
these paradigms will be investigated in patients with depression and varying degrees of 
clinical anxiety versus healthy controls using functional magnetic resonance imaging 
(fMRI). The tasks will also be analysed in relation to behavioural performance in patients 
versus controls and in relation to response to cognitive behavioural therapy (CBT) 
(looking at changes pre- to post-therapy in responders versus non-responders to CBT) in 
order to validate these measures.  
The task designed to measure self-reflection is a more implicit measure than typically 
used in this field of research (the potential advantages of which are outlined in Chapter 
4). The task involves participants reflecting on their performance on a visual perception 
task which unknown to participants has no right or wrong answers and therefore 
individual differences in self-perception of performance are the measurements of interest. 
This fits with Beck’s cognitive model of depression which was later also applied to anxiety 
(Beck, 1967; Beck et al., 2005). The theory states that depression and anxiety involve a 
distortion in perception and recall of environmental feedback in a negative direction: an 
inherent negative bias of the self, the world and the future.  
The task utilised for measuring threat avoidance has previously been piloted in healthy 
individuals and task performance has been shown to be sensitive to anxiolytic medication 
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and related to personality traits associated with depression and anxiety, hence exploration 
here in patients with anxiety and depression. It is an active threat avoidance task and fits 
with Gray and McNaughton’s Reinforcement Sensitivity Theory which postulates that 
patients with, and at risk of developing, anxiety have an overactive Behavioural Inhibition 
System (BIS, which is a system thought to regulate responses to aversive stimuli and goal-
conflicts) and therefore demonstrate over-active avoidance of, and reactions in relation 
to, threats and punishment (Gray & McNaughton, 2000). Although the theory was 
originally developed in relation to anxiety, an overactive BIS is also a common finding in 
depression (Bijttebier et al., 2009).  
 
1.2 Meta-analysis of the neural effects of psychological therapy 
This thesis will begin on meta-analyses synthesising our current level of knowledge on 
the neural correlates of psychological therapies and neural predictors of psychological 
treatment response in depression and anxiety disorders. Psychological therapies are 
considered effective first-line treatments for these disorders according to national 
guidelines and are often a preferred form of treatment for many patients (Baldwin et al., 
2014; Cleare et al., 2015). Despite this, there have been far fewer neuroimaging studies 
in relation to psychological therapies compared to pharmacological treatments (Etkin, et 
al., 2005). A recent meta-analysis has been published looking at pharmacological 
neuroimaging research in depression (Ma, 2015) but an update is required for 
psychological therapies, conducted with improved methodology (Messina et al., 2013). 
Gaining a greater understanding of the mechanisms of psychological therapies is 
important in order to understand processes which underlie their clinical effectiveness and 
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for achieving the goal of precision psychiatry, by determining on an individual level who 
will respond best to which specific pharmacological or psychological therapy. This links 
to the work throughout this thesis as, if we are to incorporate neuropsychological 
assessments into clinical practice, we need to consider the evidence to date regarding 
neural associations of therapy to understand how close we are to understanding the 
neurobiological mechanisms of treatments and also in developing personalised predictors 
of response from this research field.  
Additionally, the psychological and behavioural domains under investigation in this thesis 
(self-criticism and threat avoidance) may be more closely related to psychological than 
pharmacological therapies. For example, self-criticism has been found to be predictive of 
treatment response to psychological but not pharmacological therapies (Rector et al., 
2000) and the therapies which target maladaptive threat avoidance are typically 
psychological in nature.  
 
1.3 Self-reflection in depression and anxiety disorders 
Self-reflection is a broad domain and includes both positive and negative aspects. For 
example, self-reflection of one’s behaviour can help us perceive social cues, generate 
social emotions and also contributes to emotional regulation and self-insight (Philippi & 
Koenigs, 2014). Maladaptive levels of, and/or excessively negative, self-reflection, for 
example, excessive rumination, worry, and self-critical thoughts can be found in mood 
and anxiety disorders (Ingram et al., 1987; Woodruff-Borden et al., 2001) and 
pathological levels of these thoughts are key features of these conditions (American 
Psychiatric Association, 2013; Clark & Wells, 1995; Nolen-Hoeksema, 2000; 2008).  
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Neuroimaging research has begun to reveal the brain regions associated with self-
reflection. The mPFC is considered crucial for the generation of self-reflective thoughts 
from various fields of evidence including neurological patients, and functional and 
structural neuroimaging studies. In patients with mPFC lesions, impaired self-reflection, 
for example diminished empathy, shame, guilt and social disinhibition, is found (Barrash, 
et al., 2000; Beer et al., 2003; Eslinger & Damasio, 1985; Philippi et al., 2012). 
Additionally, patients with neurodegenerative diseases associated with degeneration of 
the mPFC, for example, patients with frontotemporal dementia, show psychopathic traits 
such as loss of empathy and disinhibition, which may be mediated by the reduced self-
reflection found in this patient group (Rascovsky et al., 2011). Functional neuroimaging 
studies, in both patient and healthy control groups, also support the relevance of the 
mPFC in self-reflection. The DMN which consists of the mPFC, PCC, and lateral parietal 
brain regions, has been found to be more active at rest (during unconstrained thought) 
than at the time of completing directive tasks (Buckner et al., 2008; Greicius et al., 2003; 
Raichle et al., 2001). When participants undergo a resting-state scan, where they are 
given no instructions other than to rest, they often report being engaged in self-reflective 
thought, for example, thinking about themselves, their future goals, and memories. The 
level of engagement in self-reflective thoughts has been found to be positively associated 
with DMN activity suggesting this network, which includes the mPFC, is involved in the 
generation of these thoughts (Andreasen et al., 1995; D’Argembeau et al., 2005; Mason 
et al., 2007; McKiernan et al., 2006). 
Additionally, the mPFC and PCC (key regions within the DMN) are frequently found to 
be activated in tasks of self-referential processing, for example, personality judgement 
tasks where the participant has to judge how relevant certain personality traits are to 
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them or others (D’Argembeau et al., 2005; Moran et al., 2006; Whitfield-Gabrieli et al., 
2011). Furthermore, Moran et al. (2006) and D’Argembeau et al. (2005) were able to 
demonstrate that the level of activation in the mPFC and PCC was positively correlated 
with the amount of self-reflection reported in these personality trait judgements. 
In depression and anxiety disorders, heightened DMN activity has been found in both 
resting-state and task based neuroimaging (Berman et al., 2011; Drevets et al., 2008; 
Greicius et al., 2007; Mayberg, 1997; Zhu et al., 2012). There is evidence that this 
heightened DMN activity is correlated with rumination and symptom severity in both 
depression and anxiety disorders (Berman et al., 2011; Drevets et al., 2008; Greicius et 
al., 2007; Mayberg, 1997; Zhu et al., 2012). Therapy has also been found to normalise 
aberrant connectivity and activation levels within regions of the DMN. This has been 
found with CBT (Yoshimura et al., 2014), antidepressants (Li et al., 2013; Posner et al., 
2013) and transcranial magnetic stimulation (Liston et al., 2014).  
Given the importance of self-reflection in emotional regulation and self-awareness, 
processes which are crucial for psychotherapy to be effective (Mansell, 2011), it makes 
sense that high levels of self-criticism are associated with poorer treatment response. 
Indeed, self-criticism has been found to be associated with lower response rates to 
interpersonal therapy (Marshall et al., 2008) and CBT (Rector et al., 2000). Also, the 
degree to which self-criticism reduces during treatment has been found to be a significant 
predictor of treatment outcomes for depression (Rector et al., 2000) and social phobia 
(Rector et al., 2000). Self-criticism has also been linked to increased risk of co-morbidity 
and negative psychosocial outcomes in mental health conditions (Dunkley et al., 2003; 
Kopala-Sibley et al., 2015). 
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The work in this thesis aimed to test self-reflection in two original ways:  
1. A novel implicit self-reflection measure called The Fake IQ test (see Chapter 4) 
where participants’ satisfaction with their performance on an impossible visual 
perception task was assessed. This task was designed with consideration to avoid 
some of the issues with existing measures of self-reflection. The task measures 
self-perception of performance including self-satisfaction and self-other 
comparison. The relationship between task measures and self-report self-criticism, 
rumination and worry scores will be explored.   
2. Dynamic functional connectivity, an underutilised method of analysing resting-
state data, in areas crucial for the generation of self-reflective thought: the mPFC 
and PCC of the DMN (see Chapter 5). The novelty of the resting-state analysis 
comes from looking at temporal (dynamic) variability in connectivity, a relatively 
new technique, which goes beyond studying averaged (or static) connectivity in 
neural networks, which is an analysis technique that has been applied widely in 
affective disorders.  
1.4 Threat avoidance in mood and anxiety disorders 
Threat avoidance is an innate defensive reaction to potential threats and is an evolved 
survival behaviour that all animals exhibit (Mobbs, et al., 2015). The inability to 
extinguish or inhibit high levels of threat response is common to all anxiety disorders 
(Graham & Milad, 2011; Otte, 2011). Threat avoidance and escape are coping strategies 
that are widely used by patients with anxiety whereby a patient learns to minimise or 
prevent contact with events or stimuli that they have learnt to be aversive (LeDoux et al., 
2017), for example, avoidance of social situations in those with social phobia (Barlow, 
30 
 
2013), repellent stimuli in people with contamination fears (Tsao & McKay, 2004), and 
in depression generally withdrawing and/or complaining (Ferster, 1973). These avoidant 
behaviours can be very successful at temporarily reducing symptoms of fear and anxiety, 
and are thus strongly reinforced via operant conditioning processes which leads to the 
continuation of these behaviours (Mowrer, 1951). However, problems arise when these 
avoidance behaviours lose their adaptive qualities by preventing people from learning 
which situations are and are not dangerous, become habitual or excessive, and interfere 
with daily life and social functioning; and are thus seen as maladaptive forms and levels 
of threat avoidance (LeDoux et al., 2017). 
Maladaptive threat avoidance is not specific only to anxiety and has also been associated 
with obsessive-compulsive disorder (OCD), major depressive disorder (MDD), suicidality 
and autism (Gillan et al., 2014; Servatius, 2016). Understanding differences between 
adaptive versus maladaptive forms of threat avoidance in individuals is important and the 
construct has been proposed to be dimensional, spanning several pathologies to 
differential degrees, rather than a specific symptom identifying a diagnosis (Gillan et al., 
2014; Servatius, 2016). Threat sensitivity may therefore help explain psychiatrically-
relevant individual differences in proneness to affective disorders, specific symptoms and 
their severity, and response to treatments. Additionally, understanding the neurological 
differences underlying maladaptive and adaptive threat avoidance may help target and 
develop more effective behavioural or pharmacological treatments. 
Currently the understanding of the need to challenge maladaptive avoidance underpins 
many treatments for these disorders, for example flooding or exposure therapy for specific 
or social phobias (Mineka, 1979), or emotional processing therapy which encourages 
individuals to fully process, and not avoid, disturbing events and thought processes (Foa 
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& Kozak, 1986). These therapies are therefore based on the principles of classical and 
operant conditioning (how the disorders are proposed to be learnt and maintained 
respectively in Mowrer’s two-factor theory of avoidance learning (Mowrer, 1951)). The 
therapies work by exposing the individual to perceived threats until habituation - a 
reduction in behavioural and sensory threat responses due to repeated exposure - has 
occurred. An additional element to these therapies is response prevention which involves 
encouraging the individual to refrain from avoidance and escape behaviours, which in 
turn reduces the reinforcement of these behaviours. Therefore, these treatments act to 
extinguish maladaptive coping strategies and work on the understanding that the 
conditions can be learned and unlearned using similar principles. Additionally, 
medications can help reduce fear and anxiety either as adjuncts to cognitive and/or 
behavioural therapies or independently by addressing underlying neurochemical causes. 
Despite the significant impact that the understanding of threat avoidance has had on the 
development of psychological therapies, there is a paucity of neurobiological research into 
active threat avoidance in human pathology with much of the initial research having been 
conducted pre-clinically in animals (LeDoux et al., 2017). However, the animal models 
generally align with what has been found in humans to date. During active avoidance 
fMRI tasks, concurring brain regions involved during threat-avoidance include the 
amygdala, hippocampus, nucleus accumbens, PAG and mPFC (Bach et al., 2014; LeDoux 
et al., 2017; Mobbs et al., 2009). 
An important element to consider when researching pathological human threat avoidance 
is the type of avoidance involved in the task. A model has been developed in which active 
threat avoidance behaviours (i.e. threats requiring action for their avoidance) can be 
differentiated in terms of their defensive direction. Fear is associated with orientation 
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away from pursuing threats (where escape is possible, leading to flight behaviour), 
whereas anxiety is associated with more ambiguous threats which require investigation 
and therefore necessitate orientation towards the threat (for example, risk assessment and 
goal-conflict behaviours when escape is not possible) (Gray & McNaughton, 2000). 
Evidence for this differentiation in terms of defensive direction comes from rodent studies 
which show that drugs with clinical effectiveness against affective disorders differentially 
alter defensive behaviour (Blanchard et al., 1990). Drugs for panic disorder have been 
found to specifically lessen fear-related threat behaviours i.e. reactions to threats where 
escape is possible (Griebel et al., 1995), whereas drugs that treat generalised anxiety 
disorder (GAD) moderate rodent behaviour during goal-conflict tasks where escape is not 
possible i.e. the rodents run from their predators less fast or not at all which is an 
illustration of altered risk assessment behaviours to ambiguous threats (Blanchard et al., 
1990). This suggests that affective disorders reflect alterations in the functioning of brain 
systems that govern responses to threat and that individuals with anxiety disorders exhibit 
not only elevated threat avoidance but also that there are distinctions between disorders 
(Blanchard et al., 2001). This distinction is supported anecdotally by the tendency of 
patients with panic disorders to feel the urge to escape or avoid situations in which a 
panic attack is likely to occur (American Psychiatric Association, 2013). Whereas patients 
with GAD tend to experience anxiety in more complex situations where escape is not 
always possible, which leads to worrying about many aspects of life (American Psychiatric 
Association, 2013).  
Chapter 6 of this thesis will explore threat avoidance behaviour in patients with MDD and 
varying degrees of clinical anxiety versus healthy controls behaviourally and via fMRI 
using a task developed by Dr Adam Perkins which allows the measurement of both fear 
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and anxiety simultaneously within subjects. These two types of defensive direction had 
previously been studied in isolation of one another in humans until the development of 
this task - the Joystick Operated Runway Task (JORT) (Perkins et al., 2011; 2009). The 
JORT has been piloted in healthy controls but has yet to be tested in a patient population 
which is important as the task cleverly taps into both fear and anxiety concurrently and 
there may be important distinctions within and between disorders which could improve 
our understanding of specific threat avoidance behaviours and their associated neural 
activity in disorders.  
 
1.5 General aims and objectives 
The research reviewed here indicates that there are clear functional neuroimaging 
differences between patients with depression and anxiety disorders versus healthy 
individuals. These results have not yet been translated into clinical practice by improving 
treatments or tailoring therapies at an individual level according to likely response. The 
thesis begins with meta-analyses to determine consistencies regarding the neural 
correlates of psychological therapies and neural predictors of psychological treatment 
response in depression and anxiety disorders to determine whether robust markers exist 
in the current literature. 
There is a lack of research into threat-avoidance or direct measures of self-reflection in 
this field which, for the reasons outlined above, could be important psychological 
measures for aiding the linking of psychiatric and neuroscientific findings. The aim of the 
studies presented in this thesis was to assess the utility of novel fMRI paradigms and a 
new analysis technique of resting-state data in discriminating patients with depression 
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and anxiety versus healthy controls. Additionally, neural activation on the tasks will be 
explored in relation to self-report measures to validate the tasks as measuring relevant 
concepts. The three fMRI paradigms tested on patients versus healthy controls were: 1) 
The Fake-IQ test – a novel MRI paradigm to study brain activity relating to self-reflection; 
2) Multi-echo resting-state fMRI – assessing dynamic functional connectivity in the DMN 
and the association of instability in this network with self-report self-reflection measures; 
and 3) The JORT - investigating neural activity to threat – the first time to be reported in 
a patient population (Perkins et al., 2013).  
The tasks relating to threat-avoidance and self-reflection are novel in this field of research 
and therefore this work will also assess these tasks behaviourally to determine if 
significant differences in behavioural outcomes or task-related self-report measures in 
patients versus controls are found. Additionally, we sought to determine whether task 
performance was associated with subsequent response to treatment, or if treatment was 
associated with changes in performance on these tasks. This aim hopes to determine the 
validity of the tasks for use in neuroimaging studies of therapeutic response. Additionally, 
we aimed to test whether the ‘Fake’ nature of the Fake IQ test was perceived by 
participants and if participants placed importance on performing well at the task.  
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Chapter 2: Meta-analyses of the neural effects 
and predictors of response to psychological 
therapy in depression and anxiety 
 
Chapter Summary 
A better understanding of the neural mechanisms underlying the effects of psychological 
therapy in depression and anxiety disorders could aid understanding of the recovery 
process and help target more effective treatments; however, research to date has yielded 
inconsistent findings. The dual process model hypothesises that psychological therapy 
should be associated with increased emotional-regulation and cognitive control processes 
in prefrontal brain regions and consequently to this decreased implicit emotional 
reactivity in limbic regions.  
Meta-analyses of 1) brain activity changes accompanying psychological therapy (22 
studies, n = 352) and 2) neural predictors of symptomatic improvement (11 studies, n = 
293) in depression and anxiety disorders were conducted on eligible studies using seed-
based d mapping. To ensure only the most robust findings were reported, a jackknife 
sensitivity analysis was conducted and publication bias assessed via tests of funnel plot 
asymmetry. 
The most robust findings were of significant decreases in activation in clusters in the 
anterior cingulate/paracingulate gyrus, left and right inferior frontal gyrus and insula 
after therapy relative to pre-therapy. There was only one significant cluster of activation 
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that was predictive of subsequent symptom change which met our inclusion for 
robustness, located in the right cuneus. 
These meta-analyses suggest that there are consistent functional brain changes that occur 
after psychological therapy in depression and anxiety disorders. The results are in 
agreement with neural models of improved self- and emotional-regulation following 
psychological therapy as evidenced by decreased activity within the anterior cingulate 
and insula. We propose compensatory as well as corrective neural mechanisms of action 
underlie therapeutic efficacy and suggest the dual process model may be too simplistic to 
account fully for the neural mechanisms of treatment. More research on predictors of 
psychotherapeutic response is required to provide reliable and potentially clinically useful 




Psychological interventions are first-line treatments for both depression and anxiety 
disorders (Baldwin et al., 2014; Cleare et al., 2015; NICE, 2009), but are ineffective for 
as many as 50% of patients (Cuijpers et al., 2014; Loerinc et al., 2015). Research 
investigating the neural correlates of therapy aims to provide a greater understanding 
about the formation and maintenance of symptoms, in addition to the development of 
improved treatments and personalised medicine according to likely response (Lueken & 
Hahn, 2016), which could improve outcomes for recipients of psychological interventions. 
Recent reviews have shown the promise of functional neuroimaging studies in this field 
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for both depression and anxiety disorders (Fu et al., 2013; Hamilton et al., 2012; Ma, 
2015; Wise et al., 2014). A meta-analysis was recently published for pharmacological 
neuroimaging studies in depression (Ma, 2015) but an update is required for 
psychological therapies, conducted using improved methodology (Messina et al., 2013).  
Neuroimaging studies take either a longitudinal approach, where patients are scanned 
before and after therapy, or a predictive approach where patients are scanned before 
therapy to determine pre-treatment brain activation predictors of subsequent 
symptomatic improvement. Longitudinal studies aim to identify changes in regional brain 
activity that is associated with the therapeutic mechanisms of the intervention. In 
contrast, prediction studies aim to provide a basis for stratified treatment according to 
likely response, potentially enabling clinicians to more effectively tailor therapies at an 
early stage to individual patients (Fu et al., 2013). These complementary approaches may 
serve as a tool for clinical decision-making, along with behavioural markers gained from 
them. 
As described in the introductory chapter (Chapter 1), the dual process model is the 
leading theory regarding how psychological therapies are proposed to regulate emotional 
processing in both depression and anxiety disorders: by increasing activation in 
prefrontal, emotional regulation systems which in turn have a top-down effect on elevated 
limbic activation (Etkin et al., 2005). A recent systematic review of functional 
neuroimaging studies in depression and anxiety concluded that the results offer support 
for the dual process model of psychological therapies. However, there are inconsistencies 
in the literature regarding the specific brain regions and direction of activation changes 
within regions (Goldapple et al., 2004; Linden, 2008) with some research being at odds 
with the model; for example, certain studies have found decreased pre-frontal activation 
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following psychological therapy (Taylor & Liberzon, 2007). Theoretically, this is not 
entirely unexpected as hyper-prefrontal activation has been associated with ruminative 
thinking which would be expected to reduce with therapy (Goldapple et al., 2004). 
Additionally, in post-traumatic stress disorder (PTSD) decreases in prefrontal activation 
have been associated with a reduction in the intrusiveness of traumatic memories 
(Lindauer et al., 2008). 
For several reasons, findings from neuroimaging studies of treatment response may not 
be robust when considered independently: studies often have small sample sizes, which 
make it difficult to find strong effects of therapy after applying multiple comparisons 
across the whole brain (Button et al., 2013). Meta-analyses in the field of neuroimaging 
provide an effective way to determine consistencies across datasets with improved 
statistical power.  
2.1.1 Aims and hypotheses 
The aim of this study was to use meta-analyses to determine the most robust findings 
with psychological therapy in two domains: 1) functional brain activation changes from 
before to after psychological therapy, and 2) pre-treatment brain activation predictors of 
subsequent symptomatic improvement in patients with depression and/or anxiety 
disorders. To our knowledge this is the first prediction meta-analysis published in this 
field across depression and anxiety. Both disorders were included in analyses due to high 
levels of comorbidity between the two (Brown et al., 2001; Kaufman & Charney, 2000), 
indeed anxiety has been identified as a risk factor for developing depression (Wittchen, 
et al., 2007) and some cases of depression lead to anxiety, with stress being a predisposing 
factor for both disorders (Nutt, 2004). Additionally, there are overlapping symptoms, 
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similarities in their neurochemistry (for example, imbalances have been found in similar 
neurotransmitter systems such as serotonin function), and both disorders respond to 
similar therapies such as selective serotonin reuptake inhibitors (SSRIs) and CBT (Ressler 
& Mayberg, 2007). However, there are distinctions between the two disorders, for 
example, differential responses have been found to certain pharmacological treatments 
such as benzodiazepines which are effective for anxiety disorders but not depression or 
OCD and SSRIs are typically effective at higher doses for panic disorder and OCD than 
depression (Nutt, 2004). Also, although there is a genetic overlap, there are also genetic 
differences between disorders (Otowa et al., 2016; Smith et al., 2016; Smoller, 2016). In 
this meta-analysis, both disorders are included despite these caveats as the same theory 
is used to model therapeutic response in these disorders (Messina et al., 2013). Further, 
meta-analyses across psychiatric disorders have found evidence of more similarities in 
functional and structural neuroimaging abnormalities across disorders than differences, 
despite variance in symptoms (Goodkind et al., 2015; McTeague et al., 2017). 
Additionally, all psychological interventions were considered due to evidence of 
commonalities between therapies, the so called dodo effect (Luborsky et al., 2002; 
Rosenzweig, 1936). 
We applied a thorough and conservative approach to identify only the most robust 
findings within this heterogeneous literature. In line with the main theory used to model 
longitudinal results in this field, the dual process model, we hypothesised that 
psychological therapy would be associated with increased prefrontal activity and reduced 
limbic activity post- compared to pre-therapy. We hypothesised that increased baseline 
ACC activation would be predictive of greater symptomatic improvement in accordance 
with results from a meta-analysis by Fu et al., (2013) in depression studies and a recent 
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review by Lueken & Hahn (2016) of neuroimaging predictors of response in anxiety and 
depression. 
 
2.2 Methods  
2.2.1 Literature searches and study selection 
Literature searches were conducted in the following electronic databases: Scopus 
(Elsevier, http://www.scopus.com) and Medline (Ovid Technologies Inc., 
http://ovidsp.uk.ovid.com), to identify articles published before 24.07.2017. The 
searches identified studies using MRI, single photon emission computed tomography 
(SPECT) or positron emission tomography (PET) (see Appendix 1 for full list of search 
criteria). The title and abstract of all retrieved articles were evaluated to check suitability. 
Reference lists of included articles and relevant reviews were also manually searched. 
The following eligibility criteria were applied: 
• Articles were excluded if they did not include subjects currently meeting DSM or 
ICD established diagnostic criteria for MDD; bipolar disorder; dysthymia; OCD; 
PTSD; panic disorder; social anxiety disorder; GAD; or specific phobia.  
• Studies looking at the above affective disorders alongside neurological conditions 
were excluded to ensure findings were not obscured by neurological pathology. 
• Participants were required to have been scanned prior to beginning a course of 
psychological therapy and have examined pre-treatment regional brain activation 
in relation to post-treatment change in symptom severity (prediction studies) or 
brain activity changes pre- to post-therapy (longitudinal studies). 
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• Articles were excluded if they were case reports, reviews, meta-analyses or not 
written in English. 
• Only adult samples were suitable; child, adolescent or geriatric populations were 
excluded to minimise the effect of neurodevelopmental and neurodegeneration 
confounders on brain activation. In geriatric populations, there is an increased 
likelihood that organic disorders underlie, contribute to, or confound depressive 
symptoms. Older patients are therefore likely to show age-specific neuroimaging 
correlates of psychological therapy (e.g. Aizenstein et al., 2014; Smith et al., 
2009). In adolescents, neurodevelopmental features need to be taken into account 
and inconsistencies have been found between adolescent and adult findings 
(Kerestes et al., 2014). 
• Articles that used a region of interest (ROI) approach only, did not apply 
consistent statistical thresholds throughout the brain, or did not report peak 
coordinates in stereotactic space were excluded. Selecting only whole brain results 
is important as publication bias is likely to be less problematic with these analyses 
due to a more exhaustive and unbiased inclusion of studies and brain regions 
compared to ROI analyses. 
• Both task-based and resting-state functional scanning paradigms were included. 
In order to control for any methodological differences observed between these 
two types of studies, standard anisotropic effect-size seed-based d mapping (AES-
SDM) meta-analyses were conducted separately for task-based and resting-state 
studies and a meta-regression was conducted controlling for paradigm type to 
increase methodological homogeneity, where the number of studies permitted. 
This approach was taken as it is known that functional paradigm type can affect 
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results and regions of activation (Fu et al., 2007; Messina et al., 2013; Palmer et 
al., 2015; Whitfield-Gabrieli et al., 2011).  
• To ensure no overlap between studies, in the case of multiple studies reporting 
the same patient group (for example, reporting results of different functional 
tasks), we included the largest sample or, in studies following up the same 
participant group at a range of time points post-therapy, the study reporting 
scanning at the time-point closest to therapy completion. 
 
2.2.2 Meta-analyses  
Analyses were carried out using AES-SDM (Version 5.141, released December 2016, 
(Radua et al., 2014). AES-SDM is a voxel-based, weighted meta-analytical method which 
creates voxel-level maps based on effect size and variance of peak coordinates reported 
within studies and analyses them with random-effects meta-analytic methods. T-statistics 
are converted to effect sizes using standard statistical techniques. Effect size is calculated 
exactly at the reported peak coordinates and estimated, depending on distance from the 
peak, for the surrounding voxels using an anisotropic un-normalized Gaussian kernel 
multiplied by the effect size of the peak, subject to tissue-type constraints. This is similar 
to the method used in an alternative neuroimaging meta-analytic technique called 
activation likelihood estimation (ALE, http://brainmap.org/ale); however, AES-SDM is 
able to provide a more accurate estimation of signal due to accounting for effect size in 
calculations (Radua et al., 2012). AES-SDM also has the advantage of permitting the 
analysis of heterogeneity between studies via meta-regressions. It addresses between-
study heterogeneity by counteracting the effects of studies reporting opposite activation 
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findings in the same region by reconstructing both positive and negative maps in the same 
image, unlike other methods (Radua et al., 2012). 
 As suggested by (Radua & Mataix-Cols, 2012), voxels with a p-value <.005 were 
considered as significant, but those from clusters with fewer than 10 voxels or peaks with 
AES-SDM Z-values <1 were discarded to reduce the false positive rate. To determine the 
most robust results and explore the influence of outliers, a jackknife sensitivity analysis 
was conducted to assess the contribution of individual studies to the overall results. This 
repeats the analyses removing one study per iteration. If brain regions remain significant 
in all or most of the combinations then it can be concluded that these findings are highly 
replicable. Results were excluded that did not remain significant in 10% or more of 
iterations. To assess publication bias, funnel plots of effect size estimates of peak voxels 
were visually inspected and an Egger regression test was implemented to examine funnel 
plot asymmetry (Egger et al., 1997). This was conducted using the metafor package for 
R software (Viechtbauer et al., 2010) (R Foundation for Statistical Computing, Vienna, 
Austria; http://www.r-project.org/). The potential effect of paradigm type (task versus 
resting state scans) was examined by simple linear models and by repeating standard 
AES-SDM meta-analyses in subgroups. 
 
2.3 Results 
2.3.1 Literature searches 
Scopus returned 3,559 and Medline 958 results. From these, 33 articles were suitable for 
inclusion in analyses (see Figure 2-a for search details). 
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Figure 2-a: Flowchart of process of publication selection.  
 
Abbreviations – ROI; Region of interest. 
2.3.2 Longitudinal results 
Twenty-two whole brain longitudinal studies (n = 352 patients) met eligibility criteria 
and were included in these analyses (see Table 2-a for study details). The studies 
comprised the following patient groups: panic disorder (n = 5); PTSD (n = 4); social 
anxiety disorder (n = 5); unipolar major depression (n = 3); specific phobia (n = 2); 
OCD (n = 2); and GAD (n = 1). Disorder severity was typically in the moderate to severe 
range. 
134 selected for full 
text review 
33 included in 
analyses 
101 excluded (ROI approach, 
sample overlap, no 
coordinates reported, no adult 
sample, no psychological 
therapy given, neurological 
illness, sub-threshold 
diagnosis, did not report 
direction of significant results) 
 
4,375 excluded based on 
review of title and abstract 
(irrelevant topic, duplicate, 
ROI approach, did not use 
adult participants with 
anxiety/depression, no 











 11 prediction studies 
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Table 2-b and Figure 2-b provide details of all significant clusters from the longitudinal 
studies (n=22), regardless of whether they met our criteria for reliability and robustness. 
Details of jacknife sensitivity analysis, visual inspection of funnel plots, and publication 
bias analyses are detailed in the table (see Appendix 2 for funnel plots, however it should 
be noted that with relatively few, small studies funnel plots are insensitive to publication 
bias, so this cannot be excluded). All regions survived our sensitivity analysis and Eggers 
regression (all ps >.05), though some regions showed signs of publication bias in visual 
inspection of funnel plots. The most robust results, with no evidence of publication bias, 
were that psychological therapy was associated with significantly decreased activity post- 
compared to pre-therapy, in the left anterior cingulate/paracingulate gyri, the right 
inferior frontal gyrus and left inferior frontal gyrus/insula.  
There were too few studies that met our eligibility criteria to perform meta-regressions to 
study heterogeneity between disorders or therapy type (Radua et al., 2010). Standard 
AES-SDM analyses were repeated and limited to task (n= 17) and resting-state studies 
(n= 5). The separate analyses showed that the clusters found overall (see Table 2-b) in 
the corpus callosum and left ACC/paracingulate gyri remained consistent across both 
subgroups (see Tables 2-c and -d). The right inferior network, right arcuate network, 
bilateral inferior frontal gyri and right middle frontal gyrus findings were only found in 
resting-state studies. Left inferior frontal gyrus and left insula (which was an additional, 
separate cluster for task-based studies) and left temporal pole / mid temporal gyrus were 
significant findings in task-based analysis only. This was confirmed with a linear model 
confirming significant differences in task versus resting state studies in these regions.  
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vs. positive images) 
11 met full and 3 partial DSM-
IV criteria, average pre-
treatment CAPS score 66.07+-
16.78 None 




Baioui et al. 
(2013) OCD 12 (8) 
CBT  




Met DSM-IV criteria for OCD, 
pre-treatment YBOCS score 
23.08+-12.63, illness duration 
at least 4 months 16.67% 
4 patients had comorbid 
axis I disorders (2 SP; 2 
MDD; 1 SAD) 
32.49 
+-8.89 
Beutel et al. 
(2010) PD 9 (6) 
Psychodynami








Met ICD-10 criteria for PD, 2 
with agoraphobia, pre-
treatment average score on 
agoraphobic cognitions 
questionnaire 2.04+-0.67 44.44% Not stated 32 
Felmingham 






(8 sessions) fMRI 
Emotional face 
processing (fearful vs. 
neutral) 
Met DSM-IV criteria for PTSD 
following assault (n=4) or car 
accidents (n=4) 25% 
4 patients had comorbid 





al. (2002) SAD 6 (-) 
Group CBT  
(8 sessions) FDG PET 
Symptom provocation 
(public speaking task) 
Met DSM-IV criteria for social 
phobia (3 generalised) None 




al. (2004) MDD 14 (-) 
CBT  
(15-20 
sessions) FDG PET Resting state 
Met DSM-IV criteria for MDD, 
mean pre-treatment HDRS 
score 20+-3 None 
Patients with other axis 1 
disorders were excluded - 
Goldin & 
Gross (2010) SAD 14 (8) 
MBSR  
(8 sessions) fMRI 
Emotional reaction to 
negative self-beliefs Met DSM-IV criteria for SAD None 
Excluded all Axis 1 
disorders except SAD, 
GAD, agoraphobia, or 
specific phobia - 
Goldin et al. 
(2012) SAD 24 (-) 
MBSR  
(8 sessions) fMRI 
Self-referential encoding 
task (negative>self) 
Met DSM-IV criteria for SAD 
(primary diagnosis) None 
Exclusion criteria included 
thought disorders, bipolar 
depression, and alcohol or 






(spider) 16 (16) 
Group 
exposure CBT 
(1 session, 4-5 
hours) fMRI 
Symptom provocation 
(phobia vs. neutral 
images) 
Diagnosed using the MINI 
(DSM), mean score on SPQ 
pre-treatment - 23.05+-2.88 None 
Free from other lifetime 
history of psychopathology 
other than spider phobia 
24 
+-3.02 
Hölzel et al. 
(2013) GAD 15 (9) 
MBSR  
(8 weeks) fMRI 
Emotional face 
processing (angry versus 
neutral) Met DSM-IV criteria for GAD. 20% 
Comorbidities: N=4 MDD, 
n= 5 SAD. 
38.5  
+-13.3 
Kircher et al. 
(2013) PD 42 (29) 
CBT  
(12 sessions) fMRI Fear conditioning 
Met DSM-IV criteria for PD, 
PAS pre-treatment score 
25.97, HAM-A 24.38 None 
31 patients had 1 or more 
comorbidities.  Excluded 
psychotic or bipolar I 
disorder, BPD. 35.42 (-) 
Klumpp et al. 
(2013) gSAD 14 (9) 
CBT  
(12 sessions) fMRI 
Emotional face 
processing (fearful versus 
happy) 
Met DSM-IV criteria for SAD. 
Moderate to severe severity: 
pre-treatment LSAS 71.21+-
9.61 14.29% 
Excluded current MDD, 
severe depressive 
symptoms, history of 














Met DSM-IV criteria for PTSD, 
pre-treatment PTSD score 
11.7+-1.6 None 





depression, PD, phobia, 
OCD and dissociative 
disorders. - 
Månsson et 






course, n=11) fMRI 
Emotional face 
processing (disgust vs. 
neutral) 
Met DSM-IV criteria for SAD, 






group Excluded current MDD - 
Pagani et al. 







(recollection of the 
traumatic event) Met DSM-IV criteria for PTSD None Not stated - 
Prasko et al, 
(2004) PD 6 (3) 





sessions) FDG PET Resting state 
Met DSM-IV criteria for PD 
with or without agoraphobia, 
mean pre-treatment PDSS 
score 16.5+-5.05 None 
Patients with other axis 1 
disorders were excluded 31.8 (-) 
Sakai et al. 
(2006) PD 
11 (9) all 
responders 
CBT  
(10 sessions) FDG PET Resting state 
Met DSM-III-R criteria, 
median pre-treatment PDSS 
score 16 None 
Excluded: current MDD, 
bipolar, schizophrenia, 
social phobia, OCD, PTSD, 





Sankar et al. 
(2015) MDD 16 (13) 
CBT  
(16 sessions) fMRI 
Self-referential 
processing 
Met DSM-IV criteria for MDD, 
average pre-treatment HDRS 
score 21.88+-1.89 None 







(spider) 14 (14) 
Group 
CBT/exposure 
(one 4 hour 
session) fMRI 
Symptom provocation 
(phobia vs. neutral 
images) 
SPQ pre-treatment score: 
21.9+-1.7 None Not stated 
27.2 
+-9.2 
Seo et al. 
(2014) PD 14 (10) 




SPECT Resting state 
Met DSM-IV criteria for PD, 
average pre-treatment PAS 
score 24.86+-11.98 78.57% 
Patients with other axis 1 

















SPECT Resting state 
Met DSM-IV criteria for OCD, 
average pre-treatment YBOCS 
score 33.5+-4.5 100% 
Patients with other axis 1 






 23 (7) 
Group CBT  
(12 sessions) fMRI 
Negative self-referential 
processing 
Met DSM-IV criteria for MDD, 
average pre-treatment HDRS 
11.0+-4.8 100% 
Does not state (excluded 




Missing data coded (-): PTSD, post-traumatic stress disorder: OCD, obsessive compulsive disorder: (g)SAD, (generalized) social anxiety 
disorder: PD, panic disorder: MDD, major depressive disorder: SP, specific phobia: FDG PET, fluorine-18-labelled deoxyglucose positron 
emission tomography: SPECT, single photon emission computed tomography: 99mTc-HMPAO, 99mtechnetium hexamethyl-propylene-
amine-oxime :Tc-99-ECD, technetium-99m-ethyl cysteinate dimer, fMRI, functional magnetic resonance imaging: DSM, Diagnostic and 
Statistical Manual of Mental Disorders: ICD, International Statistical Classification of Diseases and Related Health Problems:  LSAS, 
Liebowitz Social Anxiety Scale: PAS, Panic and Agoraphobia Scale: PDSS, Panic Disorder Severity Scale: HDRS, Hamilton Depression 
Rating Scale: HAM-A, Hamilton Anxiety Rating Scale; YBOCS, Yale-Brown Obsessive Compulsive Scale: STAI, State-Trait Anxiety Inventory: 
SPQ, Spider Phobia Questionnaire; EMDR, eye movement desensitization and reprocessing therapy: ABM, attentional bias modification: 




Table 2-b: Regions of significant difference in brain activation change pre-to 
post-treatment  








Neural activation: Post- > Pre-therapy 
Right inferior network, 
inferior longitudinal 
fasciculus1 
30, -62, -4 1.05 0.0007 118 - 
Right arcuate network, 
posterior segment2 
40, -54, 22 1.02 0.0008 82 - 
Corpus callosum1 28, -62, 10 1.02 0.0008 19 - 
 
Neural activation: Post- < Pre-therapy 
Left anterior cingulate / 
paracingulate gyri* 
-2, 44, 4 -1.98 <0.0001 1548 10 
Left inferior frontal gyrus, 
opercular part, left 
insula3 
-50, 10, 14 -1.91 <0.0001 775 44 
Right inferior frontal 
gyrus, triangular part* 
48, 32, 20 
 
-1.92 <0.0001 761 45 
Left middle frontal gyrus4 -30, 52, 6 -1.30 0.001 101 10 
Right temporal pole, 
middle temporal gyrus5 
46, 4, -34 -1.20 0.002 64 20 
Right middle frontal 
gyrus, orbital part4 
26, 48, -14 -1.17 0.003 37 11 
MNI, Montreal Neurological Institute; SDM, seed-based d mapping; BA, Brodmann 
Area. *Clusters surviving all tests of robustness and publication bias. 1 Driven only 
by two studies: Goldin & Gross (2010) and Yamanishi et al. (2009) and funnel plots 
showed evidence of publication bias in this cluster. 2 Driven only by Yamanishi et al. 
(2009)3 Driven only by Kircher et al. (2013). 4 Driven only by two studies: Goldapple 
et al. (2004) and Yamanishi et al. (2009) and a funnel plot showed evidence of 
publication bias in this cluster. 5 Driven by Kircher et al., 2013 and Prasko et al. 
(2004) and a funnel plot showed signs of publication bias in this cluster.   
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Table 2-c: Regions of significant difference in brain activation change pre-to 
post-treatment– task-based studies only 








Neural activation: Post- > Pre-therapy 
Right and left precuneus / 
corpus callosum1* 
6, -56, 38 1.19 0.0002 995 7/23 
 
Neural activation: Post- < Pre-therapy 
Left inferior frontal gyrus, 
opercular part2 
-50, 10, 14 -1.80 <0.0001 576 44 
Left anterior cingulate / 
paracingulate gyri / right 
anterior cingulate 3* 
-8, 44, -2 -1.67 0.0001 504 10 
Left insula2 -38, 0, -10 -1.21 0.003 66 48 
Right temporal pole, 
middle temporal gyrus4 
-46, 4, -34 -1.21 0.003 64 20 
Abbreviations - MNI, Montreal Neurological Institute; SDM, seed-based d mapping; 
BA, Brodmann Area. N = 274. *Clusters surviving all tests of robustness 1 Driven by 
(P. Goldin et al., 2012). 2 Driven by Kircher et al. (2013) and eggers regression test 
showed signs of publication bias. 3 Driven by Kircher et al. (2013). 4 Driven by two 
studies: Kircher et al. (2013); Klumpp et al. (2013).  
 
In task-based studies only, all but one region survived jackknife analysis criteria (the right 
temporal pole/middle temporal gyrus, see Table 2-c). The most robust findings were the 
precuneus increased activation and ACC deactivation post-therapy, which showed no 




Table 2-d: Regions of significant difference in brain activation change pre-to 
post-treatment – resting-state studies only 








Neural activation: Post- > Pre-therapy 
Right lingual gyrus / right 
inferior network, right 
fusiform gyrus1 
22, -60, -8 1.62 0.0003 686 19 
Right arcuate network, 
posterior segment1 
40, -60, 20 1.61 0.0004 232 - 
Corpus callosum1 26, -64, 14 1.50 0.001 23 - 
 
Neural activation: Post- < Pre-therapy 
Right middle frontal 
gyrus, right inferior frontal 
gyrus * 










Right middle frontal 
gyrus, orbital part1 
30, 46, -18 -2.31 0.0000
6 
279 11 
Right anterior cingulate / 
paracingulate gyri / left 
anterior cingulate1 
4, 50, 12 -2.13 0.0002 250 32 
MNI, Montreal Neurological Institute; SDM, seed-based d mapping; BA, Brodmann 
Area. N=78. *Cluster surviving all tests of robustness. 1 Driven by Yamanishi et al. 
(2009).  
 
In resting state studies only, none of the above clusters showed signs of publication bias 
in visual inspection of funnel plots and none had significant Egger regressions (see Table 
2-d). Due to few studies meeting eligibility for this analysis (n = 5), the only cluster 
meeting our criteria for robustness, surviving all iterations of the jackknife sensitivity 




2.3.3 Prediction results 
Eleven whole brain pre-treatment neuroimaging prediction studies (n = 293 patients) 
meeting eligibility criteria were included in this analysis (see Table 2-e for study 
descriptions). All studies had looked at pre-treatment neural activation in relation to 
change in scores on measures of symptom severity. The studies comprised the following 
patient groups: PTSD (n = 2); social anxiety disorder (n = 5); OCD (n = 2); MDD (n = 
1) and panic disorder (n = 1). 
Only one cluster survived jackknife sensitivity analysis (a cluster with peak coordinates in 
the right cuneus cortex which extended into the right superior occipital gyrus and right 
middle occipital gyrus); jackknife analysis revealed the other clusters were not robust. We 
report the results of all clusters in Table 2-f and Figure 2-b. Evidence of publication bias 
was observed in all clusters’ funnel plots which was supported by an Egger regression test 
with trend significance for the cluster of decreased activation (t(1, 10) = -2.17, p = 
0.055). 
 There were too few studies that met our eligibility criteria to perform meta-regressions 
(Radua et al., 2010) to study heterogeneity between disorders, therapies or 
methodologies (all but one study was task-based). When the meta-analysis was re-run on 
only studies which had used a task during scanning (n = 10), the four significant clusters 
as per the original analysis remained unchanged.  
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Aupperle et al. 













11 met full and 3 partial 
DSM-IV criteria, score>=30 
on CAPS, average pre-










Burklund, et al. 









Met DSM-IV criteria for 
primary/co-primary SAD and 
clinical severity rating of 









Carl et al. 








Met DSM-IV-TR criteria for 
MDD, pre-treatments HDRS 
score of ≥15 None 
Excluded current 
suicidal ideation, 
anxiety and mood 
disorders other than 
unipolar depression or 
dysthymia, psychosis, 
substance disorders, 







al. (2013) gSAD 39 (14) 
Group CBT 




Met DSM-IV criteria for SAD, 
pre-treatment LSAS score of 
81.8+-13.4 None 
13 participants had 
comorbid anxiety 
disorders (6 GAD, 5 
SP, 3 anxiety disorder 







Falconer, et al. 
(2013) PTSD 13 (8) 
CBT 
(8 sessions) fMRI 
Executive Inhibition 
(Go/No-Go task) - 46.15% 
Excluded history of 
psychosis or BPD.  
Comorbidities 
included: MDD 






Klumpp et al. 







Met DSM-IV criteria for gSAD, 
moderate to severe severity: 














did not exclude 
comorbid anxiety 
disorders, SP (n=3), 
GAD (n=3), PD 
(n=1) 







resolutions (fear vs. 
neutral) 
Met DSM-IV criteria for gSAD 
as primary complaint. 
Baseline LSAS 74.3+-14.9 None 
Comorbid disorders 
not excluded: 10 
GAD, 2 PD, 2 MDD, 4 
dysthymia, 3 SP, 1 







Klumpp et al., 





versus looking at 
negative images) 
Met DSM criteria for SAD 
(primary diagnosis), 
moderate to severe: pre-
treatment LSAS 77.7 +-14.0 None 
Comorbid disorders 
not excluded: 11 
GAD, PD 4, SP 3, 







Olatunji et al. 





Inpatients.  Met DSM-IV 













Reinecke et al. 
(2014) PD 14 (10) 
CBT (4 
sessions) fMRI Emotion regulation 
Met DSM-IV criteria for PD (8 
with agoraphobia) None 
Comorbidities: 3 SP, 1 
SAD.  Excluded 
current or past 






Yamanishi et al. 







SPECT Resting state 
Met DSM-IV criteria for OCD, 
average pre-treatment YBOCS 
score 33.81 (combined group 
mean calculated) 100% 
Patients with other 
axis 1 disorders were 




Missing data coded (-): PTSD, post-traumatic stress disorder: OCD, obsessive compulsive disorder: (g)SAD, (generalized) social anxiety 
disorder: PD, panic disorder: Tc-99-ECD SPECT, technetium-99m-ethyl cysteinate dimer single photon emission computed tomography: 
fMRI, functional magnetic resonance imaging: DSM, Diagnostic and Statistical Manual of Mental Disorders: LSAS, Liebowitz Social Anxiety 
Scale: YBOCS, Yale-Brown Obsessive Compulsive Scale: CBT, cognitive behavioural therapy: CAPS, Clinician-Administered PTSD Scale for 
DSM: ACT, acceptance and commitment therapy: ACQ, Agoraphobia Conditions Questionnaire: BATD, Behavioural Activation Therapy for 
Depression: MDD, major depressive disorder: BDI, Beck Depression Inventory. 
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Table 2-f: Regions significantly predicting symptomatic improvement  








Increased activity associated with greater symptomatic improvement 
Right cuneus cortex1 10, -92, 14 1.74 0.0004 1066 18 
Left median cingulate 
/ paracingulate gyri / 
left anterior cingulate2 
-4, 26, 36 1.81 0.0002 411 24 
Right frontal orbito-
polar tract3 
20, 36, -14 1.66 0.0007 96 - 
 




-44, -2, 52 -1.09 0.0003 326 6 
MNI, Montreal Neurological Institute; SDM, seed-based d mapping; BA, Brodmann 
Area. 1 Driven by Doehrmann et al. (2013) only. 2 Not significant when Carl et al. 
(2016) and Klumpp et al. (2016) were excluded. 3 Not significant when Klumpp et 
al. (2014) and Yamanishi et al. (2009) were excluded. 4 Not significant when Klumpp 
et al. (2014) and Olatunji et al. (2014) were excluded. 
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Figure 2-b: A) Results of longitudinal meta-analysis showing brain activation 
changes pre-to post- psychological therapy; B) Results of prediction meta-
analysis, pre-treatment activation associated with subsequent symptomatic 
improvement   
Blue areas denote regions where there was decreased activation – in Figure 2A) 
decreased activation post- versus pre-therapy and in Figure 2B) lower baseline 
activation associated with greater symptomatic improvement. Yellow areas denote 
regions where increased activation was found – in Figure 2A) increased activation 
post-versus pre-therapy and in Figure 2b) higher baseline activation associated with 







These meta-analyses examined changes in brain activation associated with psychological 
therapy and neuroimaging predictors of subsequent treatment response in both 
depression and anxiety disorders. Since the publication of similar reviews and meta-
analyses in this field (for example, (Fu et al., 2013; Lueken & Hahn, 2016; Messina et al., 
2013) there have been a considerable number of new publications. We used an improved 
analysis method which has various strengths compared to other neuroimaging meta-
analytical techniques (Radua et al., 2014). We implemented a thorough and conservative 
approach to identify only the most robust findings within this heterogeneous literature 
and papers were assessed for suitability more rigorously than previous reviews to ensure 
that only papers reporting whole brain data were included.  
2.4.1 Longitudinal findings 
The most robust findings were that psychological therapies resulted in decreased 
activation, post- compared to pre-therapy, in clusters with peak co-ordinates in the left 
ACC, inferior frontal gyrus (bilaterally) and left insula. It is important to note that studies 
had typically included both responders and non-responders in their analyses and 
therefore the changes are not indicative solely of treatment response. Due to our jackknife 
analyses, which indicated evidence of consistency in the findings across studies, the 
results appear to show brain activation changes which are consistent across psychological 
therapies and are trans-diagnostic. However, it is important to highlight that these 
findings do not signify that there are not changes in activation that are specific to types 
of psychological therapy or able to differentiate between disorders and their subtypes. 
There were currently, however, too few studies to study disorder- or treatment-specific 
brain activation changes via meta-regressions. Additionally, it would be difficult to 
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confidently study one disorder in isolation from another due to high levels of comorbid 
Axis I disorders in the patient samples (see Table 2-a).  
The meta-analyses were run separately on task and resting-state studies due to evidence 
that paradigm type can substantially effect results (Fu et al., 2007; Messina et al., 2013; 
Palmer et al., 2015; Whitfield-Gabrieli et al., 2011). Our subgroup analysis revealed 
substantial differences between these paradigms, highlighting the importance for future 
reviews in this field to consider the two separately. 
A decrease in ACC activity post-therapy was a common finding across both resting state 
and activation paradigms. This result is in agreement with a recently published systematic 
review on brain activation changes with CBT, which summarises that the most consistent 
finding is decreased dACC activity (Franklin et al., 2016). 
As with the Messina meta-analysis, we did not find dlPFC involvement despite this region 
being associated with attentional control and emotional regulation (Hofmann et al., 2012; 
Kane & Engle, 2002; Owen et al., 2005; Wager & Smith, 2003). This could be due to an 
insufficient number of studies in our meta-analyses to demonstrate this effect and an 
inconsistency between the designs of included studies. We did find significant effects 
elsewhere in prefrontal brain regions which suggests that involvement of the PFC in 
affective disorders may be complex and not attributable to a single region as has been 
suggested previously (Fitzgerald et al., 2006; Thomas & Elliott, 2009). 
2.4.1.1 Implications for the dual process model 
If psychological therapies were to normalise top-down prefrontal control as hypothesised 
in the dual process model, one would expect increased activity in prefrontal regions and 
consequently to this, decreased activity in the limbic network. The decreased activation 
we found in limbic regions (the left ACC and left insula) is consistent with this emotional 
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regulation model of depression and anxiety. However, the decreased activation we found 
bilaterally in the inferior frontal gyrus runs counter to this, as the theory proposes 
increased activation in pre-frontal regions. 
Despite these findings being at odds with the model, they do not necessarily undermine 
its credibility. Decreased prefrontal activity, particularly in resting-state studies, may 
signify an enhanced capacity for top-down regulation when required i.e., these areas were 
dysregulated but regained the capacity to respond appropriately and are ‘better’ utilised 
when necessary after psychological therapy.  
The dual process model is appealing due to its parsimony and fitting with the theoretical 
modes of action we would expect from treatments for affective disorders. For example, 
CBT is proposed to improve emotional regulation by challenging negative cognitions and 
improving conscious emotional regulation. We would therefore expect greater cognitive 
control to be evident in prefrontal conscious emotional-regulation brain regions. 
However, the model may be too simplistic as it ignores any compensatory changes in 
functioning that may be occurring. This more complex model has been proposed by 
Willner et al. (2013) in relation to the mode of action of antidepressants, but we suggest 
that there are also likely to be compensatory, as well as normalising, mechanisms involved 
with psychological therapies.  
Additionally, it is unlikely that the effects of psychological therapies can be solely 
represented by cognitive control and voluntary emotional regulation with a linear 
relationship between prefrontal and limbic regions. Messina et al. proposed an alternative 
neural model of action of psychological therapy, albeit with a focus on psychodynamic 
therapy models (Messina et al., 2016). They highlighted that the dual process model 
ignores that psychodynamic therapy aims to regulate emotional states, not only by 
strengthening executive control but through the resolution of early childhood parental 
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interactions and challenging negative representations of the self and others in 
relationships. They therefore postulated that one should expect direct changes in DMN 
and implicit emotional regulation regions which are involved in self-referential 
processing. Their model may also be applicable to other psychological therapies which 
place importance on directly challenging negative self-views. 
2.4.1.2 Comparison to antidepressants 
Psychological therapy is vastly understudied compared to the neural correlates of 
antidepressant medication. Ma (2015) conducted a meta-analysis of the neural correlates 
of antidepressants which included 60 studies (n=1,569). They found decreased activation 
in the ACC, amygdala and thalamus and increased activation in the dlPFC with 
antidepressant medication. Their results therefore fit well with the dual process model 
which hypothesises that antidepressants act more directly on the emotional, limbic 
network whereas psychological therapies primarily target prefrontal function by 
increasing inhibitory executive function. However, we found evidence of reduced 
activation in the emotional network with psychological therapies and therefore 
differentiation between treatment modalities may be more complex than proposed in the 
dual process model. It could be that, rather than results reflecting the effects of specific 
therapies, findings reflect processes of recovery more generally. Further studies directly 
comparing treatment modalities are required to explore how far changes reflect general 
as opposed to treatment-specific modes of recovery. A meta-analysis comparing treatment 
modalities would also be beneficial in this regard. Studies with a more frequent follow up 
throughout the course of treatment would enable us to more rigorously test the dual 
process model to see if there is a differential primary action between treatment modalities. 
Additionally, work using dynamic causal modelling of fMRI data or transcranial magnetic 
stimulation (TMS) could further allow us to determine the causal direction of results. 
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2.4.2  Prediction findings 
In terms of the prediction data, our analyses show there to be inconsistency between study 
results and too few published studies at present to determine robust predictors of 
symptomatic improvement with psychological therapy. Speculatively, this could imply 
that prediction is more disorder or treatment specific. We found one area, the right cuneus 
cortex, whose greater activation at baseline was associated with greater symptomatic 
improvement. This extrastriate region has been implicated in response inhibition, in 
particular those involving motor reactions (Booth et al., 2005; Matthews et al., 2005). 
The cuneus forms part of the DMN, and has been found to be abnormally activated in 
depression (Greicius et al., 2009). In a study included in these meta-analyses on the 
neural correlates of mindfulness-based stress reduction, the authors speculated that their 
observed increase in cuneus activation post-therapy could be due to the patients being 
less visually avoidant of negative self-beliefs and imagery, or alternatively reflect patients 
engaging in enhanced visual attention during scanning post-treatment (Goldin & Gross, 
2010). 
We hypothesised that increased baseline ACC activation would be associated with 
symptomatic improvement, in line with previous reviews (Fu et al., 2013, Lueken & Hahn, 
2016). We did find that elevated left ACC activation was associated with greater 
symptomatic improvement; however, this region did not meet our criteria for robustness. 
Our failure to find this robustly could be due to the small number of studies included in 
this analysis and between study heterogeneity. Indeed, Lueken and Hahn 2015 note in 
their systematic review that the direction of predictive effects of anterior cingulate activity 
was dependent both on the type of functional imaging paradigm used and the specific 
psychological treatment received. Therefore, anterior cingulate activation could have 
been masked in this meta-analysis by cancelling out both positive and negative effects 
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found in this brain region. Currently, however, there were too few studies to allow 
exploration of the effects of task on this analysis. 
2.4.3 General strengths and limitations of the meta-analyses 
Although these meta-analyses present a comprehensive summary of the evidence base so 
far in this field, the results should be considered cautiously. The present literature is small 
meaning the influence of between study heterogeneity, other than paradigm type, could 
not be assessed through meta-regressions. 
Between-study heterogeneity could have influenced the results of these analyses in 
several ways. Firstly, all functional neuroimaging designs were included ranging from 
resting-state to emotionally distressing or cognitively demanding tasks. Although we did 
control for resting-state versus task-based methodology to increase specificity in findings, 
even the type of task can have a great effect on the neural activation detected (Fu et al., 
2007; Palmer et al., 2015). However, by adopting inclusive eligibility criteria for 
paradigm type, this will have increased power given the paucity of research in this field 
and allowed greater generalisability of global results to broad neurobiological models. 
Secondly, the included studies comprised patients with a range of disorders, 
comorbidities, and symptom severity, another source of within-study variability. Thirdly, 
we would expect that the specific neural changes occurring with therapy would differ 
according to the type of psychological therapy the patient received (for example, as has 
been found with studies directly comparing different therapies (Burklund et al., 2017; 
Månsson et al., 2013). Finally, we included SPECT, PET and fMRI scanning 
methodologies. These methods differ in their measurement of brain activity, temporal and 
spatial resolution. Therefore, it is plausible that findings from the various modalities could 
differ considerably. However, all included PET and SPECT studies used radiotracers to 
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measure regional brain glucose metabolism, which is the measurement most related to 
fMRI BOLD signal.  Additionally, we only included studies where participants fulfilled full 
diagnostic criteria. Although warranted, given the scope of these meta-analyses, the 
results may not be generalisable to those individuals who evidence subthreshold clinical 
anxiety or depression.  
Despite considerable heterogeneity in study designs which these meta-analyses illustrate, 
patients in the included studies were typically in the moderate to severe range of severity, 
most therapies were cognitive and/or behavioural in nature, and a negative emotional 
scanning paradigm was primarily used. Commonalities did emerge, and we were able to 
demonstrate some consistent findings.  
Another limitation is that we only included results of the patient group who received 
therapy. Care should be taken when considering the results of these meta-analyses, and 
indeed studies in this area, as effects are unlikely to be solely attributable to the treatment 
under investigation and may in part be due to spontaneous remission or concomitant 
therapies. This problem could be ameliorated by the inclusion of a placebo arm (for 
example, in the case of psychological therapy, one-to-one non-therapy sessions or wait-
list control groups). Although fully balanced designs, with control groups who also receive 
scans at both time points, are best practice in order to appropriately model the effect of 
repeated scans and other non-treatment related factors (Dichter et al., 2012), including 
only these studies was not within the capacity of these meta-analyses in order to maximise 
the number of suitable studies. Many studies had either not included a control group or 
had scanned controls only once at baseline.  
Additionally, as with all meta-analyses, the potential influence of publication bias should 
be considered when interpreting the results. Although, in our longitudinal meta-analysis, 
we did not show any evidence of this, there were signs of publication bias in the prediction 
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of treatment response meta-analysis. Also, our reliance on including only peak co-
ordinates reported in published papers does not provide the level of detail that statistical 
parametric maps or individual-level data would. Indeed, if a study did not find any 
significant whole brain results, they were assumed to have an effect size of 0 which may 
not be justified.  
2.4.4 Overall conclusion 
In conclusion, our meta-analyses provide a summary of the evidence to date. Although 
the literature is relatively small, there do appear to be some consistent brain activation 
changes with psychological therapy across depression and anxiety disorders. However, 
neural changes that are robustly predictive of treatment response remain elusive. We 
suggest that more research is required to form definitive conclusions in order to benefit 
patients at an individual level by tailoring treatment according to likely response and 
understanding treatment mechanisms in order to improve treatments.  
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Chapter 3: General Methodology 
 
3.1 Study designs 
This work included two pilot studies to assess the utility of novel methods to assess self-
reflection and threat avoidance in depression and anxiety: 
 Study 1 – An MRI study where patients, with major depression and varying degrees of 
clinical anxiety, and healthy controls completed a series of structural and functional brain 
scans including the Joystick Operated Runway Task (JORT) and Fake IQ test. Participants 
also completed the JORT and Fake IQ test offline (i.e. outside of the scanner). 
Study 2 - A behavioural study where participants completed the JORT and Fake IQ test 
offline before and after a course of CBT to determine associations between task 
performance and treatment response. 
3.2 Participants  
Study 1  
40 right-handed participants aged 18-65 years were recruited from the community in 
South London via waiting lists of local psychological therapy services and using online 
advertisements (the utility of various recruitment methods in this study has been 




Table 3-a: Participant baseline characteristics, Study 1 






Age (years) 31.6 (10.4) 31.6 
(10.0) 
t = .015 
Gender (F/M) (n)  13/7 13/7 χ2 = 0 
Ethnicity 
(white /black /Asian or 
other) (n) 
13/2/5 14/5/1 χ2 = 4.0 
Employment status (full-
time/part-time/ 
unemployed / student) (n) 
2/2/10/6 8/6/1/5 χ2 = 13.1* 
BMI (kg/m2) 23.7 (4.9) 25.4 
(5.2) 
t = -1.0 
HDRS-17 19.2 (3.6) 1.0 (1.4) t = 21.0** 
HARS 23.0 (5.9) 1.0 (1.2) t = 16.4** 
Number previous episodes 
(median, interquartile 
range) 
4 (3) N/A - 
Current episode duration 
(months) 
20.0 (26.3) N/A - 
Current episode failed 
adequate antidepressant 
treatment trials (n) 
5 (4 participants 
with 1, 1 participant 
2) 
N/A - 
Comorbidities (n) Total with 1(+) 
comorbidity: 13. 
GAD (9), OCD (3) 
PTSD (2), (g)SAD 
(6), PD (1) 
N/A - 
Results are reported as mean (standard deviation) except where otherwise stated. 
* p<.05, ** p <.0001. Abbreviations - F, female; M, male; BMI, Body Mass Index; 
HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety Rating Scale; 
GAD, Generalised Anxiety Disorder; OCD, Obsessive Compulsive Disorder; PTSD, Post-
traumatic Stress Disorder; (g)SAD, (generalised) Social Anxiety Disorder; PD, Panic 
Disorder (with or without agoraphobia).  
At study entry, all patients met current DSM-IV criteria (American Psychiatric Association, 
2013) for major depressive disorder or episode, as determined by clinical interview based 
on the Mini International Neuropsychiatric Interview, Version 5.0 (MINI 5.0) (Sheehan 
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et al., 1998). Co-morbid Axis I anxiety disorders, as diagnosed by the MINI 5.0, were 
allowed alongside major depression. Depression severity was assessed using the 17-item 
Hamilton Depression Rating Scale (HDRS-17, Hamilton, 1960) and a score of 14 or 
greater required for inclusion. A diagnosis of bipolar disorder (I or II) or current psychosis 
(assessed using the MINI 5.0), borderline personality disorder (determined via the 
Structured Clinical Interview for DSM-IV Axis II disorders (First & Gibbon, 2004) or self-
report of a formal diagnosis by a psychiatrist) were exclusion criteria. 
Handedness was assessed using the Edinburgh Handedness Inventory (Oldfield, 1971). 
Patients were not receiving any form of treatment (psychotropic or psychological) at the 
time of scanning and had been psychotropic medication-free for at least 8 weeks prior to 
inclusion. Age, gender and handedness matched healthy controls were assessed to 
exclude personal and familial (first-degree relative) psychiatric history. 
All participants were required to have no neurological disorders, for example dementia, 
known cerebral lesions, head trauma resulting in loss of consciousness, learning 
disabilities e.g. dyslexia, or un-correctable visual problems. Additional exclusion criteria 
for all subjects included illicit substance use in the preceding two months, no current 
(within 12 months of study entry) alcohol or other substance abuse (as determined via 
the MINI 5.0), unstable or severe medical conditions, any treatment with potential 
psychotropic properties or interference with participants’ safety or data interpretation, 
pregnancy, or other contraindications for scanning.  
Study 2 
The above inclusion criteria applied to patients entering the behavioural arm of the study 
with the exception that current psychotropic medication did not exclude participants, nor 
did left-handedness. An additional inclusion criterion for behavioural participants was the 
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requirement for patients to be waiting for, but not yet started, one-to-one CBT. All 
participants were followed up as close as possible after completing their course of CBT.   
Recruitment to the two studies happened in parallel. Participants in Study 1 completed 
the Fake IQ test and JORT offline as well as in the scanner and therefore 9 participants 
from Study 1 are also included in Study 2 as they were waiting for a course of CBT at the 
time of enrolling in the study and subsequently completed a course of CBT (see Figure 3-
a for flow chart of patient recruitment into the two studies). 
24 participants were recruited into the behavioural arm of the study (mean age 36.28 ± 
13.12 years, 15 females). See Table 3-b for participant characteristics. Twenty-two 
participants completed a course of CBT with their local Improving Access to Psychological 
Therapies (IAPT) service, one participant with a Community Mental Health Team, and 
another with their University counselling service. The number of sessions of one-to-one 
CBT that participants received varied greatly, ranging from 6 to 28 sessions (mean 11.6+-
5.0). NICE guidelines state that patients receiving high intensity CBT should typically 
receive 16-20 sessions over 3-4 months (NICE, 2009). The guidelines also state that for 
those with mild to moderate depression (the mean HDRS-17 score of this sample is in the 
moderate range (Zimmerman et al., 2013)), 6-8 sessions should be sufficient delivered 
over 9 to 12 weeks. Therefore, all patients included met the minimum criteria of 6 sessions 
according to NICE guidelines; however, for some patients the CBT they received may have 
been suboptimal according to recommended guidelines dependent on their severity.  
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Figure 3-a: Flow chart of patient recruitment to Studies 1 and 2 
 
Abbreviations – MRI, Magnetic Resonance imaging; DSM-IV, Diagnostic and 
Statistical Manual, 4th Edition; MDD, Major Depressive Disorder; HDRS-17, 17 item 
Hamilton Depression Rating Scale.  
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Table 3-b: Participant baseline characteristics, Study 2 
 Patient  
(n=24) 
Ethnicity 
(white /black /Asian or other) (n) 
16/1/7 
Employment status (full-time/part-
time/ unemployed / 
student/retired) (n) 
7/4/8/4/1 
BMI (kg/m2) 24.87 (4.89) 
HDRS-17 19.46 (4.23) 
HARS 24.63 (7.94) 
Number previous episodes (median, 
interquartile range) 
4 (4) 
Current episode duration (months) 33.90 (40.62) 
Current episode failed adequate 
antidepressant treatment trials (n) 
11 (7 participants with 1, 3 
participants with 2 and 1 
participant with 4) 
Comorbidities (n) GAD (10), OCD (2), PTSD 
(4), (g)SAD (12), PD (10) 
Currently taking psychotropic 
medication 
8 




Responders (MÅDRS >=50% 
reduction) (n) 
10 
Remitters (MÅDRS score of 7 or less 
post-therapy) (n)  
5 
Results are reported as mean (standard deviation) except where otherwise stated. 
Abbreviations - F, female; M, male; MÅDRS, Montgomery Åsberg Depression Rating 
Scale; HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety Rating 
Scale; GAD, Generalised Anxiety Disorder; OCD, Obsessive Compulsive Disorder; 
PTSD, Post-traumatic Stress Disorder; (g)SAD, (generalised) Social Anxiety Disorder; 
PD, Panic Disorder (with or without agoraphobia). 
 
3.3 Ethical approval 
Ethical approval was granted by the London-Bromley Research Ethics Committee 
(reference: 13/LO/1897) and R&D approval received from the South London and 
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Maudsley NHS Foundation Trust (reference: R&D2014/011). All participants provided 
informed written consent and received financial compensation for taking part. 
 
3.4 Study procedures 
The participants involved in Study 1 completed all measures that participants in Study 2 
did but with the addition of fMRI. Participants attended the following study visits: 
1) Screening assessment to determine eligibility and baseline visit 
2) fMRI scan for participants in Study 1 (in Study 2, a course of CBT though nine 
participants from Study 1 were also included in Study 2 due to receiving CBT) 
3) Follow-up (post-CBT in Study 2 patients and in Study 1 participants after a similar 
length of time if not receiving CBT, mean =15.6 +- 6.6 weeks) 
In addition to the MINI 5.0 and HDRS-17 to determine eligibility, participants completed 
the following clinical assessments at baseline and follow-up:  
• The Hamilton Anxiety Rating Scale (HARS): a 14-item clinician-rated measure of 
anxiety severity. Items, including psychic and somatic anxiety symptoms, are rated 
on a 5-point scale from 0 (not present) to 4 (severe) (Hamilton, 1959). 
• The Montgomery-Åsberg Depression Rating Scale (MÅDRS): a clinician-rated 10-
item measure of depression severity with each item rated from 0-6, higher scores 
indicating greater severity (Montgomery & Asberg, 1979). Response to therapy 
was defined using the widely accepted criteria of a 50% or greater reduction in 
MÅDRS scores (post- compared to pre-therapy) and remission defined as a post-
treatment MÅDRS score of seven or less (as found by Riedel et al., 2010 to be the 
best definition of remission). As is best practice, a different measure of symptom 
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severity was used for inclusion (the HDRS-17) and response (the MÅDRS). The 
MÅDRS was selected as the measure for response and remission as it has been 
shown to have a better sensitivity for detecting symptom change than other 
measures of depression severity (Montgomery & Asberg, 1979).  
 
3.5 Scanning procedure and methodology 
In Study 1, structural and functional images were acquired on a 3-Tesla GE MR750 
scanner (GE Medical Systems, Milwaukee, Wisconsin) with a 12-channel radiofrequency 
head coil at the Centre for Neuroimaging Sciences, King’s College London. The structural 
sequence comprised a high-resolution sagittal Magnetisation Prepared Rapid Acquisition 
GRE 3D Inversion Recovery (MP-RAGE) anatomical reference image: inversion time = 
400 milliseconds (ms); echo time (TE) = 3.016 ms; repetition time (TR) = 7.312 s; flip 
angle 11°; slice thickness = 1.2 mm (196 contiguous slices). These T1-weighted gradient 
echo structural images were normalised and segmented into grey matter, white matter, 
and cerebrospinal fluid. Images were inspected for artefacts, for example motion and 
inhomogeneity, before and after normalisation. 
Before scanning, participants underwent a session in a mock MRI scanner to explain and 
demonstrate the equipment to be used, including a head coil and scanner sounds 
presented through headphones to acclimatise participants to the scanning environment. 
Studies have shown that familiarising patients with the scanning environment in a sham 
scanner reduces anxiety during scanning (Rosenberg et al., 1997). This was therefore 
especially important in our patient population where problems, for example, 
claustrophobia and panic symptoms, may have been magnified. 
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After the structural scan, participants completed three functional scans (as detailed in 
Table 3c). Functional MRI is a technique for measuring haemodynamic changes resulting 
from neural activity in the brain, an indirect measure of brain activation. The tasks 
reported in this thesis measured functional activation via blood-oxygen-level-dependent 
(BOLD) signals. BOLD signal is linked to brain activation as blood releases oxygen to 
active neurons at a greater rate than inactive neurons, a process called haemodynamic 
response (Ogawa & Lee, 1990; Ogawa et al., 1990). The level of oxygenated and 
deoxygenated haemoglobin affects the signal strength in MRI due to their different 
magnetism.  





JORT Fake IQ Task 
fMRI task order 1st 2nd 3rd 
Number of slices 33 41 41 
Slice thickness / gap (mm) 3.8/0/4 3/0.3 3/0.3 
Area of brain to be covered Whole brain Whole brain Whole brain 
FOV (cm2) 24 24 24 
TR (ms) 2300 2000 2000 
TE (ms) 12.7/31/48 30 30 
Flip Angle (degrees) 75 75 75 
Number of images per location 540 180 338 
Total scan time (mins) 08:15 18:14 11:17 
Abbreviations - JORT, Joystick Operated Runway Task; FOV, field of view; TR, 
repetition time; TE, echo time; fMRI, functional magnetic resonance imaging.  
 
In addition to the functional imaging tasks, where BOLD signal is measured over the 
course of a specific task, participants completed a resting-state scan. Paradigm free, or 
resting-state, imaging studies allow functional connectivity correlations in Blood Oxygen 
Level Dependent (BOLD) signal in time series to be explored (Biswal et al., & Hyde, 
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1995). These studies have been key in identifying functional networks between brain 
regions i.e., areas that are spatially dispersed but functionally correlated (Cordes et al., 
2000; Greicius et al., 2003). The large-scale patterns of correlated activity between distant 
brain regions, so called networks due to the assumption that they have physical 
connections, reveal neural systems that have coherent activity over time and which are 
thought to demonstrate distinct cognitive functions (Bullmore & Sporns, 2009; Fox & 
Raichle, 2007; Honey et al., 2007; Smith et al., 2009). These connectivity signals have 
been found to be related to neural activation and structural connectivity, and therefore 
are unlikely to simply result from noise in the data (Bullmore & Sporns, 2009; Fox & 
Raichle, 2007; Honey et al., 2007; Smith et al., 2009). In comparison to functional 
connectivity which infers connectivity through correlations in brain activity, structural 
connectivity maps anatomical white matter tracts between brain regions using methods 
such as diffusion imaging (Gong et al., 2009). 
Resting state analysis was also conducted in an independent validation sample of 
participants with major depression recruited into a separate study. Ethical approval and 
funding for this separate study was granted by the Bromley NHS Research Ethics 
Committee. All subjects provided written informed consent and were compensated 
financially for taking part in the research. This study was funded by an Academy of 
Medical Sciences grant (grant code: SGCL8). 
This sample included right-handed patients with unipolar depression and healthy 
controls, matched by age, sex and handedness. As with Study 1, all patients met DSM-IV 
current criteria for major depression, determined by clinical interview with a psychiatrist 
using the MINI 5.0 (Sheehan et al., 1998) and had a minimum score of 18 on the MÅDRS 
(Montgomery & Asberg, 1979) (all participants in Study 1 also met this severity criteria). 
To ensure inter-rater reliability between the samples’ raters, the two raters were trained 
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on an independent sample of patients and showed high levels of inter-rater reliability on 
the MÅDRS (intraclass correlation coefficient = 0.96, p = .004). 
Unlike in Study 1, where comorbid anxiety disorders were allowed alongside major 
depression, comorbid conditions were excluded in this validation sample. Additionally, 
patients were excluded if they reported any illicit substance use in the previous two 
months, had any physical health conditions or took any medication that could result in 
psychiatric symptoms. 
As with Study 1, patients in Sample B were recruited from the South London area through 
public advertisements and from wait-lists of local psychological therapy services (Wise et 
al., 2016). All patients were medication-free for at least 2 weeks (4 weeks for fluoxetine) 
before scanning and were not currently undergoing any psychological therapy. Healthy 
control participants were recruited from the community using online advertisements, and 
reported no current or past psychiatric diagnoses, and no history of psychiatric illness in 
first-degree relatives. Participants reporting history of head injury, major medical illness, 
pregnancy or any other contraindications for scanning were excluded. 
 
3.6 Statistical analysis 
Behavioural data were analysed using SPSS Version 24.0 (SPSS Inc. Chicago, US). Group 
differences were assessed with independent-samples t-tests for continuous data and chi-
square tests for categorical data. Analyses of the associations between CBT and task 
measures or questionnaire ratings were conducted using repeated measures ANOVAs to 
determine if these measures are associated with differences pre- to post- therapy between 
treatment responders and non-responders. This type of responder versus non-responder 
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analysis was chosen over continuous measures of symptomatic change as it is clinically 
useful to know if the measures are associated with response.  
In fMRI analyses, multiple comparisons were corrected for and only brain regions 
surviving multiple corrections, or a predefined limit on cluster-size, are reported as 
definite results. Findings are reported throughout this thesis in standard Montreal 
Neurological Institute (MNI) anatomical space.   
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Chapter 4: The Fake IQ test: a novel, direct 




Excessive negative self-referential processing is a common feature of psychiatric 
disorders, yet discerning whether it is a cause or effect of illness remains a challenge as 
the tools available for measuring self-reflection are limited to self-report questionnaires 
or reliance on invoking emotional states. Here we present an objective measure of self-
reflection, the Fake IQ Test. This computerised task measures self-reflection by presenting 
participants with sets of items that are described to them as testing an intelligence 
construct known as “visual perception ability”. This construct is fictitious and after each 
set of items, participants are asked to estimate their total number of correct answers, 
whether their performance was better or worse than average, and whether they were 
satisfied with their performance. The design of the task’s items means there are no right 
or wrong answers and so perceived differences in performance between subjects reflect 
individual differences in self-perception. 
We piloted the Fake IQ test in patients with major depressive disorder and comorbid 
anxiety and healthy controls as an fMRI and behavioural task. Behaviourally, 30 patients 
                                               
1 The behavioural results in this chapter, comparing patients versus controls performance on the 
Fake IQ test have been adapted from the following publication on which I am joint first author: 
Patrick, F., Marwood, L., Corfield, F., Cardi, V., Cleare, A. J., & Perkins, A. M. (Under Review). The 
Fake IQ Test: an objective measure of self-criticism. 
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and 20 healthy controls completed the task. We found elevated negative self-comparison 
to others, higher self-dissatisfaction, and lower perceived success in depressed patients 
relative to controls on the task. A subset of patients (n=15) completed the task both 
before and after a course of cognitive behavioural therapy to determine associations 
between this measure and treatment response. Therapy responders were not found to 
have significant differences in task subscale scores compared to non-responders at either 
baseline or post-therapy assessment. Additionally, there were no significant differences 
over time, pre- to post- therapy, on any of the task’s subscales. 
Thirty-five participants completed the Fake IQ test during MRI scanning (16 patients and 
19 healthy controls). A main effect of task was found with greater activation in self-
reflection versus control conditions bilaterally in the inferior frontal cortex, insula, 
dorsolateral prefrontal cortex, motor cortex and dorsal anterior cingulate cortex. 
However, there were no significant differences between patients versus controls in neural 
activation on the task, nor correlations between brain activity and measures of self-
reflection.  
Additionally, no relationship was found between scores on the FIQT and questionnaire 
measures of self-reflection in behavioural testing, suggesting the FIQT measures an aspect 
of self-reflection inaccessible to current questionnaires. We therefore propose the FIQT as 
an alternative to traditional self-report measures of self-reflection, with application to 
multiple patient groups and experimental paradigms, including drug and tentatively 
neuroimaging studies. Future work should study the task in a variety of psychiatric 





As described in the introductory chapter (Chapter 1), maladaptive self-reflection appears 
as a key feature in mental health pathology. Self-reflection can be considered as a 
spectrum, ranging from pathologically negative and elevated levels in MDD, anxiety and 
eating disorders (Blatt, 2004; Dunkley & Grilo, 2007) through more positive and normal 
levels of self-reflection (for example, self-reassurance and compassion) observed in 
healthy populations (Bradley et al., 2016), to diminished levels in conditions such as 
autism and schizophrenia (Philippi & Koenigs, 2014). 
Self-reflective cognitions are often assessed via global self-report measures, such as the 
Forms of Self-Criticising/Attacking and Self-Reassuring Scale (Gilbert et al., 2004). These 
relate to general experiences without contextual definitions (e.g. “I find it difficult to 
control my anger and frustration at myself”). A concern with self-report questionnaires is 
the potential for self-bias (Iancu et al., 2015) and due to their reliance on semantic, 
autobiographical memory, their output is dependent on accessible memories which may 
be influenced by personal expectations and beliefs (Rosenberg et al., 2016). These 
measures may be particularly inaccurate and insensitive to change in clinical populations 
with decreased insight as they depend on awareness of the reported cognitions (Offer et 
al., 2000; Orfei et al., 2008; Reuben et al., 1992).  
Concerns surrounding measurement of self-reflective behaviours and thoughts are 
particularly compounded when assessed in neuroimaging studies, as their paradigms 
often involve the participant engaging in imaginative states of self-referential thought. 
The most widely used neuroimaging task to measure self-reflection is trait personality 
judgement where participants consider the degree to which statements of personality 
apply to themselves or others. These studies, which again rely on insight, have identified 
that activity in the mPFC (D’Argembeau et al., 2005; Macrae et al., 2004; Moran et al., 
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2006) and PCC (Moran et al., 2006) are associated with the level of self-relevance during 
personality judgement. Other similar fMRI tasks include the participant considering the 
self-relevance of positive, negative and neutral statements, similar to those in global self-
report questionnaires, designed to cue self-referential processing, for example “I consider 
myself to be a loser” (Wagner et al., 2015). Those with an even greater imaginal element 
include, for example, a study by Longe et al. (2010) which asked participants to imagine 
being either self-critical or self-reassuring to scenarios of personal failures and mistakes 
during scanning. They found that activity in the dorsolateral PFC, hippocampal and 
amygdala complex were positively correlated with an individual's tendency to be self-
critical, whereas insular, ventrolateral and ventromedial PFC activity were positively 
correlated with the tendency to be self-reassuring. Another similar task involved 
participants imagining their hopes and aspirations (self-reflective condition) versus duties 
and obligations (comparative self-evaluative condition) (Johnson et al., 2009).  
These neuroimaging measures rely on the assumption that internally imagined states are 
equivalent to those produced by external stimuli through a specific task. Whilst there is 
some evidence of an overlap between real and imagined states, the validity of this design 
has been brought in to question (Klein & Gangi, 2010; Prigatano & Fordyce, 1986) and 
there are likely to be confounds of individual differences in a person’s ability to 
realistically imagine certain states. In addition, tasks which involve actively encouraging 
depressed participants to be self-critical, ruminative and self-blaming may be unethical. 
A further issue with those tasks involving a self-reassuring element is that they may not 
be suitable for certain patient groups. Indeed, when a highly self-critical individual is 
asked to be self-reassuring, they have been found to respond with threat-like responses 
(Rockliff et al., 2008) and patients with depression have been found to have deficits in 
self-soothing even when remitted (Ehret et al., 2015; Hooley et al., 2005). 
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In addition to these issues, there is a cause and effect confound in the relationship 
between adverse events, psychiatric illness and negative forms of self-reflection. This 
confound arises because excessive negative self-reflection may cause psychiatric illness 
but may also be a consequence of adverse life events (Monroe & Simons, 1991). Attempts 
to clarify whether excessive self-criticism causes psychiatric illness may therefore be 
hindered by the inability of current measures to distinguish between endogenous self-
criticism (i.e., a trait tendency or genetic predisposition) and exogenous, situationally-
driven self-criticism that stems from stressful life events (e.g., childhood trauma or sexual 
abuse). 
A potential solution to the inherent problems with measures of self-report and imagined 
internal states is to use more implicit measures whereby the task automatically induces 
and directly measures aspects of self-reflection. One way of approaching this would be to 
present participants with a task that they believe to be real test of ability, but on which 
all participants perform the same. This task would have three advantages over 
conventional measures of self-reflection. First, it removes the need for participants to 
imagine themselves in an evaluative context, because it is an evaluative context. Second, 
because all participants perform the same, their perceptions of their performance reflect 
individual differences in self-reflection rather than the effect of other attributes. Third, 
because the task elicits self-reflection, life history differences are somewhat controlled for 
between participants. These three features mean that such a task would be better suited 
to measuring endogenous negative self-reflection than existing questionnaires. 
The Belgian child psychologist Joseph Nuttin attempted to achieve this goal in a series of 
experiments which portrayed tasks as tests of intelligence, but were in reality implicit 
measures of self-perception (Nuttin & Greenwald, 1968). In one experiment, participants 
were asked to estimate which of two shapes presented together on one card was larger. 
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Participants were told that they had performed equally as well as one another with 
feedback based on a pre-defined schedule rather than actual performance. After 
completing the series, participants were asked: 1) how many times they thought they had 
been told that they were correct and incorrect; and 2) asked if they were satisfied with 
their performance. When Nuttin’s participants were split in to ‘pessimists’ and ‘optimists’, 
and in a second experiment, ‘depressives’ and ‘manics’; in both cases, the former grouping 
was more likely to overestimate failures. This backs up other evidence suggesting that 
correlations between perceived and actual success is low (Hilgard & Sait, 1941). These 
findings show that individuals perceive successes and failures in the context of a pre-
established conception of the self, independent of actual task performance and feedback 
received (Nuttin & Greenwald, 1968). 
Perhaps because of a lack of exposure in English-language publications, despite its 
promising application, Nuttin’s task has been largely neglected for the past 50 years. We 
have created an improved computerised version, called the Fake IQ Test (FIQT), to test 
the utility of this measure in a modern psychiatric context due to the task’s suitability to 
be utilised in various clinical populations including those with special requirements (for 
example, young children) and across various study paradigms. We have added a third 
question, probing how well individuals believe they have performed compared to peers; 
an important consideration, as research has indicated that self-criticism may arise from 
combined self-disapproval and chronic fear of criticism from others (Blatt, 2004). An 
additional improvement is our removal of task feedback, which could differentially 
influence affect and subsequently perceived performance (Besser et al., 2004; Elliott et 
al., 1996). 
Other tasks have gone some way to achieving this goal of creating a direct measure of 
self-reflection. For example, a Cyber Ball Task which manipulates the amount of exclusion 
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a participant experiences in a virtual ball passing game (van Harmelen et al., 2014). 
Participants are asked questions about self-esteem after completing the task to measure 
sensitivity to social criticism which the experiment manipulates by the number of 
rejections the participant experiences. The FIQT is designed to measure self-reflection 
more broadly than the Cyber Ball Task which is focused specifically on social self-esteem. 
As there is evidence that patient groups with high levels of negative self-evaluation find 
it hard to feel assured when performing cognitive and behavioural tasks (Lee, 2005), the 
FIQT should be able to pick up group differences in tendency to be self-critical, 
perfectionistic, worry and ruminate about performance rather than only measuring a 
single aspect of self-reflection. An additional strength of the FIQT, compared to the Cyber 
Ball Task, is that self-reflection is measured independent of actual performance - all 
participants perform the same and participants receive no feedback or cues to task 
performance – and therefore only participants’ internal perceptions of performance affect 
outcomes. 
The computerised version of the FIQT was first piloted in a group of patients with 
anorexia nervosa, as excessive self-criticism is associated with the instigation and 
maintenance of disordered eating behaviours (Starrs, Dunkley, & Moroz, 2015) and self-
critical attitudes have been found to predict the development of anorexia nervosa (Fennig 
et al., 2008). These pilot studies indicated higher levels of negative self-reflection on all 
three subscales of the FIQT: self-comparison (against others); self-satisfaction; and 
perception of performance (self-identification of number of correct answers given) 
(Corfield, 2014; Patrick et al., Under Submission). This task has yet to be validated in 
patients with affective disorders and the neural correlates of the task have yet to be 
explored despite the task’s suitability for adaptation into an fMRI paradigm and clear 
rationale for exploration in MDD and anxiety disorders. Gaining a better understanding 
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of self-reflective attitudes using improved tasks could be beneficial for predicting and 
tailoring treatment (due to the association of these concepts with treatment response, see 
Chapter 1) and better understanding common and distinct symptoms in and between 
disorders. More generally, the validation of this novel tool could provide a useful counter 
to traditional measures of self-reflection due to known issues with global self-report 
questionnaires and existing neuroimaging paradigms. 
 
4.1.1 Hypotheses & aims 
In order to test the psychiatric validity of the FIQT, we conducted two studies in patients 
with MDD and comorbid anxiety: behaviourally and as an fMRI task. The aims were to 
improve understanding of the FIQT’s three subscale aspects of self-reflective attitudes in 
pathological and non-pathological functioning, as well as examination of the concepts 
tapped by the FIQT through exploring correlations with previously validated global self-
reflection measures.  
4.1.1.1 Behavioural sample 
Higher scores in the patient group relative to controls were expected on all three subscales 
of the FIQT (self-disapproval, negative comparison with others, and perception of failure) 
due to the observed relationship between these factors and depression and anxiety 
(Dunkley et al., 2006; Zuroff et al., 2004). Positive correlations were expected between 
existing self-reflection measures and the FIQT, suggesting these tools approach similar 
aspects of self-reflection. To assess whether exposure to the FIQT incites changes in 
reported self-reflection over time, comparison of outcomes across trial blocks was 
conducted, with the expectation of no observable differences. To assess whether 
differences in task measures might be explained by differences in the perceived 
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importance of the task between groups, participants’ post-task ratings of importance were 
compared in patients and controls with the expectation of no significant differences 
between groups.  
4.1.1.2 Behavioural Results with therapy 
A subset of participants completed the task twice - both before and after a course of CBT. 
It was expected that patients would have lower FIQT scores post- compared to pre-therapy 
due to CBT challenging negative self-reflective cognitions and evidence that psychological 
therapies reduce negative self-reflection (Rector et al., 2000). Additionally, it was 
predicted that treatment responders would show a greater reduction in FIQT subscale 
scores than non-responders as research has shown that the degree to which self-criticism 
reduces during treatment is a significant predictor of treatment outcomes for depression 
and social phobia (Blatt et al., 1995; Marshall et al., 2008; Rector et al., 2000). We also 
hypothesised that these patterns of reduction post-therapy would be found in self-report 
measures of self-reflection.  
It was expected, due to evidence that those with higher levels of negative self-referential 
thought (including increased perfectionism, self-criticism and rumination) have poorer 
therapeutic responsiveness, that treatment responders would have lower baseline self-
report scores (on the FIQT subscales and self-report self-reflection measures) than non-
responders to CBT (Ciesla & Roberts, 2002; Egan et al., 2011; Jones et al., 2008; Mennin 
& Fresco, 2013; Schmaling et al., 2002; Shahar et al., 2004). 
4.1.1.3 Neuroimaging sample 
It was hypothesised that BOLD activity in DMN regions, in particular the PCC and mPFC 
which are considered crucial for the generation of self-reflective cognitions (Andrews-
Hanna et al., 2010; Perkins et al., 2015), would be related to the task. Specifically, we 
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hypothesised that activation in the mPFC and PCC would be increased in the task’s self-
reflection versus the control condition. Additionally, this elevation would be greater in 
patients versus controls.  
Due to evidence of differences in neural activation in self-reflective tasks versus resting-
state scans (Whitfield-Gabrieli et al., 2011), we additionally expected, in addition to 
higher activation in DMN regions which is found in both resting-state scans and tasks 
based on self-reflection, that this task would invoke activation in brain regions involved 
in error processing. When individuals believe that they have made errors, have particular 
faults or undesirable attributes that could lead to social disapproval, this can be perceived 
as being a threat to the self (Gilbert & Irons, 2005; Rockliff et al., 2008). This internal 
focus on personal faults via error processing is relevant to the FIQT as we ask participants 
to evaluate their performance. We therefore expected to find brain activation in regions 
found to be crucially involved in error processing: the lateral PFC including the 
dorsolateral PFC (dlPFC) and dorsal ACC (dACC) (Garavan et al., 2003; Gehring & 
Knight, 2000; Longe et al., 2010). Additionally, the insula has been proposed to be 
involved in self-related processing (Modinos et al., 2009). Therefore, in addition to DMN 
regions, we expect to find elevated activation in these error processing regions and the 
insula in self-reflection versus control conditions and predicted that activation in these 
regions would be significantly greater in patients versus controls. 
Additionally, we examined whether the neural activations observed were correlated with 
scores on self-report measures of self-reflection using multiple regression analyses. We 
hypothesised that elevated mPFC, PCC, ACC, insula and dlPFC activation would be 
positively correlated with FIQT subscale scores as well as self-report self-criticism, 




4.2.1 The Fake IQ Task  
The software for the FIQT, a computerised and adapted version of the “Impressions of 
Success and Failure Task” by Nuttin & Greenwald (1968), was programmed at the Centre 
for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s 
College London. 
Participants read a brief statement before beginning the task (see Appendix 3 for the full 
text) which informed subjects that the task was an examination of their visual perception 
and purposefully designed to be challenging and test their analytical ability. This 
statement was intended to increase participant expectation that the task is linked to 
intellectual ability and performance on which they would be judged, and minimise their 
expectation that self-reflective attitudes were in fact the measurements of interest. The 
explanation was consistent across participants to reduce any potential confounds arising 
from instruction interpretation. Participants were instructed to make quick and accurate 
judgements about predefined properties of two images of geometric shapes displayed side 
by side. This visual perception performance on the task was not measured; all problems 
were impossible in that the two geometric shapes are equivalent in terms of the criteria 
the participant had to judge them on, for example, length, surface area, or volume (see 
Figure 4-a). Individuals were debriefed after taking part in their follow up visit, and the 
necessary deception of the task explained.  
The images were displayed, and the participant had 5.5 seconds to respond within. After 
a set of 10 images, participants were asked three questions about their perception of their 
performance to which they had 6.5 seconds to respond on a visual analogue scale (VAS) 
by holding down the left or right buttons/arrows to move the pointer with responses 
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ranging from 0-100. The pointer of the VAS was set to appear at a randomised start 
position varying from 30-70. This sequence, which included an average inter-stimulus 
interval between trials of 4.2 seconds, was repeated four times giving a total of 40 trials 
and a task length of 11 minutes, 17 seconds. All participants were given a practice session 
to familiarise them with trial timings and the response mechanism. The three questions 
were: 
1) “How many of the last 10 trials do you think you got correct?”  Answers from 
‘none’ (0) to ‘all’ (100)  2) “Do you think your performance was better or worse than average?” Answers 
from ‘much worse’ (0) to ‘much better’ (100) 3) “Overall, do you feel satisfied with your performance?” Answers from ‘very 
unsatisfied’ (0) to ‘very satisfied’ (100) 
Scores on these three questions were reverse scored so higher scores reflect more negative 
self-reflection (the questions had been presented in a more ‘positive’ framing to minimise 
causing a negative bias). These questions produce three subscale scores, as follows: 1) 
The number of estimated correct responses is reversed to give the number of estimated 
incorrect responses (Incorrect subscale), 2) the degree of positive self/other comparison 
becomes negative comparison to peers (Comparison subscale) and 3) satisfaction is 
translated in to level of dissatisfaction (Dissatisfaction subscale).  
Additionally, after completing the task, participants were asked two questions: 
1) To generally express how they felt during the task (this was used to determine 
whether they realised it was ‘fake’ and impossible).  
2) “Is how you performed on this task important to you?” Answers from ‘Not at all’ (0) 
to ‘Very Important’ (10).  
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Differences between fMRI and behavioural task 
In the event-related fMRI task (See Figure 4-a for example stimuli), after each set of 
images, the participant saw a screen saying either ‘Wait’ or ‘Satisfied’ displayed for 5 
seconds with an inter-stimulus interval varying between 2-6 seconds afterwards (average 
of 4.2 seconds, a white cross presented on a black screen). On the ‘Satisfied’ trials, 
participants were instructed to reflect on their perceived performance on that trial (self-
reflection trial). On the ‘Wait’ trials, the participants were instructed to not think about 
their performance but rather rest, relax and try to free their mind from the task 
(neutral/control trial). In the behavioural version of the task, after each image pairing 
the participant was asked “How satisfied were you with your performance” and had to 
respond on a VAS ranging from 0-100. 
The participants’ scores on the questions about their performance were used as measures 
of self-reflection and the neural activity on the ‘Wait’ (control condition) compared to 
‘Satisfied’ (self-reflection condition) trials in the fMRI paradigm used as comparisons for 






 5.0 seconds 
5.5 seconds 
6.5 seconds 
Figure 4-a: Example stimuli and display of the Fake IQ fMRI paradigm 
91 
 
4.2.2 Self-report questionnaires 
Participants completed the following measures to allow examination of the association 
between the FIQT and existing self-report measures of self-reflection:  
The Rumination Response Scale (RRS), a 22-item measure of rumination, self-reflection 
and brooding, where item scores are summed to give a total (Treynor et al., 2003). 
Questions, for example “Think about a recent situation wishing it had gone better” are 
rated on a 4-point scale from 1 (“almost never”) to 4 (“almost always”). 
The Forms of Self Criticising/Attacking and Self-Reassuring Scale (FSCSR) (Gilbert et 
al., 2004). This is a 22-item questionnaire, with answers rated on a 5-point Likert scale 
ranging from 0 (“not at all like me”) to 4 (“extremely like me”), exploring ways in which 
people respond when things go wrong i.e. one’s tendency to be self-critical or self-
reassuring to personal setbacks and failures. Two subscales measure different aspects of 
self-criticism, but can be combined to study overall self-criticism (e.g. as done by Gilbert 
et al., 2004). Additionally, there is a subscale capturing self-reassuring thoughts (total of 
8 items, e.g. “I still like being me”). This questionnaire has been found to be a reliable 
measure with good psychometric properties (Baião, Gilbert, McEwan, & Carvalho, 2015). 
The Penn State Worry Questionnaire (PSWQ), a 16-item questionnaire measuring trait 
worry (Meyer et al., 1990).  
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4.2.3 Behavioural statistical analysis 
Differences in group performance were assessed with independent-samples t-tests. Effects 
between the FIQT and other measures of self-reflection (RRS, FSCSR, PSWQ) and 
depression severity (HDRS-17) were assessed with Pearson’s correlations using False 
Discovery Rate (FDR) correction (Benjamini & Hochberg, 1995). A repeated-measures 
ANOVA was used to check whether first and final trial scores differed in the primary 
sample, which would be indicative of practice effects including participant’s realising the 
‘fake’ nature of the task.  
Repeated-measures ANOVAs with Greenhouse-Geisser correction were conducted to test 
whether patient scores on self-reflection measures (FIQT subscales, PSWQ, RRS and 
FSCSR-SC) differed pre- to post-CBT. This was conducted in all patients undergoing 
therapy and additionally with treatment response as a between-subjects’ factor. 
Independent samples t-tests comparing responders versus non-responders on all self-
reflection measures (the FIQT subscales, RRS, PSWQ, and FSCSR-SC scales) were 
conducted on baseline and post-treatment data.  
4.2.4 Neuroimaging analysis 
4.2.4.1 MRI Acquisition 
The functional MRI sequence comprised T2*-weighted gradient echo planar image (EPI) 
sessions of 338 whole brain volume acquisitions: flip angle 75°; TR = 2000 ms; TE = 30 
ms; FOV = 24 x 24 cm; slice-thickness = 3 mm; inter-slice gap = 0.3 mm (total of 41 
slices); matrix size = 64 X 64 voxels with an isotropic 3 mm x 3 mm in-plane resolution. 
A high-resolution T1-weighted image was also acquired as outlined in Chapter 3.  
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4.2.4.2 fMRI pre-processing 
Pre-processing of data was conducted using custom Nipype scripts 
(http://nipy.org/nipype/), using tools from Statistical Parametric Mapping, Version 12 
(SPM12, Wellcome Department of Cognitive Neurology, London, UK, 
http://www.fil.ion.ucl.ac.uk/spm/), and custom code. Functional images were realigned, 
slice time corrected, and co-registered to the high-resolution T1 image. T1 images were 
segmented and normalised and functional images were normalised into MNI space using 
deformation fields. Data were then smoothed using a 6mm full-width half maximum 
(FWHM) Gaussian kernel. To limit the effect of motion artefacts, participants with 
substantial translation of more than one voxel were removed from further analysis. 
Additionally, volumes with high levels of motion (based on realignment parameters and 
signal intensity changes from volume to volume) were identified using ArtifactDetect 
(implemented on Nipype) to be later removed from analysis. Physiological signals were 
processed using custom script implementing AFNI’s RETROspective Image COrrection 
tool (RETROICOR) algorithm (Glover et al., 2000). This produced cardiac and respiratory 
regressors for use in first level analyses. 
4.2.4.3 First and Second Level Analysis 
Data were analysed using SPM12. First level models were formed on each participant’s 
data to generate mean images for each participant that included regressors for each trial 
type (‘Wait’ (neutral condition), ‘Satisfied’ (self-reflection condition) and baseline 
fixation)), along with 6 motion parameters which were generated during realignment, 
and the physiological regressors generated by RETROICOR. In addition, motion scrubbing 
regressors were included to exclude volumes with high motion. This procedure has been 
shown to increase statistical power of fMRI analyses and reduce the impact of motion 
artefacts (Siegel et al., 2014). 
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The contrast of interest for our main effects analyses was formed by comparing the ‘Wait’ 
versus ‘Satisfied’ trials (controlling for fixation which was modelled as an implicit baseline 
condition). We tested for group effects between these conditions (differences in neural 
activation between patients versus controls) using one-sample t-tests in SPM12, with head 
motion (total distance travelled), age and sex as covariates. 
We performed exploratory whole brain analyses due to this being the first use of this task. 
A cluster-defining threshold of p <.001 and a cluster-wise threshold of p <.05 FDR 
corrected for multiple comparisons was used across the whole brain. 
In addition to whole brain analyses, we used an ROI approach. ROIs were derived from 
Neurosynth maps (neurosynth.org) for the term ‘self-referential’, thresholded at z>10 to 
identify regions most likely to be associated with self-reflective thought. This map was 
combined with the Automated Anatomical Labelling (AAL) atlas (Tzourio-Mazoyer et al., 
2002) to create the ROIs and additionally eliminate non-DMN regions from these maps. 
Regions within default mode systems, especially the mPFC and PCC were selected due to 
these regions being considered imperative to the generation of self-referential thoughts 
(Perkins et al., 2015). The ROI analyses were conducted separately for each mask with a 
small volume correction. For these bidirectional ROIs, the significance level for the F 
contrasts were set to p <.05.  
Regressions were conducted to explore relationships between neural activation on the 
task (‘satisfied’ compared to ‘wait’ conditions) and self-report measures of self-reflection. 
These included: the FIQT’s subscale scores, self-criticism (FSCSR-SC), self-reassurance 
(FSCSR-RS), rumination (RRS), and worry (PSWQ) questionnaire scores. These 
regressions were conducted at both a whole brain level and on a mask of the main effect 
of the task (i.e. running correlations only in the areas that were significantly activated in 
the task) to explore correlations between behavioural scores and neuronal activity. 
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4.3 Results 
4.3.1 Behavioural results 
Thirty patients from both Study 1 and Study 2 (21 females, aged 35.2+-13.1 years) and 
20 healthy controls (13 female, 32.0+-10.1 years) completed the FIQT behaviourally. 
Significant differences were observed between the patient and control group on all 
measures (see Table 4-a). As expected, patients scored significantly higher on the HDRS-
17, PSWQ and RRS measures and also scored significantly higher on the self-criticism 
subscale of the FSCSR scale, whilst scoring significantly lower on the self-reassurance 
FSCSR subscale. The patient group also scored significantly higher on all three subscales 
of the FIQT compared to healthy controls: the patients estimated that they made more 
mistakes (Incorrect, p <.05, d = .82, CI = 6.03 – 21.19, effect size – Cohen’s d 0.81), 
gave greater ratings of perceived negative performance compared to peers (Comparison, 
p <.005, d = .90, CI = 5.4156 - 20.62, effect size – Cohen’s d 0.90), and showed overall 
higher dissatisfaction (Dissatisfaction, p <.05, d = .61, CI = 1.67 – 19.27, effect size – 
Cohen’s d 0.61). There was no significant difference between patients and controls in the 
post-task rating of importance they gave to performing well on the task.  
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Table 4-a: Descriptive statistics and independent samples t-test results for 






FIQT-Incorrect 54.1 (21.1) 40.6 (10.3) 2.7* 
FIQT-Comparison 56.9 (18.5) 43.9 (8.5) 2.9** 
FIQT-Dissatisfaction 54.4 (22.3) 43.2 (12.8) 2.0* 
FIQT Importance 6.6 (2.4) 5.4 (2.8) 1.6 
FSCSR – RS 12.5 (6.0) 25.6 (3.4) -8.8** 
FSCSR – SC 36.6 (4.0) 13.1 (7.9) 9.1** 
HDRS-17 19.4 (4.0) 0.95 (1.4) 19.8** 
RRS 66.8 (9.9) 31.4 (7.5) 13.6** 
PSWQ 65.9 (7.5) 34.8 (11.8) 11.3** 
Patients n = 30, Controls n = 20, * significant at p < .05, ** significant at p < .001. 
Abbreviations - SD: Standard Deviation; FIQT: Fake IQ test; FSCSRS: Forms of Self-
Criticising and Self-Reassuring Scale; SC, Self-Criticism; RS: Reassure Self; RRS: 
Ruminative Response Scale; PSWQ: Penn State Worry Questionnaire; HDRS-17: 
Hamilton Depression Rating Scale – 17 item. 
 
Bivariate correlational analysis was conducted to explore relationships within the FIQT 
and between the FIQT, FSCSR, PSWQ, RSS and HDRS-17 (Table 4-b). Significant positive 
correlations were observed within both groups, between all subscales of the FIQT. 
However, no significant correlations were found between the FIQT subscales and self-
report self-reflection or depression severity measures in either group.  
No significant differences were found between the first and final trial in any of the FIQT 
subscales by group (f(1) = .532, p = .469), suggesting participant ratings did not change 
over time.  
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Table 4-b: Correlations between Fake IQ test subscales, the FSCSR, HDRS-17, 
RRS and PSWQ, by group.  
Variable 1 2 3 4 5 6 7 8 
1 FIQT-Incorrect - .87** .76** -.01 -.33 -.16 .28 .01 
2 FIQT -Comparison .94** - .82** .11 -.35 -.18 .25 .01 
3 FIQT –Dissatisfaction .81** .88** - -.28 -.16 .02 .01 -.14 
4 FSCSRS-RS .03 .01 -.13 - -.51* -.07 -.27 -.37 
5 FSCSRS-SC .19 .24 .26 -.65** - .37 .68** .73** 
6 HDRS-17 -.04 .08 .12 -.35 .29 - .47* .07 
7 RRS .11 .10 .10 -.26 .40* .25 - .64** 
8 PSWQ -.08 -.11 .00 .09 .29 .06 .11 - 
N = 50 (correlations for 30 patients in lower half of matrix, 20 controls in upper 
half). * p <.05 level ** p <=.01. Abbreviations - FIQT: Fake IQ test; FSCSRS: Forms 
of Self-Criticising and Self-Reassuring Scale; SC: self-criticism; RS: Reassure Self; RRS: 
Ruminative Response Scale; PSWQ: Penn State Worry Questionnaire; HDRS-17: 
Hamilton Depression Rating Scale.  
 
4.3.2 Behavioural results with therapy 
15 patients (9 females) with MDD and comorbid anxiety disorders completed the FIQT 
before and after a course of CBT (mean age 37.7+-15.2 years). The mean number of 
sessions of CBT attended was 10.3 (+-2.8), range 6-16 sessions. See Table 4-c for sample 
characteristics of both responders and non-responders to CBT. Responders were 
significantly younger on average than non-responders. Unexpectedly, non-responders did 
not have higher FIQT subscale, worry (PSWQ) or rumination (RRS) scores at baseline or 
post-therapy compared to responders. However, responders did have significantly lower 
self-criticism self-report scores (FSCSR-SC) post-therapy compared to non-responders as 
expected (p =0.02), but did not differ at baseline on this measure. 
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Age, years 26.3 (6.2) 45.3 (14.7) t = 3.0*  
Male/Female (n) 2/4 4/5 χ2 = 0.2 
Baseline MÅDRS 29.8 (7.7) 28.4 (7.0) t = -0.4 
Number of CBT sessions 8.7 (2.8) 11.4 (2.3) t = 2.1 
Baseline FIQT Incorrect 60.0 (19.5) 48.0 (29.7) t = -0.9 
Baseline FIQT 
Comparison 
61.1 (20.5) 52.5 (22.8) t = -0.7 
Baseline FIQT –
Dissatisfaction  
64.2 (19.6) 44.5 (23.2) t = 0.6 
Baseline FSCSR-SC 41.2 (8.6) 36.4 (7.7) t = -1.1 
Baseline PSWQ 69.2 (6.8) † 63.3 (8.7) t = -1.3 
Baseline RRS 69.4 (5.9) † 66.8 (13.9) t = 0.5 
Post therapy FIQT 
Incorrect 
58.0 (22.9) 38.5 (14.8) t = -2.0 
Post therapy FIQT 
Comparison 
57.5 (15.1) 44.7 (14.6) t = -1.6 
Post therapy FIQT –
Dissatisfaction  
52.3 (15.2) 38.9 (17.1) t = -1.5 
Post therapy FSCSR-SC 20.7 (7.3) 33.2 (9.7) t = 2.7* 
Post therapy PSWQ 53.7 (13.4) 58.9 (9.4) t = 0.9 
Post therapy RRS 51.0 (13.4) 57.4 (12.3) t = 1.0 
†n=5 due to missing data for one participant. Values are reported as mean 
(standard deviation) unless otherwise stated. Comparison was by independent 
samples t-tests or Pearson chi-square for categorical variables. * Significant to p 
<.05. Abbreviations - FIQT: Fake IQ test; MÅDRS: Montgomery-Åsberg Depression 
Rating Scale: CBT; Cognitive Behavioural Therapy; FSCSRS: Forms of Self-Criticising 
and Self-Reassuring Scale; SC: Self-Criticism total scale; RRS: Ruminative Response 
Scale; PSWQ: Penn State Worry Questionnaire. 
 
A repeated measures ANOVA on all patients (both responders and non-responders to 
CBT) showed no significant differences pre- to post-therapy on any of the FIQT measures: 
Incorrect (f(1,14) = 1.16, p =.30); Comparison (f(1,14) = 2.79, p =.12); or 
Dissatisfaction (f(1, 14) = 2.26, p =.16). There were significant differences though on all 
self-report measures of self-reflection from baseline to post-therapy: self-criticism 
(FSCSR-SC, f(1,14) = 11.8, p =.004), rumination (RRS, f(1, 13) = 13.3, p =.003), and 
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worry (PSWQ, f(1,13) =12.7, p = .003), all demonstrating reductions at time-point 2 
compared to time-point 1.  
Including treatment response as a between-subjects factor in the repeated-measures 
ANOVAs showed there were no significant group by time interactions on the FIQT 
subscales: Incorrect (f(1,13) = .36, p =.56); Comparison (f(1,13) = .25, p =.63); or 
Dissatisfaction (f(1, 13) = .38 , p =.55). With the self-report measures, there was no 
significant group by time interactions on the RRS: f(1,12) = 1.15, p =.31. However, 
significant effects were found on self-report self-criticism measured using the FSCSR-SC 
scale (f(1,13) = 18.65, p =.001) and worry measured using the PSWQ (f(1,12) = 5.54, 
p =.036). On both of these measures, treatment responders showed a greater reduction 
post-therapy compared to non-responders. These patterns of results were not altered 
when age was added in as a covariate to the repeated measures analysis due to significant 
differences between responders and non-responders in age. 
 
4.3.3 fMRI results 
Eighteen patients and twenty healthy controls completed the FIQT as an fMRI paradigm. 
However, three participants (two patients and one healthy control) were excluded from 
analyses due to excessive head motion during the task. Table 4-d shows participant 
characteristics for those included in these analyses. Patients scored significantly higher 
than the healthy controls on the RRS, FSCSR-SC, PSWQ and MÅDRS and significantly 
lower on the FSCSR-SR. Additionally, as with the behavioural sample, the patients scored 
significantly higher on the three subscales of the FIQT (Incorrect: p <0.5, effect size – 
Cohen’s d 1.06; Comparison: p <0.5, effect size – Cohen’s d 0.91; Dissatisfaction: p <0.5, 
effect size – Cohen’s d 0.64).  
100 
Table 4-d: Sample characteristics of the Fake IQ test fMRI sample.  
 
Major Depression 





Age, years 32.5 (11.5) 32.2 (10.2) t = 0.2 
Male/Female (n) 6/10 7/12 χ2 = .42 
MÅDRS 31.3 (6.5) 1.6 (2.0) t = 17.2** 
FSCSR - SC 33.7 (9.5) 12.7 (7.9) t = 7.3** 
FSCSR-RS 13.5 (5.6) 25.6 (3.5) t = -8.1** 
RRS 67.6 (7.7) 30.6 (6.7) t = 13.8** 
PSWQ 66.9 (7.5) 33.8 (11.3) t = 9.7** 
FIQT Incorrect 53.7 (14.6) † 40.2 (10.5) t = 3.4* 
FIQT Comparison 54.7 (14.7) † 43.7 (8.6) t=3.1* 
FIQT 
Dissatisfaction 
53.4 (18.7) † 43.0 (13.1) t = 2.3* 
†n=15 due to data collection errors for one participant. Values are reported as mean 
(SD) unless otherwise stated. Comparison was by independent samples t-tests or 
chi-square for categorical variables. * Significant to p <.05, ** Significant to p 
<.001. Abbreviations - FIQT: Fake IQ test; FSCSRS: Forms of Self-Criticising and Self-
Reassuring Scale; SC, Self-Criticism subscale; RS: Reassure Self subscale; RRS: 
Ruminative Response Scale; PSWQ: Penn State Worry Questionnaire; MÅDRS: 
Montgomery-Åsberg Depression Rating Scale. 
 
See Table 4-e and Figure 4-b for task main effects in both patients and controls. All results 
in the table met the criteria for significance: a cluster defining significance of p <.001 and 
a cluster-wise threshold of p <.05 FDR corrected. The tables include the significance level 
of the peak voxel within each cluster. There was increased activation if the self-reflection 
versus control condition bilaterally in the inferior cortex extending to dACC and insula, 
as well as left dlPFC, and motor area activation. There were no significant areas of 
decreased activation with self-reflection.  
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Table 4-e: Fake IQ Test Brain Activation (main effect of task) 






Voxels F Direction of 
activation 
Left inferior 
occipital / left mid 
occipital cortex 
-15, -91, -7 0.006 89 63.43 Satisfied>Wait 
condition 
Left inferior 
frontal gyrus / 
dorsolateral 
prefrontal cortex / 
insula 








slightly into right 
insula 




motor area / left 
frontal superior 
cortex 
-12, 5, 62 0.006 92 25.91 Satisfied>Wait 
condition 
N = 35 (Patients = 16; Controls = 19), whole brain analysis. Abbreviations – MNI, 
Montreal Neurological Institute.  
 
No significant results were found in our ROI analysis. There was no significant difference 
in head motion between the groups (p =.55). No group effects (whole brain or ROI) 
showing significant differences in brain activation between patients compared to controls 
on the task were found. For the regression analyses, one patient was removed due to an 
incomplete dataset.  No significant results were found whole brain or when the main 
effect of task was compared with other measures: the FIQT subscale scores or self-report 
measures of self-reflection (PSWQ, RRS and FSCSR-SC and RS).  
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This chapter presents a psychiatric validation of the FIQT, an objective measure of self-
reflection based on the “Impressions of Success and Failure” experiments by Nuttin & 
Greenwald (1968). As hypothesised, the patient group scored higher than the healthy 
participants on all FIQT subscales, indicative of lower levels of implicit positive self-
evaluation. No association was found between task measures and treatment response 
perhaps suggesting the domains measured with the FIQT are more indicate of trait, rather 
than state, self-evaluation. BOLD response on this novel task (comparing active self-
reflection versus control trials) in patients and controls was also examined. A main effect 






















bilaterally in the inferior frontal cortex, insula, motor cortex and dACC. However, no 
group differences in neural activation, or correlations with FIQT subscale scores or self-
report measures of self-reflection were found. 
4.4.1 Discussion of results from the behavioural task 
The patient group showed significant differences compared to the control group in all 
three subscales of the task: heightened negative comparison to others, higher self-
dissatisfaction, and greater perceived failures. These findings were expected due to 
evidence of high self-criticism, low self-esteem and heightened perception of failure in 
depression (Beck, 1967; Blatt, 2004; Dunkley & Grilo, 2007; Nuttin & Greenwald, 1968) 
and anxiety disorders (Blatt, 2004; Dunkley & Grilo, 2007). 
No relationship was found between scores on pre-existing self-reflection scales (the 
FSCRS, RRS, or PSWQ) and the FIQT, despite scores on all measures being significantly 
raised in the patient group. As such, data do not support the notion that the FIQT is a 
direct alternative to current self-report measures. Self-report questionnaires of self-
reflection use broad, global statements, which relate to general experience without 
context (e.g. “I find it difficult to control my anger and frustration at myself” (Gilbert et 
al., 2004) or “Think about how passive and unmotivated you feel” (Nolen-Hoeksema et 
al., 2008)). Comparatively, the FIQT assesses perception of performance in a specific 
context. Considering the role of self-report bias which may be particularly problematic in 
a self-critical and ruminative sample (Offer et al., 2000), it is informative how contextual 
restriction in assessment (and without any feedback) can tease out differences in self-
reflection. Many researchers have challenged the idea of a single-concept and instead 
favour a multidimensional approach to self-critical attitudes (Castilho, Pinto-Gouveia, & 
Duarte, 2015). The FIQT and current self-report measures may be tapping differential 
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concepts of self-reflection, together contributing to a more comprehensive picture of 
pathological self-judgement. 
Additionally, no correlation was observed between depression severity and the FIQT, 
contrary to our hypothesis. It may be that the sample size was too small to reveal detailed 
differences related to symptom severity, despite our results indicating sensitivity to 
pathology. As the MDD sample included patients with co-morbid anxiety, it may also be 
that anxiety-based symptomology and clinical heterogeneity was affecting this 
relationship.  
The FIQT subscales showed strong internal correlation, suggesting that dissatisfaction 
with task performance, number of estimated incorrect responses, and negative 
comparison with peers are related. Importantly, comparing scores on the FIQT subscales 
across blocks indicates that the task does not appear to have induced negative self-
appraisal, which would have been shown in increasingly negative scores on the measures 
over time, in either the patient sample or healthy controls. Additionally, the false nature 
of the task did not appear to have been picked up quantitatively, which could have been 
demonstrated by increasing or decreasing levels of task satisfaction over the blocks if the 
participant had guessed they were completing an impossible task and altered responses 
accordingly. Indeed, self-report from the participants (after completing the task and being 
unblinded as to its fake nature) showed that no participant fully guessed that there were 
no quantifiable differences between the shapes (although a few of the participants had 
mild suspicion the task was unsolvable and when they were informed that it was fake 
after the second application were not shocked). The task was therefore successful in its 
ability to deceive.  
There was no significant difference between patients and controls in the post-task rating 
of importance they gave to performing well on the task which adds credibility that 
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differences between groups are not due to healthy controls caring less about performance 
but are reflective of differences in self-perception of performance. Additionally, mean 
scores of 6.6 and 5.5 in patients and controls respectively suggest that subjects viewed 
their performance as being relatively important which suggests that self-esteem could be 
impacted and measured in task performance subscales. However, it should be noted that 
the scale characteristics of importance (rated on a scale of 0-10) may have made this 
measure less sensitive than a VAS of 0-100, as used for the subscale scores on the Fake 
IQ test. This may have potentially obscured any difference between patients and controls 
and therefore this finding should be interpreted cautiously. Patients did indeed score just 
over one point higher on rated importance which is translated to a 0-100 VAS scale could 
have led to finding significantly different ratings between groups. Future use of the task 
should ensure consistent scales are used across all task-related measures. 
 
4.4.1.1 Sensitivity of the FIQT to treatment response 
We hypothesised that patients would have significantly lower FIQT subscale scores post- 
compared to pre-therapy due to evidence that CBT reduces negative self-referential 
processing (Rector et al., 2000). Further to this, we postulated that responders would 
show a greater reduction in FIQT scores than non-responders. We did not find this pattern 
of results as there were no significant differences in FIQT scores over time nor an 
interaction between time point and treatment response. We also hypothesised that these 
patterns of reduction post-therapy would be found in self-report measures of self-
reflection (the RRS, FSCSR-SC, and PSWQ). Indeed, we did find that patients scored 
significantly higher pre-treatment compared to post-treatment on all self-report measures. 
It was also found that this decrease in scores was significantly greater in responders than 
non-responders in self-report self-criticism (FSCSR-SC) and state worry (PSWQ). 
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These results may suggest that self-report questionnaires measure more state aspects of 
self-criticism than the FIQT, which could be argued to reflect trait-related aspects of self-
referential processing. Alternatively, the questionnaire measures could be more sensitive 
to change, illustrating patient’s subjective experiences of a reduction in their levels of self-
criticism, worry and rumination in everyday life. These experiential reductions may not 
translate to how they actually behave in certain situations (for example, the Fake IQ test) 
with these behavioural changes taking longer to emerge or requiring a longer course of 
therapy to alter. Due to evidence showing that negative self-referential thoughts are not 
only associated with poorer treatment response but also a more fragile response trajectory 
(i.e. these patients have a higher risk of relapse) (Jones et al., 2008; Mennin & Fresco, 
2013), it could be that our follow up was too short to reveal any group differences on the 
FIQT. Alternatively, the FIQT could measure an aspect of self-referential behaviour that 
is not relevant to treatment response in depression and anxiety. To determine whether 
the FIQT is sensitive to treatment response, further investigation is warranted. Studies 
should explore this in larger samples, with a longer follow up and in alternate samples, 
for example, those who have remitted or are at risk of developing depression/anxiety. 
This could help elucidate how much of a trait or state measure of self-reflection the FIQT 
is.  
Due to our finding that FIQT subscale scores did not correlate with existing self-report 
measures of self-criticism, rumination and worry, further work should explore the FIQTs 
relationship to alternative negative self-reflective processes for example self-report self-
blame (Marschall et al., 1994), perfectionism (Frost et al., 1990) and self-punitiveness 
(Carver & Ganellen, 1983). The latter of which is proposed to consist of three components 
including: 1) perfectionism in setting high, possibly unattainable standards; 2) negative, 
self-critical responses to failures and setbacks; and 3) overgeneralisation to 
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disappointments, each of which can be measured using the Attitudes Towards Self Scale 
(Carver & Ganellen, 1983) to determine which, if any, component is related to FIQT 
scores. The FIQT may more closely measure these aspects of negative self-reflection which 
have been argued to be personality trait measures and therefore may be less amendable 
to change (Blatt et al., 1995) explaining why the observed changes in self-report self-
criticism, rumination and worry with treatment were not observed in FIQT scoring.  
It was expected, due to evidence that those with higher levels of negative self-referential 
thoughts have poorer therapeutic responsiveness, that treatment responders would have 
lower baseline self-report scores (on the FIQT and self-report measures) than non-
responders to CBT (Ciesla & Roberts, 2002; Egan et al., 2011; Jones et al., 2008; Mennin 
& Fresco, 2013; Schmaling et al., 2002; Shahar et al., 2004). This was not found on any 
measure except for self-report self-criticism (FSCSR-SC) post-therapy where responders 
scored significantly lower than non-responders. It is likely that the sample size of this pilot 
study was too small to reveal any group differences should they exist. 
4.4.1.2 Strengths of the use of the FIQT as a behavioural task and suggested future work 
The FIQT may measure additional dimensions of self-criticism that are not covered by 
traditional self-report questionnaires. It is suitable for use in multiple experimental 
paradigms, including drug and neuroimaging studies. Importantly, comparing scores on 
the FIQT subscales across blocks indicates that the task does not appear to have incited 
negative self-appraisal, an issue with studies using valance feedback (Besser et al., 2004).  
The work presented in this thesis complements pilot studies that also tested this measure 
(albeit with slight methodological differences in response scoring mechanisms) in patients 
with anorexia nervosa (Corfield, 2014; Patrick et al., Under Submission). These studies 
also found patients to score significantly higher on all three FIQT subscales versus 
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matched healthy controls and therefore the psychiatric validity of this task has now been 
replicated in two patient groups. Future work should explore this task in alternate 
disorders, in particular those associated with reduced self-reflection, such as autism 
spectrum disorders or psychopathy (Philippi & Koenigs, 2014). The minimal use of 
vocabulary and removal of global introspection on the FIQT means this measure is 
applicable to groups with special requirements (for example, young children). 
Additionally, previous work has suggested self-criticism may mediate between 
maladaptive perfectionism and psychological distress (James et al., 2015); future work 
could evaluate the role of this factor alongside the FIQT in psychopathology.  
4.4.1.3 Weaknesses of the use of the FIQT as a behavioural task 
The patient sample was not selected to exclude co-morbid anxiety disorders; it would be 
beneficial to explore FIQT output in both MDD and anxiety disorders separately 
controlling for co-morbidity which could be affecting the resulting pattern of results. 
Although this was an exploratory investigation to pilot this novel task, we appreciate that 
the sample sizes are relatively small.  
This work focuses on quantitative differences in self-evaluation but there may be 
important qualitative differences as well such as distinctions in the quality or content of 
self-reflective thoughts between groups. In depression, we typically think of negative 
ruminative thoughts about the self, e.g., I am worthless / inadequate / to blame. In GAD, 
worries are often about potential threats to the self, health problems, or worries about 
one’s future. Subsequent studies could explore qualitative differences in thoughts 
surrounding the FIQT which may reveal important differences across disorders, an 
understudied area in this field (Philippi & Koenigs, 2014). 
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Regarding our null finding of changes in task measures with therapy and in relation to 
treatment response, this may demonstrate that the task measures more ingrained trait 
aspects, rather than state characteristics, of self-evaluation. Indeed, there is evidence that 
the ability to be self-reassuring and resilient when things go wrong is a result of early 
attachment style and temperament (Masten, 2001; Mikulincer & Shaver, 2007) and 
therefore there may be aspects of self-reflection that are less amenable to change. 
Specialist therapy, focusing on self-compassion and reassurance, may be more likely to 
result in changes in this behaviour (Gilbert & Irons, 2005) despite evidence showing that 
CBT does reduce negative self-reflection by challenging negative cognitions (Beck, 1970; 
Mennin & Fresco, 2013; Rector et al., 2000). Future work should explore the task in 
relation to different forms of therapy, especially those specifically targeted to negative 
self-reflective processes. Longer term follow-up, in order to understand any long-term 
association with treatment outcome, as well as administering the task to remitted or at-
risk populations could elucidate the task’s sensitivity to treatment response.  
 
4.4.2 Discussion of neuroimaging results 
We hypothesised that the self-reflection versus control condition of the FIQT would be 
associated with higher activation in DMN regions (predominantly the mPFC and PCC), 
the insula, dlPFC, and dACC. We found evidence of increased insula, dACC and dlPFC 
activation in line with our predictions and literature associating these regions with self-
reflective tasks of error processing (Garavan et al., 2003; Gehring & Knight, 2000; Longe 
et al., 2010; Modinos et al., 2009). Additionally, significantly elevated activation in the 
self-reflection condition was found in the posterior inferior parietal lobe. This region is 
part of the DMN and associated with attending to visual, spatial stimuli (Zhang & Li, 
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2014); however, no further DMN activation was found against our expectation due to this 
network being considered crucial for self-reflective cognition (Philippi & Koenigs, 2014). 
The observed elevation in activation in inferior, occipital and parietal cortices could be 
interpreted, along with the raised dACC and insula activation, in terms of the increased 
emotional salience of the self-reflection trials. These regions form part of the ‘salience 
network’ which is associated with the processing of salient, internally-generated 
emotional thoughts (Uddin, 2015). The insula is thought to mediate the detection of 
motivationally salient and emotional stimuli (Paulus & Stein, 2010) and the ‘salience 
network’ has been found to have reciprocal connections and causally influence activity in 
the DMN (Uddin, 2015). Our finding of elevated motor activation in the self-reflection 
condition could be due to the participants imagining the shapes and translating them 
mentally. Indeed, motor imagery has been found to mimic the brain activity found during 
actual motor movement (Miller et al., 2010).  
Not finding elevated mPFC and PCC activation in the self-reflection condition, two key 
DMN regions thought to be essential for the generation of self-reflective cognition, could 
be due to the design of the task in that the control condition still somewhat comprises a 
self-reflection condition. Resting-state studies, where participants often report being 
engaged in self-reflective thought, find involvement of the DMN and the FIQT’s control 
condition is similar to resting-state scans where the participant is instructed to rest. This 
could additionally explain why our ROI analyses did not reveal any significant task effects, 
due to our focus on DMN regions in selection of these regions. Despite evidence of 
differences between resting-state and task-based self-reflective neural activation, many 
studies do use similar control conditions to ours in self-reflective tasks and find DMN 
activation (Whitfield-Gabrieli et al., 2011). Perhaps our small sample size limited our 
ability to find such an effect. 
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We expected to find increased activation in all brain regions associated with the task in 
patients versus controls due to our expectation that patients would be engaged in elevated 
levels of self-reflection. However, no group differences in neural activation were found. 
Larger sample sizes are required to determine the sensitivity of this neuroimaging task to 
psychopathology. Additionally, no correlations with BOLD response and self-report 
measures of self-reflection were found. This backs up our findings from behavioural 
piloting of this task where we found no significant associations between FIQT scores and 
self-report rumination (RRS), self-criticism (FSCSR) or worry (PSWQ). Future studies 
should consider the relationship of the FIQT with alternate measures of self-reflection to 
determine if the FIQT more closely reflects, for example, self-blame or perfectionist 
aspects of self-reflection. There remains the possibility that the task, having been designed 
to have no emotional content or performance feedback, is simply an assessment of a 
general negative bias in perception of abilities rather than a robust measure of self-
reflection more generally. 
Regressions were also conducted on FIQT subscale scores and neural activation but no 
associations were found. This prevents us from interpreting whether the regions of 
increased activation on the self-reflection compared to the control condition relate to 
negative or positive forms of self-reflection. For example, elevated insula activation has 
been associated with increased self-reassurance and compassion (Farb et al., 2007; Longe 
et al., 2010; Lutz et al., 2008) but we are not able to confidently interpret such a direction 
from our findings. The FIQT is designed to measure the whole spectrum of self-reflective 
thoughts; for example, individuals may engage in high levels of self-reassurance or exhibit 
reduced self-reflection which the task has been designed to measure alongside negative 
cognitions. Future research is required to determine associations between neural 
activation on the FIQT and self-report measures. As self-reflection is considered as a 
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spectrum, with both high and low levels found in a range of psychopathologies, a better 
understanding of the neural correlates of specific aspects of self-reflection may inform us 
about the development and maintenance of disordered thinking. 
4.4.2.1 Strengths of the FIQT as an fMRI paradigm  
To date, no studies to our knowledge have explored the neurophysiology of implicit self-
reflection. One of the key benefits of this task in its potential as a neuroimaging paradigm 
is that it is a more implicit measure of self-reflection than existing tasks. Self-reflective 
neuroimaging paradigms often require the individual to recall or envisage a self-critical 
attitude and therefore rely on the assumption that internally imagined states are 
equivalent to those produced by external means, which has been questioned in the 
literature (Klein & Gangi, 2010; Prigatano & Fordyce, 1986). The FIQT has the advantage 
of avoiding invoking imagination when assessing self-reflective cognitions as the task 
creates the state. Additionally, the task is suitable for a wide range of patient populations 
due to its minimal use of vocabulary and removal of global introspection; for example, it 
is appropriate for young children. 
In this pilot study of the FIQT as an fMRI paradigm we were able to demonstrate a main 
effect of task. Potentially due to our limited sample size, we did not find significant 
differences in neural activation between patients and controls, or an association between 
brain activation on the task and self-report measures. Further research is required in 
larger sample sizes to further validate the task as well as determine what aspects of self-
reflection the FIQT is tapping into by looking at associations with other measures of self-
reflective cognition. 
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4.4.2.2 fMRI limitations and suggested refinements to the FIQT 
A potential reason for not finding significant differences between patients and controls 
on the task (self-reflection versus control condition) could be that the patient group were 
not able to shift their attention to this ‘wait’ or relaxation condition i.e. they could not 
inhibit self-reflective thought and shift their attention away from negative self-evaluation 
within the timescales necessitated by the fMRI paradigm. Alternatively, patients may have 
had higher activation (i.e. engaged in higher levels of self-reflection) in both conditions. 
Both of these may have confounded group differences. Indeed, some participants reported 
that the ‘Wait’ and ‘Satisfied’ conditions felt too short to fully reflect on their satisfaction 
or relax. Further work should determine if the length of the self-reflective and control 
conditions impacts results. Additionally, patients may not have been able to relax and free 
their mind due to self-compassion being an inaccessible emotion to patients, who have 
been found to respond with threat like responses when they are asked to be self-soothing 
(Rockliff et al., 2008). This, along with the design of the task whereby the control 
condition still somewhat reflects an inherently self-reflective condition, may have 
compounded our ability to detect group differences.  
Future studies could pilot the task with alternative control conditions or analyse the self-
reflection condition against baseline (when participants fixated on a blank screen with a 
cross between trials). Alternate control conditions could include a distractor (for example, 
hand-tapping, or thought cues such as thinking about the shape of Africa or the layout of 
a local supermarket) which may minimise self-reflective cognitions (Johnson et al., 2006; 
Nolen-Hoeksema & Morrow, 1993; Roelofs et al., 2009). However, our control condition 
was designed so as to match the self-reflection condition as closely as possible to control 
for confounds, such as differences in displayed visual information, motor and external 
cognitive stimulation. Potentially suitable distractor tasks could be cues for the 
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participants to reflect on the properties of the presented shapes in the task – for example 
asking the participants to think about what the images looked like or trying to memorise 
their properties. This is external and not internal self-reflection and could be cued with a 
single word (as with the self-reflection condition), for example ‘shape’.  
Our lack of significant differences between patients and controls may be interpreted as 
indicating that neurally the task is not sensitive to pathology. However, we believe further 
exploration is warranted as other studies have found differences in patient groups 
associated with negative self-reflection and further, self-reflective tasks have been shown 
to be sensitive to therapeutic response, for example, with pharmacological (Kilts et al., 
2006) and psychological therapies (Yoshimura et al., 2014). Our relatively small sample 
size in this piloting of the task may have hindered us from detecting significant differences 
should they exist. 
4.4.3 Overall conclusion 
One promising method of approaching the need to develop more pathophysiologically-
based systems of diagnosis and predictors of response in psychiatry (Insel et al., 2010) is 
to identify quantitatively measurable, specific dysfunctions in cognitive or behavioural 
domains that are related to distinct pathology (Hyman, 2007). This research has initiated 
exploration of a task that has been designed with various advantages over existing 
measures and could contribute to this goal. The presented data suggests the task is 
sensitive to clinical pathology and gives an interesting insight into the role of self-
dissatisfaction, negative performance evaluation and self-depreciation in depression and 
anxiety. The FIQT appears to tap aspects of self-reflection not accessible to existing self-
report questionnaires and has strong potential for use in a wide range of patient 
populations and study design. We did not find that the FIQT was sensitive to treatment 
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response nor find differences in neural activation during the task between patients and 
controls. Despite this, we believe further work should be conducted in the task both in 
relation to treatment response and in relation to brain activity, and associations with 
alternative measures of self-reflection. Small sample sizes may have hindered our ability 
to detect effects should they exist. Further research is therefore required before strong 
conclusions can be drawn, due to the novelty of the FIQT, as well as our sample size.   
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Chapter 5: Dynamic functional connectivity 
in the default mode network in major 
depression: a two-sample validation study2 
 
Chapter summary 
Altered static, or average, functional connectivity strength over the course of a resting-
state scan has been found in various brain networks in major depression. These functional 
abnormalities have been suggested to reflect the negative thinking styles characteristic of 
the disorder, particularly in the default mode network (DMN), which is associated with 
self-referential thought. Dynamic functional connectivity, the study of temporal 
fluctuations in connectivity strength, is a relatively novel analysis technique which has 
not been applied widely in affective disorders to date despite the method’s potential to 
inform us in greater detail about connectivity abnormalities.  
We assessed the stability of connectivity between two key nodes in the DMN associated 
with negative self-reflection: the medial prefrontal cortex (mPFC) and posterior cingulate 
cortex (PCC). This functional connectivity stability was assessed over the course of a 
multi-echo resting-state magnetic resonance imaging scan and compared between Study 
1 patients (n=19) and healthy controls (n=19). The replicability of results was assessed 
in an independent sample using a standard, single-echo resting-state scan. The validation 
sample was a group of patients with un-medicated unipolar depression (but free from 
                                               
2 This chapter has been adapted from the following publication on which I am joint first author: 
Wise, T. and Marwood, L et al. (2017). Instability of default mode network connectivity in major 
depression: a two-sample confirmation study. Translational Psychiatry, 7(4), e1105. 
DOI: 10.1038/tp.2017.40.  
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other psychiatric comorbidities). All patients (n=20) were right-handed and their 
respective control group (n=19) matched for age, handedness and sex.  
Significantly greater variability in connectivity between the mPFC and PCC was identified 
in the patient group in both samples, suggesting that the results were reliable and not due 
to the fMRI resting-state acquisition approach used or due to the specific patient group 
recruited. These results demonstrate that aberrant connectivity in the DMN in depression 
goes beyond alterations in connectivity strength and suggest that individuals with major 
depression show increased variability in functional connectivity within this key functional 
circuit. Replicating the results in two independent samples is a specific strength of this 
work suggesting that the findings are robust.  
These outcomes add a further dimension to theories that suggest altered functional 
connectivity underlies some of the symptoms of mood disorders and may be associated 
with rumination. Further research is required to understand the nature of these 
fluctuations in this newly emerging field of research and to understand their relationship 
to the aetiology of depression, anxiety and rumination.  
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5.1 Introduction 
In major depression, alterations have been identified within both structural and functional 
brain networks (Kaiser 2015; Wise et al., 2015). One of the most studied networks is the 
DMN, which has been proposed to underlie self-referential thought including negative 
rumination (Andrews-Hanna et al., 2010; Perkins et al., 2015). A recent meta-analysis of 
static functional connectivity studies in major depression found hyper-connectivity within 
the DMN and fronto-parietal systems (Kaiser, Andrews-Hanna, et al., 2015). In particular, 
the subsystem of the DMN connecting the medial prefrontal cortex (mPFC) with the 
posterior cingulate cortex (PCC) is considered crucial in generating affective, self-directed 
thoughts as outlined in the introductory chapter of this thesis (Andrews-Hanna et al., 
2010; Perkins et al., 2015).  
Recent work in functional connectivity has begun to look beyond average, or static, 
connectivity and develop a richer understanding of the dynamic nature of these networks 
by examining how their connectivity changes over time, so called dynamic functional 
connectivity (Calhoun et al., 2014; Hutchison et al., 2013; Kopell et al., 2014). To date, 
few studies have been published using this method (Calhoun et al., 2014; Hutchison et 
al., 2013) with one study in major depression (Kaiser, Whitfield-Gabrieli, et al., 2015). 
This study found increased variability in connections between the mPFC and insula and 
decreased variability between the mPFC and parahippocampal gyrus in a large sample of 
patients with depression (n=100) (Kaiser, Whitfield-Gabrieli, et al., 2015), suggesting 
that alterations in dynamic functional connectivity are present in MDD. Despite the mPFC 
and PCC being considered crucial in the generation of negative self-reflective thoughts, 
Kaiser et al. 2015 found no significant differences in variability between these regions, 
potentially due to the whole-brain analysis method used in their analysis, which may have 
lacked power to identify an effect.  
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5.1.1 Aims and hypotheses 
In this study we aim to further understand mPFC dynamic interactions with the PCC in 
depression given their relevance to negative self-referential cognitions associated with 
affective disorders (Andrews-Hanna et al., 2010; Perkins et al., 2015). To investigate the 
dynamic nature of interactions within this network, we examined the variability of 
connectivity between these two regions in participants from Study 1. We then evaluated 
the robustness of our results by seeking replication in an independently recruited sample 
with similar characteristics. Additionally, we tested the association of measures of self-
reflection and depression severity with dynamic functional connectivity between these 
regions.  
Kaiser et al. found increased connectivity variability between the mPFC and insula in 
patients with major depression versus healthy controls. Although not strictly part of the 
DMN, this part of the ‘salience network’ has been found to reciprocally influence the DMN 
when processing salient, internally–generated, emotional thoughts (Uddin, 2015), and 
activation in these regions has also been found to correlate with level of rumination 
(Kaiser, Whitfield-Gabrieli, et al., 2015). Due to these findings, we hypothesised increased 
connectivity variability in patients with major depression versus healthy controls between 
the mPFC and PCC and hypothesised that this variability would be correlated with self-
report measures of self-reflection.  
We tested these hypotheses in two samples of medication-free patients with major 
depression: Sample A (participants from Study 1) and Sample B (an independent 
validation sample who were selected to be free from psychiatric comorbidity). These two 
separate samples were selected to validate the robustness of results arising from the study 
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which is encouraged in fMRI (Nichols et al., 2017). As the two samples varied in their 
presence of clinical comorbidities, this allowed the stability of the result with clinical 
heterogeneity to be tested. Additionally, the fMRI acquisition parameters varied between 
samples – multi-echo versus standard single-echo fMRI pulse sequences in Samples A and 
B respectively. This allowed us to test that results were not due to non-neural artefacts 
owing to utilising the recently developed multi-echo fMRI which is superior to traditional 
de-noising methods of extracting BOLD signal from non-BOLD signal components of 





Sample A comprised patients and healthy controls from Study 1 (see Chapter 3 of this 
thesis for full details of inclusion and exclusion criteria).  
Sample B 
Sample B included patients and healthy controls from the validation sample detailed in 
Chapter 3 of this thesis. 
5.2.2 Functional MRI acquisition 
Data were acquired on the same model of scanner for each sample - identical GE MR750 
3 Tesla scanners with 12-channel radiofrequency head coils. The same high-resolution 
T1-weighted structural scans were acquired in both studies (TR = 7.31ms, TE = 3.02ms, 
256 x 256 matrix, 196 slices, voxel size = 1.2 x 1.05 x 1.05mm). For the resting-state 
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scans, data were acquired in the following sequences: Sample A, an 8-minute multi-echo 
sequence (TR = 2300ms, TEs = 12.7/31/48ms, FOV = 24cm, flip angle=90˚, 33 slices, 
resolution = 3.75 x 3.75 x 4.2mm) and; in Sample B, a 6-minute single-echo resting-state 
scan was acquired using a T2*-weighted echo-planar imaging sequence (TR = 2000, TE 
= 30ms, FOV = 22.1cm, flip angle=75°, 39 slices, resolution = 3.3mm3). In both studies, 
participants were instructed to keep their eyes open and fixate on a cross displayed on a 
computer screen for the duration of the resting-state scan. Cardiac and respiratory signals 
were recorded throughout the duration of the scans. Sample B was an opportunistic, 
validation sample and therefore the scanning parameters differed from Sample A.  
5.2.3 Functional MRI pre-processing 
Pre-processing of data was conducted using Nipype scripts (http://nipy.org/nipype/) 
using tools from SPM-12, the FMRIB Software Library (FSL 5.0.9, 
http://fsl.fmrib.ox.ac.uk/), and Analysis of Functional NeuroImages (AFNI, 
https://afni.nimh.nih.gov/afni/), along with custom code created by Dr Toby Wise. 
The four first volumes of the resting-state series were deleted to allow the magnetisation 
to reach equilibrium, before slice-timing correction was applied and the images were 
realigned and co-registered to the T1 structural images. For Sample B, cardiac and 
respiratory physiological signals were regressed from the data using AFNI’s 
RETROspective Image CORrection tool: RETROICOR (Glover et al., 2000). For Sample A, 
multi-echo data were pre-processed using the multi-echo independent component 
analysis (ICA) tool in AFNI (Kundu et al., 2012) to isolate components in the signal likely 
representing true BOLD signal. This was used in place of RETROICOR for the multi-echo 
data as it has been shown to be a more effective method of de-noising multi-echo data 
(Kundu et al., 2012). Except for the method outlined above for de-noising the data, which 
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varied due to the method of image acquisition, all proceeding processing steps were 
identical for both samples to ensure comparability between the two data sets. 
Data were next demeaned, de-trended, and smoothed with a 6mm FWHM Gaussian 
kernel. Further pre-processing included correction for six rigid-body movement 
parameters (three translations and three rotations, which were determined from the 
middle echo image for Sample A) and extracting time series from white matter and CSF 
regions along with regressing these signals from the data. Data were high-pass (0.008 
Hz) and low-pass (0.09 Hz) temporally filtered to remove low frequency signal drifts and 
high-frequency noise in the data.  
5.2.4 Head motion  
Time points in the data with substantial motion were identified in the BOLD time series  
as even small head movements can affect signal and correlations in resting-state data if 
not controlled for (Power et al., 2012). We assessed motion at each time point using the 
FSL motion outliers tool with its default thresholds using root mean square (RMS) 
intensity difference between volumes and DVARS (Derivative of rms VARiance over 
voxelS, which is a measure of how much the intensity of a brain image changes from one 
volume to the next) (Power et al., 2012). Instead of removing time points exhibiting 
excessive motion, data were inserted at these points using 3rd order b-spline interpolation. 
This was so as not to affect the length of the sliding window in the dynamic functional 
connectivity analysis, and hence dynamic connectivity estimates. All analyses were 
conducted on the pre-processed and motion scrubbed data. 
Motion was compared between the samples in terms of total distance travelled, framewise 
displacement (head movement from one volume to the next) and absolute displacement 
(movement of the head from the origin position at each time point) (Power et al., 2012).  
123 
5.2.5 Definition of regions of interest 
Canonical ICA, a data driven method, was used to identify DMN components in the data 
(Varoquaux et al., 2010). This was implemented in Nilearn (machine learning for 
Neuroimaging in Python, https://nilearn.github.io/) using 20 clusters. Clusters centred 
on the PCC and mPFC regions in the identified DMN component were used to create 
regions of interest (ROIs) for the connectivity variability analysis. This process was 
conducted separately for the two samples to identify more accurate, sample-specific ROIs 
as anatomy and connectivity can vary considerably between individuals and therefore 
defining the ROI for one sample and applying it to the other sample could lead to 
inaccuracies (Poldrack, 2007). The size of each ROI was set to a sphere of 10mm 
diameter, centred on the peak of each cluster from the canonical ICA analysis. Limiting 
the size of the ROI, instead of using the whole cluster, ensured a more consistent signal, 
less affected by activation in surrounding regions. 
We also extracted a negative control region to ensure that any results relating to these 
ROIs were specific to these regions rather than being a global brain-wide pattern or 
caused by non-neural influences. The negative control ROI, not previously linked to 
depression, was a 10mm spherical region in the medial primary motor cortex (MNI co-
ordinates: -1, -8, 63). Mean time series were extracted from each of these ROIs.  
5.2.6 Sliding window correlation analysis  
Most studies of dynamic functional connectivity have used a sliding window approach to 
investigate the changes in correlations across the course of a scan (Allen et al., 2012; 
Kiviniemi et al., 2011). This method involves conducting connectivity analyses on a set 
number of scans in an fMRI session (a defined window) and then repeating the analysis 
shifting the window by a certain number of scans. 
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Our sliding window analysis was conducted using custom Python scripts created by Dr 
Toby Wise (https://www.python.org/). The window was set at 40-seconds and staggered 
by one TR. We used a Gaussian window, which produces a tapered window (see Figure 
5-a for an illustration of the analysis technique). It has been shown that window lengths 
of greater than 30 seconds are sufficient to measure robust effects (Shirer et al., 2011). 
The time period we chose has been shown to be appropriate for dynamic functional 
connectivity analysis previously, providing a detailed depiction of temporal connectivity 
changes (Zalesky & Breakspear, 2015). While longer windows are suitable for 
investigating low-frequency changes in connectivity strength, they fail to detect higher 
frequency fluctuations, as illustrated via simulation data in the supplementary material 
of the published version of this chapter (Wise et al., 2017). The simulation data validated 
the method used here and showed that we are likely measuring real and not spurious 
fluctuations in connectivity based on our choice of window length and high-pass cut-off 
frequency.   
Within each window, the correlation between variance-normalised time series were 
calculated from the two ROIs using Pearson correlations. These results were transformed 
to Z-scores. The standard deviation of these correlations was calculated, giving a measure 
of variability of these correlations. Any participant with outlying variability, defined as 
greater than three standard deviations from the mean, were removed from further 
analyses.  
The relationship between connectivity variability and clinical measures was explored 
using Pearson partial correlations in both samples: depression (total MÅDRS score) and 
anxiety severity scores (HDRS-17 anxiety subscale e.g. (McClintock et al., 2011), time 
since illness onset (years) and self-report level of rumination (measured using the total 
score on the RRS,(Treynor et al., 2003). In Sample A, additional correlations between 
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connectivity variability were conducted with self-report measures of worry (total score on 
the PSWQ, (Meyer et al., 1990) and self-criticism (measured using a total of the two self-
criticism subscales of the FSCSR scale, Gilbert et al., 2004).  
Figure 5-a: Dynamic functional connectivity method.  
 
A) Image of the default mode network components identified using ICA, showing 
clusters in the mPFC and PCC (step 1). B) Illustration of the dynamic functional 
connectivity sliding window analysis method (steps 2:4). Abbreviations - PCC: 
Posterior cingulate cortex, mPFC: Medial prefrontal cortex, ICA: Independent 
Component Analysis. 
 
5.2.7 Static functional connectivity analysis 
To understand any relationship arising between static and dynamic functional 
connectivity, we calculated static functional connectivity between the ROIs. This was 
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conducted by calculating the average connectivity strength between these regions using 
the whole, non-windowed time series. 
5.2.8 Voxel-based morphometry analysis 
Additionally, we examined the existence of grey matter volumetric differences in the 
chosen ROIs and at a whole-brain level between patients and controls which could 
account for any differences found in connectivity. The high-resolution T1-weighted 
structural images were pre-processed using voxel-based morphometry in SPM-12 and the 
images segmented into different tissue types using DARTEL (Ashburner, 2007). Images 
were then normalised in MNI space. The grey matter images were smoothed with an 8mm 
FWHM Gaussian kernel before the grey matter volume was compared in the mPFC and 
PCC ROIs between patients and healthy controls with a two samples t-test. An uncorrected 
voxel-wise threshold of p < .001 was used, with a cluster threshold of p < 0.05, FDR 
corrected. A whole brain comparison, looking at total grey matter volume in the 
segmented maps between groups, was calculated at a threshold of p <.05. 
5.2.9 Additional analyses 
Additional statistical analyses were conducted using R (R Core Team, 2015). Group 
comparisons and correlations were corrected for the number of comparisons using FDR 
correction: mPFC-PCC, PCC-negative control region, and mPFC-negative control region. 
Additionally, group comparisons and correlations were adjusted for total head movement 





Nineteen patients with unipolar major depression in Sample A and twenty patients in 
Sample B were matched with 20 and 19 healthy controls in each sample respectively (see 
Table 5-a for participant characteristics). A healthy participant from Sample A was 
excluded from the analyses due to outlying variability values.  
The two samples did not differ in terms of depression severity (total MÅDRS scores): t(37) 
= -1.83, p = 0.07. However, as expected due to the higher levels of comorbid anxiety 
disorder in Sample A, this sample had significantly higher anxiety scores: t(37) = 3.45, p 
= 0.001. Sample A also had significantly higher RRS scores: t(37) = 3.51, p = 0.001 and 
a longer illness duration (time since illness onset): t(37) = 2.62, p = 0.01 than Sample 
B. 
The peak MNI co-ordinates of the ROIs in each sample were identified in Sample A as: 
mPFC: 2, 60, -4; PCC: 6, -44, 11 and in Sample B: mPFC: 4, 60, 0; PCC: 2, -62, 22. 
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Table 5-a: Sample Characteristics   
 Patient Groups Control Groups p 
Sample A 
Age, years 32.34 (10.62) 31.91 (10.30) 0.90 
Male/Female (n) 7, 12 6, 13* 0.73 
MÅDRS 30.74 (7.31) 1.37 (1.86) < .001 
HDRS anxiety subscale 7.16 (1.30) 0.31 (0.58) < .001 
RRS 66.47 (8.22) 30.63 (6.83) < .001 
FSCRS: SC scale 33.60 (9.84) 13.89 (9.68) < .001 
PSWQ 63.05 (11.45) 37.11 (14.98) < .001 
Time since illness onset 
(years) 13.50 (8.26) - - 
Comorbid diagnoses 
N=12 (9 GAD, 5 SAD, 4 




Previous hospitalisations 4 participants - - 
Number of depressive 
episodes 4 (2.5) - - 
Sample B 
Age (years) 29.55 (6.59) 30.05 (6.71) 0.81 
Male/Female (n) 2, 18 2, 18 1 
MÅDRS 27.25 (4.24) 0.95 (1.39) < .001 
HDRS anxiety subscale 4.95 (2.48) 0.21 (0.42) < .001 
RRS  56 (10.23) 29.67 (6.44) < .001 
Time since illness onset 
(years) 6.35 (6.41) - - 
Comorbid diagnoses None - - 
Previous hospitalisations 0 participants - - 
Number of depressive 
episodes 1.5 (1.25) - - 
*Demographics for Sample A represent the 19 healthy controls included in the final 
analysis. Values are reported as mean (standard deviation) apart from number of 
previous episodes where, due to skewed data, we instead report median 
(interquartile range). Abbreviations - MÅDRS, Montgomery-Åsberg Depression Rating 
Scale: HDRS, Hamilton Depression Rating Scale (17 item): RRS, Ruminative Response 
Scale: FSCRS SC: Forms of Self-Criticising/Attacking and Self-Reassuring Scale: Self 
Criticism subscale: PSWQ, Penn State Worry Questionnaire: GAD, Generalized Anxiety 
Disorder: SAD, Social Anxiety Disorder: OCD, Obsessive Compulsive Disorder: PD, 
Panic Disorder (with or without agoraphobia): PTSD, Post-Traumatic Stress Disorder. 
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5.3.2 Connectivity variability 
Connectivity variability (the standard deviation of connectivity strength) between the 
mPFC and the PCC over the course of the sliding windows (see Figure 5-b) was 
significantly greater in patients with major depression versus healthy controls in both 
Sample A (t(36) = 2.53, p = .045, d = 0.82) and Sample B (t(37) = 2.56, p = .044, d = 
0.82). This replication across samples supports the consistency of this finding regardless 
of the method of image acquisition and presence of clinical heterogeneity in the patient 
groups. 
In the negative control regions, there were no group differences in connectivity variability 
between the mPFC and primary motor cortex in either sample (Sample A: t(36) = 1.85, 
p = .22 or Sample B: t(37) = 0.79, p = .44), or between the PCC and primary motor 
cortex in either sample (Sample A: t(36) = 0.63, p = .99 or Sample B: t(37) = 1.76, p = 
.17). This suggests the results found in connectivity variability in the DMN do not 
represent global brain instability differences.   
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Figure 5-b: Connectivity variability between the mPFC and PCC for patient 
and healthy control groups in both samples.  
 
Plots represent the distribution of data in each group, along with individual 
participant data points. Larger dashed lines represent means and small dashed lines, 
standard errors. Abbreviations - MDD: Major depressive disorder, HC: Healthy 
control, SD: Standard deviation; * p < .05 in comparison between patient and control 
groups.  
 
5.3.3 Static connectivity 
There was no significant difference between patients and healthy controls in static 
connectivity strength between the mPFC and PCC in either Sample A: t(36) = .75, p = 
0.45, d = 0.24) or Sample B: t(37) = 0.33, p = .74, d = 0.11.  
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5.3.4 Connectivity variability and self-reflection measures 
In the patient group in Sample A, a positive correlation between RRS and connectivity 
variability was found (r(14) = 0.51 p = .045, see Figure 5-c). This was not found in 
Sample B (r(15) = 0.18, p = .48). In Sample A, the additional correlations with other 
self-report measures of self-reflective thoughts were not found to significantly correlate 
with connectivity variability (worry: r(14) = -0.04, p = 0.88 or self-criticism: r(14) = 
0.21, p = 0.43). 
Figure 5-c: Correlation between connectivity variability and rumination (RRS 
score) in major depression in the both samples. 
 SD: Standard deviation.  
 
5.3.5 Correlations with clinical variables 
No significant correlations between connectivity variability and the following clinical 
variables were found in either sample: depression symptom severity (Sample A: r(14) = 
0.16, p = 0.56, Sample B: r(15) = 0.37, p = 0.14); anxiety symptom scores, measured 
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by the anxiety subscale of the HDRS (Sample A r(14) = -0.55, p = 0.56, Sample B: r(15) 
= 0.11, p = 0.66); or time since illness onset (Sample A: r(14) = 0.10, p = 0.71, Sample 
B: r(15) = 0.25, p = 0.33). 
5.3.6 Grey matter volumes 
There was no significant difference in total grey matter volume between the patient and 
control groups (Sample A: t(36) = 0.79, p = 0.43 or Sample B: t(37) = 1.43, p = 0.16). 
Nor any differences between groups in grey matter volume in the selected ROIs (no 
significant clusters at p < 0.05, FDR corrected thresholds). 
5.3.7 Head motion 
A comparison of total head distance travelled between patients and controls showed no 
significant differences in either Sample A: t(36) = 0.56, p = 0.58 or Sample B: t(37) = -
1.31, p = 0.20. Additionally, there were no significant differences between groups in 
mean framewise displacement (Sample A: t(36) = 0.26, p = 0.80, Sample B: t(37) = 
0.88, p = 0.38) or maximum absolute displacement (Sample A: t(36) = 1.48, p = 0.15, 
Sample B: t(37) = 0.42, p = 0.68). Furthermore, there were no significant differences in 
the number of interpolated time-points in the fMRI series between groups in either 
Sample A: t(36) = 1.60, p = 0.12 or Sample B: U(37) = 173, p = 0.64 (non-parametric 
test used due to non-normally distributed data). This suggests group differences in 




5.4.1 Interpretation of findings 
We compared temporal variability in connectivity strength within the DMN between 
medication-free patients with major depression and healthy controls and found that 
connectivity between the mPFC and PCC, two key nodes of the DMN implicated in 
depression, was significantly more variable in the patient group. We replicated this 
finding in an independent sample free from comorbidities and using a different method 
of image acquisition, highlighting the robustness of our result. 
The current findings complement previous research which has found abnormal dynamic 
connectivity in depression (Kaiser, Whitfield-Gabrieli, et al., 2015) and add to the 
growing field of dynamic functional connectivity research generally (Calhoun et al., 2014; 
Kopell et al., 2014). Despite the recent emergence of this field, a number of studies have 
begun to identify alterations in dynamic functional connectivity in other psychiatric 
conditions such as schizophrenia (Damaraju et al., 2014; Ma et al., 2014), Alzheimer’s 
disease (Jones et al., 2012; Wee et al., 2015) and bipolar disorder (Rashid et al., 2014). 
These findings, along with the results of the present study, suggest that dynamic 
connectivity holds promise for providing a clearer, novel insight into connectivity 
abnormalities in psychiatric disorders. 
The previous study assessing dynamic functional connectivity in unipolar depression by 
Kaiser et al., demonstrated altered connectivity variability between the mPFC and insula, 
and decreased variability in connectivity between the mPFC and parahippocampal gyrus 
in depression. They did not find any significant altered connectivity variability between 
the mPFC and PCC, the areas under investigation in this study. This lack of finding might 
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be explained by the more limited power in whole brain analyses used in Kaiser et al.’s 
study, due to the necessary correction for multiple comparisons. 
Presently, the causes of time varying properties of connectivity are not well understood 
(Hutchison et al., 2013). One potential explanation for our findings is that they result 
from altered structural connectivity which has been associated with dynamic functional 
connectivity – higher structural connectivity being associated with more stable dynamic 
functional connectivity (Shen et al., 2015). Therefore, it is plausible that the increased 
connectivity variability between the mPFC and PCC we found was a result of reduced 
structural integrity. However, we believe this to be unlikely as a recent meta-analysis 
found that patients with depression do not have reduced integrity in the tracts connecting 
these regions (Wise et al., 2015). We therefore believe that these results reflect primary 
functional alterations as opposed to being secondary to aberrant structural connectivity. 
However, research clarifying the exact causes of connectivity variability, and its 
relationship to static connectivity is an important area for future research. 
It is possible that the functional alteration found is related to negative self-reflection. The 
DMN, and mPFC-PCC connectivity in particular, is believed to underlie self-referential 
thought (Hamilton et al., 2011; Perkins et al., 2015). As a result, high levels of intrusive, 
self-generated, ruminative thoughts may be associated with fluctuations in connectivity 
within this network. In Sample A, we found a positive correlation between connectivity 
variability and trait rumination, which is in line with this explanation. This association 
with rumination, however, was not found in Sample B, and as such this finding should be 
interpreted with caution and warrants further investigation. It is possible that this may be 
due to differences in the clinical characteristics of the samples. For example, patients in 
Sample A had more comorbid anxiety disorders, higher average RRS scores, and had 
experienced a greater number of previous depressive episodes. However, we did not find 
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an association in Sample A between variability and self-report self-criticism and worry 
(two other measures of self-reflection) calling into question links with all forms of self-
generated thought. 
Despite not finding a consistent association with rumination, we cannot rule out that the 
heightened variability we found is not related to ruminative thought processes. We used 
a trait measure of rumination which may not reflect state levels of rumination experienced 
during the scans. A measure of reported rumination throughout the scan may be required. 
This also applies to our measures of self-critical thoughts and worry and could explain 
our null results. A post-scan report method was used in a previous study in healthy 
controls (Kucyi & Davis, 2014) which revealed a positive correlation between variability 
in the DMN and reported daydreaming, a related phenomenon to rumination, during 
scanning. This indicates that variability of connectivity within the DMN may be associated 
with daydreaming or self-reflection. Building on this, alterations in these processes might 
underlie the results with rumination shown here, although this merits confirmation in 
further work with post-scan measures of self-reflection during scanning or alternative 
global self-report measures of self-reflection (the limitations of current methods to assess 
self-reflection are discussed in Chapter 4). 
It is possible that alterations in dynamic connectivity observed here reflect neuronal level 
processes. Simulation studies have indicated that patterns of synchronisation and de-
synchronisation in neuronal populations lead to fluctuations in functional connectivity 
(Honey et al., 2007), while noise-driven neuronal simulations produce switches between 
states of functional connectivity (Hansen et al., 2015). A simultaneous 
electroencephalography (EEG) and fMRI study has shown that changes in BOLD 
functional connectivity coincide with EEG power variations (Tagliazucchi et al., 2012) 
further indicating that fluctuations in functional connectivity are reflective of neuronal 
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processes. Whether the observed increased connectivity variability in major depression is 
reflective of neural functioning corresponding to certain cognitive or emotional states or 
whether it is an abnormal neurophysiological function, perhaps causing increased noise 
in neural circuits, is not clear. Indeed, due to the lack of certainty surrounding the causes 
and correlates of variability in dynamic functional connectivity (Hutchison et al., 2013), 
we are limited to speculative interpretations about what they may imply in terms of 
pathological neural activity in depression. 
No association was found in either sample between connectivity variability and 
depression severity which may suggest that variability is not directly related to depressive 
symptoms. Alternatively, our lack of association could be due to our measure of symptom 
severity, the MÅDRS, being heavily weighted to physical symptoms of depression rather 
than cognitive or psychological aspects. Indeed, previous research has suggested that 
alterations in DMN connectivity are more likely to be related to psychological symptoms 
such as negative self-referential thought patterns (Hamilton et al., 2011), which could 
explain our null results. In addition, studies have found symptoms to be uncorrelated with 
biological disease processes which is likely due to their unreliable nature and indirect 
relationship with biological mechanisms (Calhoun et al., 2014). 
It has previously been suggested that static hyper-connectivity will imply lower temporal 
variability in connectivity (Chang & Glover, 2010; Kaiser, Whitfield-Gabrieli, et al., 2015); 
however, this is at odds with our results, where we did not find static hyper-connectivity 
between groups but did find increased temporal variability. Our results therefore suggest 
that the relationship between dynamic and static connectivity is complex with dynamic 
functional connectivity providing distinct information about network communication in 
pathology independent from, and beyond that of, static connectivity. This echoes findings 
from previous research (Calhoun et al., 2014; Rashid et al., 2014) that classified patients 
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with schizophrenia, bipolar disorder and healthy controls based on functional 
connectivity and found that classification using a combination of static and dynamic 
connectivity was more accurate than static connectivity alone. Our findings are 
concordant with this, in that they demonstrate that each form of connectivity provides 
distinct and complementary information. 
5.4.2 Strengths and limitations 
A key strength of this study is our control of non-neural influences on the data. It is well 
known that resting-state fMRI analyses are susceptible to influences from confounding 
factors such as subject motion and physiological variables, such as heart rate and 
respiration (Glover et al., 2000; Power et al., 2012); however, we thoroughly controlled 
for these. Firstly in Sample B, we corrected for cardiac and respiratory signals using the 
RETROICOR method (Glover et al., 2000) to limit the influence of physiological factors. 
Secondly, in addition to regressing out motion parameters, as is commonly done in fMRI 
analysis, we scrubbed time points exhibiting high motion in both samples. This technique 
has been shown to limit the occurrence of spurious correlations in resting-state 
connectivity analysis (Power et al., 2012). Finally in Sample A, we used multi-echo fMRI 
with ICA-based de-noising, which has been shown to be more effective than traditional 
de-noising methods at distinguishing true BOLD from non-BOLD signal (Kundu et al., 
2013, 2012). Together, these measures ensured that effects of confounding factors on our 
results were limited, and we can be confident that our results do not simply reflect 
physiological or motion-related artifacts. Moreover, our negative control analyses (with a 
motor cortex ROI) indicated that our findings were not reflective of global differences 
between groups and were instead specific to the disease-relevant network. We also 
showed that the patient and control groups did not differ on motion parameters and 
therefore motion artefacts cannot explain group differences. 
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A further strength of the present study is that all patients were free from psychotropic 
medication at the time of scanning, and as such our results are not due to an acute effect 
of pharmacotherapy. In addition, many patients in Sample B were medication naïve and 
had experienced few, if any, depressive episodes previously, making it less likely that the 
effects observed here are cumulative effects of illness or previous therapies. The fact that 
altered connectivity variability was also found in Sample A, which included patients with 
more chronic and heterogeneous illnesses, suggests that variability may not be modified 
by extended illness or be specific to a distinct patient population.  Additionally, the two 
samples resting-state data being acquired by different methods – single versus multi-echo 
image acquisition – further increased confidence in the findings not being due to 
methodological parameters. However, causality cannot be inferred from our results, and 
further research is necessary to replicate these outcomes and determine whether 
alterations in dynamic functional connectivity play a role in the aetiology of major 
depression. Furthermore, it is unclear from this study whether heightened variability in 
connectivity in key nodes of the DMN is specific to the depressed state or whether this is 
a trait marker of vulnerability to depression. Studies in remitted patients or in individuals 
at heightened risk of depression will be required to answer this question. Additionally, 
longitudinal studies scanning patients before and after psychological or pharmacological 
therapy could explore whether treatment normalises this increased variability.  
A limitation of this study is the ROI approach used. We focused on two regions of the 
DMN, chosen due to their key role in affective disorders and negative self-reflective 
thoughts (Andrews-Hanna et al., 2010; Fransson & Marrelec, 2008; Perkins et al., 2015), 
and limited our analyses to these a priori regions of interest to increase our power to 
detect changes given our relatively small sample sizes. It would have been of interest to 
replicate the findings of Kaiser et al.’s, for example, altered variability in the insula. 
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However, we chose to focus on the key areas of the DMN that have been most linked to 
aberrant levels of self-reflection in affective disorders given the novelty of this field to 
reduce likelihood of type 2 errors given our small sample sizes. Despite the relatively 
small samples, the replication of the results across the two samples increases our 
confidence that the results are not spurious. We selected the ROIs separately for each 
sample using canonical ICA, a data driven method. Alternative and widely used methods 
for selecting ROIs in fMRI analysis are based upon brain atlases or previous functional 
studies. A group ICA approach is less affected by noise in the data and avoids prior spatial 
assumptions (Cole et al., 2010; Sohn et al., 2015). However, there is still the issue of 
defining the region of interest across all groups in a given study as the method of 
canonical ICA, takes into account but, does not fully control for individual variability. 
Canonical ICA has been shown to provide better group level data than other ROI selection 
approaches (Varoquaux et al., 2010). However, although the same ICA method was 
applied to both samples in this chapter, it cannot be fully ruled out that the regions 
identified do not align precisely in terms of anatomical regions between the groups.  
A further limitation was the length of the resting-state imaging sequences. The multi-echo 
sequence for Sample A was only 8 minutes long, and in Sample B, only 6 minutes. Less 
frequent fluctuations in connectivity may therefore have been missed in these relatively 
short sequences. Due to high comorbidity between anxiety and depression, it is impossible 
to rule out the possibility that these results are reflective more of anxiety symptoms. 
However, as we found the same effect in separate samples, with differing levels of 
comorbid anxiety, this is unlikely. Further work is required to determine if the increased 




5.4.3 Overall conclusion 
In conclusion, our study shows that major depression is associated with increased 
variability in the DMN, which is likely to represent an intrinsic neural property of disease 
related, network-specific brain function that cannot be explained by structural 
abnormalities or static functional connectivity. A major strength of our study is that we 
could replicate the result in a second independent sample, suggesting that our finding is 
robust. More generally, this work highlights the importance of studying functional 
connectivity dynamically to gain a more detailed picture than previous static functional 
connectivity studies in this field. As ruminative thoughts may partially explain our results, 
further work is required to explore the link between self-referential thoughts during the 
scanning session and connectivity variability. Additionally, future work should investigate 
whether connectivity variability differences are specific to the depressed state, a 
vulnerability marker, or common to all affective disorders.  
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Chapter 6: Threat-related pursuit and goal-
conflict in patients with depression and 
anxiety versus healthy controls 
 
Chapter Summary 
Threat avoidance is a prominent symptom of anxiety disorders and major depression, yet 
its biological basis remains poorly understood. In particular, it is unclear what neural 
systems underlie distinctions between anxiety and fear in pathological avoidance and 
anticipation of perceived threats. Here we used a validated task, the Joystick Operated 
Runway Task (JORT), involving avoidance of mild electric shocks, combined with fMRI, 
to explore whether abnormal function in circuits responsible for avoidance underlies these 
symptoms. Behavioural performance on this task was also studied in a comparison 
between patients with depression and comorbid anxiety disorders and healthy controls, 
and in relation to response to cognitive behavioural therapy due to this treatment 
targeting aberrant levels of avoidance and attentional bias towards threats. 
Eighteen individuals with major depression and comorbid anxiety disorders, in addition 
to seventeen healthy controls, performed the in-scanner task which involved using 
physical effort to avoid threatening stimuli, paired with electric shocks on certain trials. 
Activity during anticipation and avoidance of threats was explored and compared 
between groups. Behaviourally, 29 participants (16 patients and 13 healthy controls) and 
14 patients before and after a course of cognitive behavioural therapy completed the 
JORT. 
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Anticipation of avoidable aversive stimuli was associated with significant activation in the 
dorsal anterior cingulate cortex, superior frontal gyrus and striatum, while active 
avoidance of aversive stimuli was associated with activity in dorsal anterior cingulate 
cortex, insula and prefrontal cortex. No differences in neural activation were observed 
between healthy controls and patients. Behaviourally, there were no significant 
differences in JORT measures between patients and controls despite patients reporting to 
experience more dread whilst being chased on the task. Additionally, JORT behavioural 
measures did not significantly change post- compared to pre-therapy. 
Our results suggest that the task was effective in identifying neural systems involved in 
avoidance and anticipation of aversive stimuli. However, the absence of significant 
differences in activation between patients and controls suggest that major depression is 
not associated with abnormal function in these networks. Similarly, no group differences 
were found behaviourally on the JORT task and performance was not found to be related 
to response to cognitive behavioural therapy. Future research should investigate the basis 
of passive avoidance in major depression and this task should be further explored in 
patients with anxiety disorders (free from comorbid major depression), where threat 




As discussed in the introductory chapter (Chapter 1), threat sensitivity is a compelling 
model for explaining psychiatrically relevant individual differences in proneness to 
negative emotion owing to the capacity for drugs with clinical effectiveness against 
affective disorders to alter innate defensive reactions to threats (Blanchard et al., 1990; 
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Griebel et al., 1995; Perkins et al., 2013; Perkins et al., 2009) and this concept underlying 
many psychological therapies (LeDoux et al., 2017). Threat avoidance is proposed to 
comprise of two forms of defensive direction in Gray and McNaughton’s reinforcement 
sensitivity theory: fear when escape is possible and anxiety where escape is not always 
possible and threats require approach (Gray & McNaughton, 2000). However, much of 
the evidence for this differentiation comes from rodent models of threat avoidance. 
As such, these defensive directions had previously been studied in isolation of one another 
in humans until the development of the Joystick Operated Runway Task (JORT) by Dr 
Adam Perkins which allows within-task, within-subject comparison of these elements of 
threat behaviours. The JORT is an adaptation of the Mouse Defence Test Battery (MDTB, 
Griebel et al., 1997) which is an established active-avoidance model used to study threat 
behaviour in mice when they are chased by an anaesthetised rat under both simple pursuit 
(fear) and goal-conflict (anxiety) conditions. In the human translation of this task, 
participants are chased by digital predators on a computer screen under two equivalent 
active-avoidance conditions: pursuit trials when participants are chased by one predator 
requiring flight behaviour, and goal-conflict conditions when participants are chased by 
two predators which leads to an approach-avoidance conflict. The task requires the 
participant to engage in physical effort to avoid getting caught thus mimicking real-world 
threatening experiences. On certain trials the innately fearful threats are paired with mild 
electric shocks or loud bursts of aversive white noise, adding an additional element of 
threat by association with a cued aversive event. Along with anxiety and fear related 
behaviours, defensive intensity is another aspect of threat avoidance that can be measured 
on the task by quantifying the overall speed, acceleration and oscillations in movement 
made by participants to avoid getting caught (Perkins et al., 2009, 2011).  
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In support of the differentiation between fear and anxiety being psychiatrically relevant, 
Perkins et al. (2011) found that flight behaviour on the JORT was increased in healthy 
participants determined post-hoc to have a genetic risk factor for panic disorder, 
compared to participants without the risk factor. In addition to increased flight behaviour, 
carriers of the risk gene for panic disorder reported being more fear prone via self-report 
on the tissue damage fear subscale of the Fear Schedule Survey (Wolpe & Lang, 1964), 
but not more anxiety prone. 
The task was also piloted behaviourally in healthy participants across two blinded, 
randomised, within-subject trials to explore the effects of the anti-anxiety drug lorazepam 
versus the anti-panic drug citalopram on defensive direction. It was found that lorazepam 
decreased Risk Assessment Intensity, a measure of anxiety on the task (i.e. the level of 
forward-backward oscillations during approach to threat) but that citalopram did not 
significantly decrease Flight Intensity on the pursuit trials as expected (a measure of fear 
related behaviour) (Perkins et al., 2009). A second study further exploring the effects of 
lorazepam on threat behaviours by Perkins et al. (2013) found a personality-dependent 
effect of lorazepam on Flight and Risk Assessment Intensity. Specifically, lorazepam was 
found to increase Risk Assessment Intensity in those with high trait anxiety scores but 
decrease it in low scorers. In contrast, lorazepam was found to decrease Flight Intensity 
on those scoring high on a measure of fear and increase Flight Intensity in low scorers.  
Evidence from the JORT task is therefore mixed in terms of support for the reinforcement 
sensitivity theory, suggesting that the model, which is based largely on rodent studies, 
may be too simplistic or not translate precisely to human avoidance behaviours. 
Potentially, psychotropic medications may have broader modes of action in humans than 
rodents. Nevertheless, further work has supported the differentiation in humans via self-
report questionnaire data which has shown specific associations between trait anxiety and 
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threat approach, and fear with orientation away from threats (Perkins & Corr, 2006; 
Perkins et al., 2007).  
As the JORT’s behavioural studies have shown that the task’s goal–conflict and pursuit 
trials are differentially sensitive to anxiolytic medication, and potentially psychiatrically 
relevant measures, the JORT has been adapted to be suitable as an fMRI paradigm to 
facilitate understanding of the brain systems underlying fear and anxiety. Rodent studies 
have found that pursuit of threat activates midbrain regions and that goal-conflict is 
governed by the hippocampus (Gray & McNaughton, 2000). Ethological fMRI studies in 
humans, albeit in healthy controls and using other rodent paradigms such as foraging or 
maze based tasks with chasing virtual predators, provide evidence of similar brain systems 
governing threat-related pursuit and goal conflict. Prefrontal regions such as the ACC and 
ventromedial prefrontal cortex (vmPFC) and low-level midbrain regions (such as the 
PAG) have been found to be activated in threat pursuit (Mobbs et al., 2009, 2007), 
whereas the anterior hippocampi have been found to be activated in goal-conflict tasks 
(Abraham et al., 2013; Bach et al., 2014; O’Neil et al., 2015) as well as more recently the 
amygdala (Korn et al., 2017). Prefrontal cortices have been found to be activated with 
distal threats, possibly reflecting the higher level cognitive planning of threat-avoidance, 
whereas midbrain regions have found to be activated when threats are close, potentially 
reflecting a shift to evolutionarily older brain regions that control reflexive defensive 
behaviours such as flight, fight and freeze behaviours (Mobbs & Kim, 2015; Mobbs et al., 
2007). These ventral midbrain regions have also been associated with basic reward and 
incentive motivation (Mobbs & Kim, 2015).  
The fMRI version of the JORT was first piloted in healthy control participants (Perkins et 
al., Under Submission). In line with other human and rodent research, differentiations 
were found between pursuit and goal-conflict conditions with midbrain and prefrontal 
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activation being associated with flight in pursuit trials and hippocampal activation being 
associated with goal-conflict (Bach et al., 2014; Mobbs et al., 2009, 2007). The runway 
design of the task allowed the measurement of the effect of threat distance on brain 
activity; however, no main effect of the threat of receiving an electric shock was found. 
Perkins et al. also found that brain activation was associated with psychological measures. 
Lower hippocampal activation in goal-conflict plus imminent threat was associated with 
higher neuroticism scores, which suggests that those with a personality more susceptible 
to anxiety and depression have altered goal-conflict processing under threat. This adds 
further to evidence suggesting that affective disorders reflect alterations in the 
functioning of brain systems which govern responses to threat.  
The JORT has thus far only been validated in healthy participants. Due to the potential 
psychiatric relevance of the task, observed association between neural activation on the 
JORT and neuroticism, and sensitivity to psychotropic medications behaviourally, we 
piloted the measure in patients with depression and comorbid anxiety disorders. Due to 
findings linking depression and anxiety disorders with elevated attentional focus on 
threats and negative anticipation (Grupe & Nitschke, 2013), we also evaluated brain 
activation during anticipation, when the type of trial was cued - a previously unstudied 
phase of the fMRI task. Anticipation of the need to avoid an aversive stimulus has been 
positively associated with activity in the ACC, ventromedial PFC (vmPFC) and striatum 
(Critchley, Mathias, & Dolan, 2001; Mobbs et al., 2007; Rzepa et al., 2017). These regions 
have been found to relate to cognitive processing of emotions such as fear, evaluation of 
context, vigilance and behavioural control (Amat et al., 2006; Critchley et al., 2004; Liotti 
et al., 2000; Mobbs et al., 2009; Schiller et al., 2008).  
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6.1.1 Hypotheses and aims 
6.1.1.1 Neuroimaging sample 
We hypothesised that anticipation of the need to avoid an aversive stimulus would be 
associated with increased activity in the ACC, vmPFC and striatum (Mobbs et al., 2007; 
Rzepa et al., 2017). It was expected that active avoidance in pursuit trials (relating to 
fear) would elicit activity in the vmPFC, cerebellum and PAG (Mobbs et al., 2007; Perkins 
et al., Under Submission) and that active avoidance in goal-conflict (anxiety related) trials 
would elicit hippocampal activation (Bach et al., 2014; Perkins et al., Under Submission). 
In our group comparison (patients versus controls from Study 1), the hypotheses were 
that: patients would show increased activation, compared to controls in the regions 
hypothesised for both anticipation and threat pursuit conditions. An equivalent prediction 
was made for the main effects of each condition and association with threat (a comparison 
between threat versus no threat trials). 
As well as whole brain analyses, we conducted ROI analysis with the expectation that: 1) 
PAG activity would be positively associated with threat proximity and that 2) goal-conflict 
sensitivity would be associated with activation of the anterior hippocampus and that this 
activation would be positively associated with neuroticism, as per findings in the fMRI 
piloting of the JORT in healthy controls (Perkins et al., Under Submission).  
Regressions explored the relationship between psychological variables in anticipation and 
flight phases of the JORT. These included post-task subjective dread ratings (which we 
hypothesised would relate to the anticipation phase and Risk Assessment Intensity on 
goal-conflict trials, (Berns et al., 2006), trait anxiety (STAI, which was hypothesised to 
relate to neural activity on goal-conflict trials) and fear (FSS tissue damage subscale, 
which was hypothesised to correlate with brain activation on pursuit trials) (Perkins et 
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al., 2013; Perkins & Corr, 2006; Perkins et al., 2007). Additionally, regressions between 
behavioural JORT performance and neural activation were explored. These behavioural 
measures included: Flight Intensity (the degree that signalled threat increased speed of 
movement in fear conditions) and Risk Assessment Intensity (the degree that signalled 
threat increased anxiety behaviour) along with average velocity on pursuit trials and 
average oscillations in movement on goal-conflict trials. It was expected that elevated 
JORT threat-avoidance behaviours would be associated with exaggerated activation 
patterns in the hypothesised regions.  
6.1.1.2 Behavioural sample 
Due to evidence that anxiolytic medication reduced threat-related behaviour on the JORT 
(Perkins et al., 2013; Perkins et al., 2009) and elevated sensitivity to threats being key 
features of affective disorders (LeDoux et al., 2017), higher Flight Intensity and speed of 
movement in pursuit trials, and Risk Assessment Intensity and oscillations in movement 
on the goal-conflict trials scores were expected in the patient group relative to controls 
(measures from participants in both Study 1 and 2 who completed the JORT task offline). 
Positive correlations between JORT behavioural measures and the following self-report 
measures were expected: neuroticism (EPQ-R), state dread and depression severity 
(MÅDRS), due to findings of elevated threat sensitivity in psychopathology (LeDoux et 
al., 2017). Additionally, positive correlations were expected between fear (FSS fear of 
tissue damage scale) and Flight Intensity, and trait anxiety (STAI) and Risk Assessment 
Intensity scores, in line with the differential directions of threat avoidance; fear being 
associated with flight behaviours and anxiety with risk assessment, as proposed in the 
reinforcement sensitivity theory (Gray & McNaughton, 2000). 
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6.1.1.3 Behavioural results with therapy 
A subset of participants completed the task twice - both before and after a course of CBT 
(Study 2 participants). It was expected that patients would have lower Flight Intensity 
and Risk Assessment Intensity scores post- compared to pre-therapy due to CBT’s aim of 
reducing anxiety, attentional focus and anticipation towards threats (Grupe & Nitschke, 
2013; Hadwin & Richards, 2016; Maslowsky et al., 2010). Additionally, it was predicted 
that treatment responders would show a greater reduction in JORT Flight Intensity and 
Risk Assessment Intensity scores, as research has shown that the degree to which threat-
avoidance reduces during treatment is a predictor of treatment outcomes in anxiety 
disorders (Legerstee et al., 2010, 2009). We also hypothesised that these patterns of 
reduction post-therapy would be found in self-report measures related to threat-
avoidance (level of fear measured with the FSS tissue damage subscale, dread rating on 
the JORT, neuroticism and trait anxiety). 
It was expected, due to evidence that those with higher levels of threat-avoidance and 
attentional-bias towards threats have poorer therapeutic responsiveness (Legerstee et al., 
2009; Mogg & Bradley, 2016; Price et al., 2011), that treatment responders would have 
lower baseline Flight Intensity and Risk Assessment Intensity than non-responders to CBT.  
 
6.2 Methods 
6.2.1 JORT fMRI and behavioural paradigm 
The fMRI task that Study 1 participants completed is illustrated in Figure 6-a. The 
participant viewed a two-dimensional linear runway presented on a computer screen 
whilst in the scanner (Figure 6-a, B). The task has four trial types: Pursuit; Pursuit plus 
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threat (of electric shock); Goal-Conflict; and Goal-Conflict plus threat (of electric shock). 
In Pursuit trials (Figure 6-a, C), the participant was instructed to squeeze a force sensing 
hand gripper to move a virtual agent (a green dot) along a runway fast enough to remain 
ahead of the moving predatory red dot so as not to get caught. The gripper was force 
sensing, in that the greater the force applied to the handle the faster the green dot would 
move, allowing the participant to control the dot’s speed of movement. Half of the Pursuit 
trials presented to participants had a lightening flash symbol displayed in the corner of 
the screen (Figure 6-a, D). On these trials the participant would receive an electric shock 
to the right foot if the red dot caught up to the green dot (delivered on an MRI compatible 
electric stimulator with a choice of 8 shock levels). Before beginning the task, the 
participant calibrated the electric shock machine to a level that they found aversive but 
not painful (i.e. their own tolerance level, and no more than 80 Volts at 20 amperes). The 
goal-conflict trials comprised a second additional red dot which travelled above the green 
dot (Figure 6a, E). This required the participant to move the green dot cursor fast enough 
to avoid the pursuing red dot but not too fast that it would collide with the leading red 
dot. As with the Pursuit trials, at the start of the trial the chasing predator approached the 
agent requiring the agent to accelerate to an escape velocity. The second preceding agent 
would then appear on screen. The participant was instructed to keep the speed of the 
agent constant to avoid nearing one of the predators. The speed of the proceeding 
predator was kept constant but the preceding predator’s speed varied to ensure this dot 
was always visible on screen. Again, in half of the goal-conflict trials, as with the pursuit 
trials, a lightening flash symbol was presented to let the participant know that they would 
receive an electric shock if they got caught by a red dot (Figure 6-a, F). 
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Figure 6-a: The fMRI Joystick Operated Runway Task (JORT).  
The JORT (B: F) is a human translation of the Mouse Defence Test Battery (A). 
As illustrated, participants squeezed a force-sensitive interface to control the 
speed of a green dot as it was pursued on the runway by red dot(s) (B). If the 
red dots collided with the green dot, on certain trials an electric shock was 
inflicted. The task comprised 12 trials of each type: C) Pursuit; D) Pursuit plus 
threat of electric shock; E) Goal-Conflict; and F) Goal-Conflict plus threat of 
electric shock. 
 
Therefore, in all trials the participant was instructed to avoid getting virtually caught by 
a predator which required tightly controlled regulation of speed. If the participant 
succeeded in not getting caught, after 7 seconds the predator(s) disappeared allowing the 
participant to decelerate to rest. If the participant was caught, the trial was terminated 
leading to variable trial durations for unsuccessful trials. However, in these unsuccessful 
trials, successive tests did not start earlier. Participants were presented with 12 trials of 
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each class, 48 in total, presented in a pseudo-randomised order and with inter-trial 
intervals varying between 15 to 30 seconds to heighten unpredictability. The task was 18 
minutes and 14 seconds in total. Participants were instructed to continue to rest at the 
beginning of each trial until the chasing red dot appeared. If caught, the participant was 
not explicitly punished in low threat (safe) conditions but was with cued threats in high 
threat conditions.  
The force-sensing hand gripper was set to require a force of 7.5 kilograms to keep the 
green dot ahead of the red dot. This level was chosen due to pilot testing which found 
this to be a generally appropriate level for participants over the course of 48 trials: 
effortful but without causing pain. In the behavioural version of the JORT, illustrated in 
Figure 6-b, the player controls the agent not through a hand gripper but a force sensing 
joystick that is individually calibrated according to physical strength to ensure the 
requirement of force for operation. These instruments were designed to mimic biological, 
real-world predatory threat scenarios where physical effort is required. The threat in the 
behavioural task also differed - the threat being an unpleasant loud burst of white noise, 
rather than an electric shock. Behaviourally the two phases of the task (Pursuit, Figure 6-
b, B, and Goal-Conflict, Figure 6-b, C) are also repeated 24 times, half with and half 
without threat of noise, totalling 48 trials.  
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Figure 6-b: The behavioural human translation of the Mouse Defence Test 
Battery (MDTB, A): The Joystick Operated Runway Task (JORT, B and C).  
 
All participants underwent a practice session before completing the JORT behaviourally 
or as an fMRI paradigm to familiarise subjects with the skill and force required to 
successfully complete the task. Multiple sessions were conducted if required. 
6.2.1.1 Behavioural measures from JORT performance 
The behavioural measures calculated from participant performance on the JORT and used 
in the analyses were calculated from the amount of pressure the participant applied to 
the joystick or hand-gripper and their resulting movement on the runway. These included: 
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Flight Intensity, which is the degree that the signalled threat (icon of lightning) increased 
the velocity of the participant controlled green dot during the pursuit trials (i.e. the 
average velocity of pursuit trials with threat minus the average velocity of pursuit trials 
with no threat). Risk Assessment Intensity, which is the oscillations in movement 
measured by the standard deviation of the average speed of movement in the goal-conflict 
plus threat trials minus the standard deviation of speed of movement of the green dot in 
goal-conflict without threat trials. Additionally, the average velocity of movement was 
calculated for pursuit trials (both threat and non-threat trials) and the average oscillations 
(standard deviation of speed of movement) calculated for goal-conflict trials (both threat 
and non-threat trials combined). 
6.2.2 Psychological measures 
Participants completed the following self-report questionnaires to allow examination of 
the association with these measures and JORT outcomes:  
State dread rating: Upon completing the JORT, participants were asked to rate how 
much dread they had experienced whilst the red dot(s) were chasing them on a scale of 
0 (no dread) to 10 (maximum dread). 
Neuroticism, measured using Eysenck’s Personality Questionnaire – Revised Version 
(EPQ-R), a 100 item self-report scale (Eysenck, Eysenck, & Barrett, 1985). 
Trait Anxiety, via Spielberger’s State Trait Anxiety Inventory, (STAI, (Lushene et al., 
1970). This scale consists of 20 trait items scored on a 4-point Likert scale from “Almost 
Never” to “Almost Always” with higher scores indicated greater trait anxiety. For example, 
“I get in a state of tension/turmoil as I think over my recent concerns and interests”.  
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Fear, via the Fear Schedule Survey (FSS): this measure has 108 stimulus items for which 
it is maladaptive to have more than mild anxiety in response towards, for example, fear 
of “fainting”, “kissing”, or “large open spaces” (Wolpe & Lang, 1964). Item scores are 
summed to give a total measure of fear proneness and subscales include an interpersonal, 
social fear subscale and fear of tissue damage (the latter of which has been found to be 
related to flight intensity on the JORT and a relatively pure measure of fear, Perkins et 
al., 2011, 2013).  
6.2.3 Image analysis 
6.2.3.1 Functional MRI acquisition 
The functional sequence comprised T2*-weighted gradient EPI sessions of 543 whole 
brain volume acquisitions: flip angle 75°; TR = 2000 ms; TE = 30 ms; FOV = 24 x 24 
cm; slice-thickness = 3 mm; inter-slice gap = 0.3 mm (total of 41 slices); matrix size = 
64 X 64 voxels with an isotropic 3 mm x 3 mm in-plane resolution. A high-resolution T1-
weighted image was also acquired as outlined in Chapter 3.  
6.2.3.2 Functional MRI pre-processing 
Data pre-processing was conducted using SPM-12. Images were realigned to the first 
image of the run, slice timing was corrected, and functional images were co-registered to 
the high-resolution T1 image. Segmentation and normalisation was performed on the T1 
images and deformation fields were then used to normalise the functional images to MNI 
space. Smoothing was not performed at this step due to subsequent first level analysis 
which is best performed on unsmoothed data (Diedrichsen & Shadmehr, 2005). 
Realignment parameters were inspected and subjects demonstrating translation of over 
one voxel were excluded from further analysis. The first four volumes from each session 
were discarded to allow for magnetization equilibrium prior to acquisition.  
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6.2.3.3 First level analysis 
First level analysis was performed using SPM-12 using a general linear model. Regressors 
for each trial type in this event-related fMRI paradigm were included for Anticipation (the 
time preceding the start of the chase when the type of trial was cued), Active-Avoidance 
(time during the chase by the red dot(s)), and the End of the Chase, split into trials where 
the subject was Caught and those where the subject Escaped. See Figure 6-c for an 
illustration of the trial timings. 
Figure 6-c: Illustration of trial timings. 
 
Abbreviations – ITI, Inter trial interval: S, seconds. 
The following parametric modulators were also included: 1) Cumulative Threat, defined 
as the area under the curve of the participants’ distance from the closest chasing stimulus; 
2) Peak Threat, defined as the closest distance to either chasing stimulus during the trial; 
3) Oscillation Amplitude (as a measure of threat assessment, anxiety-related behaviours), 
defined as the standard deviation of the participant’s movement. 
On some trials for certain subjects, the subject either failed to react to the trial or a 
technical issue with the force sensor on the hand gripper led to an absence of movement. 
These trials were excluded through inclusion in the model as nuisance regressors. Subjects 
whose data were unusable for more than four trials of any condition were excluded from 
analyses (therefore at least 8 trials for every participant in each of the 4 conditions were 
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required: Pursuit; Pursuit with threat; Goal-Conflict; Goal-Conflict with threat). This 
criterion was also used for behavioural analysis. 
Given the risk of head motion induced by the electric shocks in the task, ensuring non-
neural motion-related artefacts in the data did not influence the results was a priority. In 
addition to including motion regressors in pre-processing steps, we used further methods 
to reduce the impact of motion at the first level. Firstly, time points exhibiting high levels 
of motion were identified using the motion outliers tool included in the FMRIB software 
library (FSL, https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) based on DVARS (Derivative of rms 
VARiance over voxels, which is a measure of how much the intensity of a brain image 
changes from one volume to the next) and framewise displacement measures (head 
movement from one volume to the next) (Power et al., 2012). Regressors for these time 
points were included in first level modules to exclude them from model estimation. 
Secondly, we used CompCor (Behzadi et al., 2007) to identify signals in the data likely 
representing signals of non-neural origin. Briefly, this involves extracting signal from 
white matter and cerebrospinal fluid (CSF) voxels, based on segmented T1 images, before 
using principal component analysis (PCA) to reduce the dimensionality of this data and 
produce a chosen number of components (six in this case) representing non-neural 
signals. These component time series were then included in first level models to reduce 
the impact of both motion and physiological arousal. 
Finally, we estimated first-level models using robust weighted least squares (WLS) 
estimation. WLS down-weights the contributions of time points with high estimated noise 
to reduce the impact of motion on model estimation. As this step is best performed on 
unsmoothed data (Diedrichsen & Shadmehr, 2005), smoothing was subsequently applied 
to the contrast images produced by the first-level analysis with an 8mm FWHM Gaussian 
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kernel. First level contrasts of interest were taken forward to the second level for group-
level analysis. 
6.2.3.4 Second level analysis    
Main task effects were evaluated in the control and patient group together to allow 
identification of systems involved in active avoidance and anticipation on this task overall. 
Group comparisons of patients versus controls were performed using independent t-tests. 
All analyses included total distance travelled, an index of subject-level motion, as a 
covariate. Group comparisons also included age and gender as covariates.  
The primary contrasts were the task conditions (the anticipation phase when the type of 
task was cued and the active-avoidance phase when participants were being chased by a 
red dot in the goal-conflict and pursuit trials), both compared to the baseline resting 
condition (fixation on a cross). The following neural main-effects were explored in both 
anticipation and active-avoidance task conditions: 1) pursuit versus goal-conflict 
conditions; and 2) threat versus no threat (safe) trials. Additionally, in the active 
avoidance phases of the task, we tested: 1) whether activity in the active avoidance phase 
correlated with the level of oscillations in movement made, and 2) explored activity in 
the active avoidance phase correlating with how close the red dot predator(s) were, giving 
a measure of brain activity in peak threat. 
Regressions explored the relationship between individual differences in clinical and 
psychological variables and neural activity in the anticipation and avoidance phases of 
the JORT. These included post-scan ratings of subjective dread and trait individual 
differences in proneness to negative emotions: neuroticism, trait anxiety (STAI), and fear 
(FSS, tissue damage subscale). The anticipation phase was correlated with trait anxiety, 
dread rating and an interaction between threat versus no threat trials. In the active-
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avoidance phase, relationships between self-report trait anxiety and neural activation in 
goal-conflict trials were explored and self-report fear with activation on pursuit trials. 
Our a priori hypotheses were to explore the degree to which trial to trial variation in PAG 
activity correlated with dread rating and trial to trial variation in peak threat (a measure 
of red dot proximity). Our second a priori hypothesis tested the sensitivity of the anterior 
hippocampi to goal-conflict. We correlated this with neuroticism scores, predicting that 
neuroticism would be negatively associated with hippocampal activity.  
For the exploratory whole brain analyses, results were thresholded with a voxelwise, 
cluster-defining threshold of p <.001 and a cluster-level threshold of p <.05, family-wise 
error (FWE) corrected (Nichols & Hayasaka, 2003). This has been shown to be an 
appropriate level where the false positive rate is well controlled in SPM (Eklund, Nichols, 
& Knutsson, 2016). The bilateral hippocampal ROIs were generated using the WFU-
Pickatlas toolbox (Wake Forest University) using automatic anatomical labelling (AAL). 
The PAG ROI was defined as per Mobbs et al., (2007; 2009) using the following co-
ordinates with a 6mm radius, x = 4, y = -30, z = -24 in MNI space. The ROI analysis was 
conducted separately for each region with a small volume correction and a significance 
threshold of p <.05.  
6.2.4 Behavioural analysis, comparison between patients and controls 
Data were analysed using SPSS Version 24.0 (SPSS Inc. Chicago, US). Differences in 
group performance were assessed with independent-samples t-tests. Effects between 
JORT Risk Assessment Intensity, Flight Intensity, velocity on pursuit trials, and 
oscillations on goal-conflict trials and other measures relevant to threat avoidance (the 
FSS-tissue damage subscale, STAI, neuroticism and JORT dread rating) were assessed 
with Pearson’s correlations. 
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6.2.5 Behavioural analysis with cognitive behavioural therapy 
Repeated-measures ANOVAs with Greenhouse-Geisser correction were conducted to test 
whether patient scores on Flight Intensity, Risk Assessment Intensity, average velocity 
and oscillations differed pre- to post-CBT. This was conducted in all patients undergoing 
therapy and additionally with treatment response as a between subjects factor. 
Independent samples t-tests comparing responders versus non-responders on JORT 
behavioural measures were conducted on baseline and post-treatment data. Additionally, 
these analyses were conducted on JORT dread rating, self-report fear (FSS-tissue damage 
subscale), trait anxiety (STAI) and neuroticism. 
 
6.3 Results 
6.3.1 fMRI Results 
Twenty patients and nineteen age and gender matched healthy controls completed the 
fMRI task from Study 1 (see Chapter 3 for eligibility criteria). One participant’s data was 
removed due to excessive head movement and a further two participants’ data were 
removed due to more than four trials with unusable data. Therefore, eighteen individuals 
with major depression and comorbid anxiety disorders, in addition to seventeen healthy 
controls’ data, were included. See Table 6-a for participant characteristics. 
There were no significant differences between patients and controls on the JORT’s 
behavioural measures of Flight Intensity (effect size – Cohen’s d = 0.31), Risk Assessment 
Intensity (effect size – Cohen’s d = 0.08), average velocity (effect size – Cohen’s d = 0.29) 
or average oscillations (effect size – Cohen’s d = 0.22); however, the patients reported 
experiencing significantly more dread on the task (effect size – Cohen’s d = 1.27). 
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Additionally, the patient group scored significantly higher on trait neuroticism, trait 
anxiety and fear proneness (FSS tissue damage). 
Table 6-a Participant characteristics and JORT performance.  
 Patient Group  
(n=18) 





Age (years) 30.4 (9.2) 32.4 (10.7) t = -0.6 
Gender (M/F) 7/11 7/10 χ2 = 0.9 
MÅDRS 30.6 (7.5) 1.6 (2.0) t = 15.8** 
 
STAI – Trait 
anxiety 
62.1 (7.8) 33.4 (6.1) t = 12.0** 
HARS 22.9 (6.2) 0.9 (1.3) t = 14.4** 
Dread Score 5.4 (2.8) 1.9 (2.7) t = 3.8** 
Neuroticism 20.3 (3.5) 6.8 (5.1) t = 9.2** 
FSS – tissue 
damage 
49.0 (29.0) 23.9 (18.0) t = 3.1* 
JORT FI .18 (.73) -.07 (.86) t = 1.0 
JORT RAI -.17 (.42) -.14 (.27) t = -0.3 
Average speed 
on pursuit trials 




















t = 0.4 
Values are reported as mean (standard deviation) except where otherwise stated. 
Comparison was by independent samples t-tests or Pearson chi-square for 
categorical variables. * Significant to p <.005 ** Significant to p <.001 Abbreviations 
– M, Male: F, Female: MÅDRS, Montgomery-Åsberg Depression Rating Scale: STAI, 
State Trait Anxiety Inventory: HARS, Hamilton Anxiety Rating Scale: FSS, Fear 




6.3.1.1 Anticipation phase of the JORT 
The results in the following table are the second level analyses for the main effects of the 
anticipation phase of the task’s contrasts including both patients and controls (see Table 
6.-b and Figure 6-d). Only results that survived a cluster defining significance of p <.001 
and a cluster-wise threshold of p <.05 FWE corrected are reported in the table, as per all 
whole brain results reported in tables throughout chapter. The tables (6-b and 6-c) 
include the significance level of the peak voxel within each cluster. The anticipation phase 
was associated with significantly elevated activation in two clusters including the right 
putamen / right anterior insula and left superior occipital gyrus / left cuneus and 
significantly reduced activation compared to baseline in right occipital, superior and 
temporal gyri. There were no significant main effects of neural activation in the 
anticipation phase correlating with condition type (i.e. goal-conflict versus pursuit trials). 
We did find a main effect of threat on neural activity: trials signalling the potential of an 
electric shock if caught were associated with elevated activity in the left superior frontal 
gyrus/dACC, right caudate, right superior frontal gyrus and supplementary motor area in 
the anticipation phase.  
There were no correlations between self-report measures (neuroticism, trait anxiety, or 
subjective dread rating) and neural activity during anticipation. Nor any correlations with 
behavioural measures of JORT performance and any of the neural main effects. 
There were no significant results for group comparisons (patients versus controls) on any 
contrasts during the anticipation phase of the JORT.  
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Table 6-b: Joystick Operated Runway Task Brain Activation During 
Anticipation 
















24, 10, 6 <.001 4058 133.0 Anticipation>Baseline 
Left superior 
occipital gyrus / 
left cuneus 
-18, -76, 34 <.001 9835 68.5 Anticipation>Baseline 
Right occipital 
fusiform gyrus 




46, -16, -12 <.001 1284 36.4 Baseline>Anticipation 
 
Anticipation and Threat (main effect of threat: threat versus no threat trials in 
the anticipation phase) 
Left ACC / 
superior frontal 
gyrus 
-16, -6, 51 <.001 881 34.8 Threat>No Threat 
Right Caudate 20, 26, 2 <.001 2196 32.2 Threat>No Threat 
Right superior 




16, -4, 54 .022 378 30.3 Threat>No Threat 
N = 35 (18 patients and 17 healthy controls). Significance was FWE cluster 
corrected. Peak coordinates are reported in MNI space. Abbreviations – MNI: 
Montreal Neurological Institute.   
164 
 
Figure 6-d: Main effect of threat in the anticipation phase of the Joystick 
Operated Runway Task (p <.05 FWE corrected) 
 
Abbreviations – ACC: anterior cingulate cortex; SFG: superior frontal gyrus; SMA: 
supplementary motor area. Blue regions denote decreased activation in threat versus no 
threat trials and yellow regions represent increased activation in threat versus no threat trials 
in the anticipation phase. 
 
 
6.3.1.2 Active-avoidance phases of the JORT 
Table 6-c details regions of significant activation in the active avoidance (goal-conflict 
and pursuit) phases of the task when participants were chased by the red dot predator(s). 
The main effect of both active-avoidance conditions (pursuit and goal-conflict trials 
combined) compared to baseline fixation showed elevated activation in prefrontal brain 
regions. A comparison between the active avoidance conditions (goal-conflict versus 
pursuit trials) showed significantly elevated activation in the left cerebellum, left 
orbitofrontal cortex and right anterior insula in pursuit trials compared to goal-conflict 
trials and elevated left anterior orbitofrontal cortex activation in goal-conflict compared 
to pursuit trials.  
165 
There was no significant main effect of peak threat (i.e. no correlation between activation 
in the flight phases of the task with proximity of the red dot predator(s) to the green dot 
agent). There was a main effect of threat (i.e. a comparison of trials with a threat of 
electric shock versus trials with no-threat of shock, see Figure 6-f). Threat trials were 
associated with significantly elevated activation in a cluster including the right insula and 
hippocampus. Safe, no threat trials were associated with elevated activation in prefrontal 
regions and the caudate. Further, striatum and middle temporal gyrus activity during 
avoidance was associated with Risk Assessment Intensity (p =.003 and .007, 
respectively), see Figure 6-g for direction of findings. There were no further correlations 
with psychological variables or JORT behavioural measures with brain activation for the 
main contrasts.  
There were no significant results for group comparisons (patients versus controls) on any 
of the contrasts during the active avoidance phases of the JORT. There were no significant 
differences between the groups in the number of times they were caught by the chasing 
predators combined across all conditions (t(33)=1.04, p = .30), suggesting ability did 
not confound results. However, there was a significant difference between the two threat-
avoidance conditions as to whether participants were caught, participants being 
significantly more likely to fail to escape the predators in the goal conflict compared to 
simple pursuit trials (t(34) = 14.6, p <.001.   
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Table 6-c: Joystick Operated Runway Task Brain Activation During active 
threat avoidance (pursuit and goal-conflict) 









Main effect of both goal-conflict and pursuit active avoidance phases compared to 
baseline  
Right precuneus / 
superior parietal 
lobule 
14, -52, 58 <.001 62177 339.1 Avoidance> 
Baseline 
Left precuneus / 
posterior cingulate 
gyrus 
-8, -54, 20 <.001 3043 102.6 Baseline> 
Avoidance 
Left angular gyrus -44, -64, 30 <.001 1485 90.5 Baseline> 
Avoidance 
Right middle frontal 
gyrus 
34, 40, 32 <.001 1464 82.3 Avoidance> 
Baseline 
Left occipital pole, 
left calcarine cortex, 
left occipital fusiform 
gyrus 




-26, 32, -16 <.001 4268 54.3 Baseline> 
Avoidance 
Right lingual gyrus 
and right occipital 
fusiform gyrus 
20, -88, -8 0.002 550 48.1 Baseline> 
Avoidance 
Left superior / 
middle frontal gyrus 
-20, 24, 44 <.001 810 36.1 Baseline> 
Avoidance 
Pursuit versus goal-conflict trials main effect 
Left cerebellum 0, -66, -34 <.001 30141 67.69 Pursuit> Conflict 
Right temporal and 
superior cortex 
50, -32, 20 <.001 3290 51.40 Pursuit> Conflict 
Left anterior 
orbitofrontal cortex 
-22, 38, -10 <.001 1531 39.43 Conflict>Pursuit 
Right anterior insula 40, 18, -10 .001 712 36.02 Pursuit> Conflict 
 
Main effect of both goal-conflict and pursuit active avoidance phases correlated with the 




14, -52, 58 <.001 68267 209.09 Positive 
Left & right 
precuneus and 
posterior cingulate  
-8, -52, 18 <.001 2060 107.12 Negative 
Left angular gyrus, 
left mid temporal 
cortex 
-44, -62, 28 <.001 993 71.01 Negative 
Right mid frontal 
gyrus 
38, 44, 22 <.001 1413 49.88 Positive 
Left occipital cortex -16, -96, -4 .002 537 46.34 Negative 
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Right lingual gyrus, 
right occipital 
fusiform gyrus, right 
calcarine cortex 
18, -88, -8 .011 329 45.02 Negative 
Left anterior 
cingulate, left medial 
frontal cortex 
-6, 44, -8 <.001 1255 34.40 Negative 
Left temporal cortex -56, -44, -14 .005 424 31.17 Negative 
Left middle frontal 
cortex 
-40, 38, 32 .007 375 29.82 Positive 
Left orbitofrontal 
cortex (anterior / 
medial and posterior 
orbital gyrus)  
-24, 34, -12 .013 306 29.81 Negative 
 
Main effect of threat on neural activation in active-avoidance phase of the trial 
Left middle/superior 
temporal gyrus  
-28, 56, 12 .004 562 37.07 Safe>threat trials 
Left caudate -16, 24, 2 .041 269 35.62 Safe>threat trials 
Left frontal superior 
gyrus 
-12, 38, 38 .005 489 35.17 Safe>threat trials 
Right postcentral 
gyrus 




40, -22, -4 .041 276 20.47 Threat > safe trials 
N = 35 (18 patients and 17 healthy controls). Significance was FWE cluster 
corrected. Peak coordinates are reported in MNI space. Abbreviations – MNI: 





during avoidance is 
associated with risk 
assessment intensity 
(p = .003, .007) 
Figure 6-e: Main effect of threat on neural activation in the active avoidance 
(flight phase) of the Joystick Operated Runway Task  (p < .05 FWE corrected) 
  
Abbreviations – FWE: family wise error. Blue regions denote decreased activation in threat 
versus no threat trials and yellow regions represent increased activation in threat versus no 
threat trials in the flight phase. 
Figure 6-f: Joystick Operated Runway Task correlation between Risk 
Assessment Intensity and neural activation in active avoidance 
 







6.3.2 Behavioural Results 
Behaviourally, 29 participants (16 patients and 13 healthy controls from Study 1 and 2) 
completed the JORT task offline at baseline (see Table 6-d for participant characteristics 
and measures of task performance). Against expectations, no significant differences were 
observed between the patient and control group on any of the behavioural measures of 
JORT threat avoidance: Flight Intensity, p >.05, effect size – Cohen’s d = 0.13; Risk 
Assessment Intensity, p >.05, effect size – Cohen’s d = 0.33; average velocity, p >.05, 
effect size – Cohen’s d = 0.0; or average oscillations, p >.05, effect size – Cohen’s d = 
0.67. However, patients did report experiencing more dread on the task when being 
chased by the red dot(s), p <.05, effect size – Cohen’s d = 0.88. As would be expected, 
patients scored significantly higher on the MÅDRS, FSS tissue damage scale, STAI, and 
neuroticism measures.  
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Table 6-d: Behavioural participant characteristics and JORT performance, 
split by group 









Age (years) 36.9 (14.9) 32.5 (11.3) t = 0.9 
Gender (M/F) 6/10 4/9 χ2 = 0.1 
MÅDRS 29.8 (6.6) 1.2 (1.5) t = 15.3*** 
Anxiety (STAI)  63.9 (7.6) 31.5 (4.4) t = 14.4 
Dread Score 4.8 (3.2) 2.2 (2.7) t = 2.3* 
FSS tissue 
damage 
44.4 (18.2) 23.6 (18.6) t = 3.0** 
Neuroticism 20.5 (3.6) 5.6 (4.6) t = 9.8*** 
JORT FI 0.45 (0.63) 0.38 (0.45) t = 0.36 
JORT RAI 0.02 (0.15) 0.07 (0.18) t = -0.81 
Pursuit 
velocity 
9.6 (0.8) 9.6 (0.4) t = -0.3 
Goal-conflict 
oscillations 
















t = 0.7 
Values are reported as mean (standard deviation) except where otherwise stated. 
Comparison was by independent samples t-tests or Pearson chi-square for 
categorical variables. * Significant to p <.05, ** significant to p ≤.005, *** 
significant to p <.001. Abbreviations - M, Male: F, Female: MÅDRS, Montgomery-
Åsberg Depression Rating Scale: STAI, State Trait Anxiety Inventory (trait score): FSS, 
Fear Schedule Survey: JORT, Joystick Operated Runway Task: FI, Flight Intensity: RAI, 
Risk Assessment Intensity. 
 
Bivariate correlational analysis was conducted to explore relationships within JORT 
measures and between trait anxiety (STAI), dread ratings, fear (FSS tissue damage), 
depression severity (MÅDRS), and neuroticism (Table 6-e). Significant positive 
correlations were observed in the patient group between: neuroticism and trait anxiety; 
neuroticism and dread rating of the JORT; depression severity and trait anxiety; and 
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neuroticism and oscillations on goal-conflict trials (a measure of anxiety behaviour). 
Significant negative correlations in the patient group were found unexpectedly between: 
depression severity and Risk Assessment Intensity; and trait anxiety and average velocity 
on pursuit trials. In the control group, negative correlations were found between Flight 
Intensity on pursuit trials and oscillations in goal-conflict trials, and dread rating and 
oscillations in goal-conflict trials.  
Table 6-e: Correlations between the JORT and personality variables relevant 
to threat sensitivity, by group.  
Variable 1 2 3 4 5 6 7 8 9 
1 JORT FI - .35 .48 .22 .14 -.13 -.31 .17 -.81** 
2 JORT RAI .04 - .33 .45 .27 .08 .14 -.20 -.32 
3 Dread -.34 .08 - .51 .08 .09 -.03 .15 -.63* 
4 FSS tissue .14 .04 -.01 - .32 -.07 -.05 .38 -.32 
5 STAI -.08 -.13 .38 -.09 - .55 <.01 -.08 -.19 
6 Neuroticism -.18 -.13 .61* -.08 .51* - -.03 -.45 .19 
7 MÅDRS .02 -.62* .30 .14 .64** .27 - -.03 -.05 
8 Velocity .28 .10 -.06 -.16 -.590* -.12 -.43 - -.35 
9 Oscillations -.25 -.15 .23 .09 .449 .58* .20 -.36 - 
N = 29 (correlations for 16 patients in lower half of matrix, 13 controls in upper 
half). * p < .05 level ** p <= .01. Abbreviations - M, Male: F, Female: MÅDRS, 
Montgomery-Åsberg Depression Rating Scale: STAI, State Trait Anxiety Inventory 
(trait score): FSS, Fear Schedule Survey: JORT, Joystick Operated Runway Task: FI, 
Flight Intensity: RAI, Risk Assessment Intensity. 
 
6.3.3 Behavioural results with treatment 
14 patients (9 females) from Study 2 completed the JORT before and after a course of 
CBT (mean age 34.5 +- 14.4 years). The mean number of sessions of CBT attended was 
10.7 (+- 3.0, range 6-16). See Table 6-f for participant characteristics, split by treatment 
response. Responders were significantly younger than non-responders and had received 
significantly more sessions of CBT. In terms of self-report measures, responders scored 
172 
significantly lower at both baseline and post-treatment assessment on the FSS tissue 
damage subscale (a measure of fear), and post-treatment scored lower on trait anxiety 
(STAI). There were no significant differences between responders and non-responders on 
JORT measures of Flight Intensity, Risk Assessment and oscillation intensity. There was 
trend for responders to show higher post-therapy average velocity on the pursuit trials 
compared with non-responders (p =.051).  
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Age, years 26.6 (6.1) 42.4 (16.2) t = 2.4*  
Male/Female (n) 2/5 3/4 χ2 = 0.3 
Baseline MÅDRS 30.7 (7.4) 27.9 (6.0) t = -0.8 
Number of CBT 
sessions 
9.0 (2.5) 12.6 (2.3) t = 2.8* 
Baseline JORT FI 0.52 (0.42) 0.37 (0.42) t = -0.6 
Baseline JORT RAI 0.05 (0.20) 0.005 (0.11) t = -0.5 
Baseline velocity, 
pursuit trials 
9.7 (0.5) 9.6 (1.0) t = -0.2 
Baseline oscillations, 
goal-conflict trials 
4.2 (0.4) 4.4 (0.2) t = 1.1 
Baseline STAI  66.6 (8.8) 61.1 (5.8) t = -1.4 
Baseline Neuroticism 20.9 (4.3) 21.0 (3.1) t = 0.1 
Baseline FSS-tissue 
damage 
32.6 (11.8) 51.3 (18.1) t = 2.3* 
Baseline Dread Rating 5.0 (2.3) 5.1 (4.0) t = 0.1 
Post-treatment JORT FI 0.29 (0.27) 0.59 (0.93) t = 0.8 
Post-treatment JORT 
RAI 
-0.07 (0.11) -0.002 (0.10) t = 1.2 
Post-treatment STAI  46.3 (5.5) 58.7 (7.8) t = 3.4** 
Post-treatment 
Neuroticism 
17.1 (5.8) 20.3 (1.8) t = 1.4 
Post-treatment FSS-
tissue damage 
25.0 (10.1) 62.6 (21.5)† t = 4.1** 
Post-treatment Dread 
Rating 
3.2 (3.5) 4.0 (3.2) t = 0.4 
Post-treatment velocity, 
pursuit trials 




4.3 (0.2) 4.1 (0.4) t = -1.2 
†n=5 due to missing data for two participants. Values are reported as mean 
(standard deviation) unless otherwise stated. Comparison was by independent 
samples t-tests or Pearson chi-square for categorical variables. * Significant to p 
<.05 ** significant to p <.005, ° trend significant (p =0.051). Abbreviations - JORT: 
Joystick Operated Runway Task; MÅDRS: Montgomery-Åsberg Depression Rating 
Scale; CBT: Cognitive Behavioural Therapy; STAI: State Trait Anxiety Inventory; FI, 
Flighty Intensity; RAI: Risk Assessment Intensity; FSS: Fear Schedule Survey.  
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Repeated measures ANOVAs on all patients (both responders and non-responders to CBT) 
showed no significant differences pre-to post-therapy on JORT Flight Intensity (f(1,13) = 
<.001 , p =1), Risk Assessment Intensity (f(1,13) = 2.1, p =.17), average speed in 
pursuit trials (f(1, 13) = 0.006, p =.94) or oscillations in goal-conflict trials (f(1, 13) = 
0.81, p = .39). Subjective dread ratings also did not differ significantly over time (f(1, 
13) = 1.9, p=.19), nor self-report fear (measures using FSS tissue damage scale, f(1, 11) 
= 0.6, p=.45). There was a significant reduction in trait anxiety (STAI) and EPQ-R 
neuroticism scores from time one to time two: f(1, 13) = 9.0, p =.01 and f(1,13) = 6.2, 
p =.03, respectively.  
Including treatment response as a between subjects factor in the repeated-measures 
ANOVAs showed non-significant group by time interactions for Flight Intensity (f(1,12) 
= 0.8, p = 0.39); Risk Assessment Intensity; f(1,12) = 1.8, p =.21; average velocity of 
pursuit trials (f(1,12) = 1.8, p =.20); and subjective dread rating (f(1,12) = 0.07, p 
=.79). However, there was a significant difference from pre-to post-therapy between 
responders and non-responders in the oscillations in goal-conflict trials. Against our 
hypothesis, responders showed significantly higher levels of oscillation post-therapy 
compared to non-responders who showed a reduction: f(1,12) = 5.6, p =.03. There was 
a trend interaction (f(1,10) = 4.1, p =.07) for self-report fear with non-responders 
showing an increase and responders showing a decrease in FSS tissue damage score. 
Similarly, there was a trend interaction for neuroticism with responders displaying a 
greater reduction than non-responders (f(1,12) = 3.3, p =.09). There was a significant 
group by time interaction with self-report trait anxiety. Non-responders scored stably at 





This chapter presents a psychiatric validation of the JORT, a measure of threat-avoidance 
that allows within-task, within-subject comparison of fear and anxiety (Perkins et al., 
2009, 2011). Neural main effects of the task were found for both the anticipation and 
active avoidance phases of the task. However, no group differences, or correlations with 
self-report measures of threat-sensitivity were found. Against our hypothesis, the patient 
group were not found to score significantly higher than the healthy participants on JORT 
behavioural measures, though patients did report experiencing higher levels of dread 
whilst being chased on the task. No association was found between task measures and 
treatment response. 
6.4.1 Neuroimaging results discussion 
6.4.1.1 Main effects of task 
Our results suggest that the JORT was effective in identifying neural systems involved in 
both anticipation and active avoidance of aversive stimuli. The key main effects of the 
task were that anticipation of avoidable aversive events was associated with significant 
activation in the ACC/superior frontal gyrus, insula and striatum, while active avoidance 
of aversive stimuli was associated with activity in prefrontal regions, the dACC and insula 
- regions which align with previous research (e.g., Mobbs et al., 2007, 2009; Rzepa et al., 
2017).  
More specifically during anticipation, trials signalling the potential of an electric shock 
were associated with elevated activity in the left superior frontal gyrus, right caudate, 
right superior frontal gyrus and supplementary motor area. This aligns with our 
hypothesis, and previous research suggesting that the ACC, supplementary motor area 
and striatum are activated with threat anticipation (Mobbs et al., 2007; Rzepa et al., 
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2017). Mobbs et al. found that dACC activity was related to imminent threat, as opposed 
to distal threats, supporting our observed relationship with avoidance intensity. Our 
additional finding of supplementary motor activation in anticipation, a region involved in 
planning and initiation of movements, fits with other research involving threats of electric 
shocks (Maresh, Beckes, & Coan, 2013). 
Our results offer support for a differentiation in the neural systems that govern the JORT’s 
goal-conflict (anxiety-related) and simple threat avoidance (pursuit, fear-related) trials. 
Goal-conflict, compared to pursuit trials, resulted in significantly elevated activation in 
the left anterior orbitofrontal cortex and significantly reduced activation in the left 
cerebellum, left orbitofrontal cortex and right anterior insula, potentially signifying the 
increased attentional demands required in goal-conflict conditions. However, no 
correlations with behavioural measures of JORT performance or psychological variables 
were found on main effects in either the anticipation or active avoidance phases of the 
JORT. This limits our ability to draw conclusions regarding the reinforcement sensitivity 
theory – the defensive direction hypothesis whereby anxiety (threats that require 
approach, represented in the goal-conflict conditions) and fear (threats that need not be 
approached, i.e., pursuit conditions) - activate distinct brain regions and are associated 
with trait fear and anxiety measures.  
We found a main effect of threat in that trials with threat of electric shock, compared to 
no-threat trials, resulted in increased activation in the right insula and hippocampus. Safe 
(no threat) trials were associated with elevated activation in prefrontal regions and the 
caudate. Further, elevated striatal and vmPFC activation and a reduction in middle 
temporal gyrus activity during avoidance predicted risk assessment intensity with threat. 
The elevated PFC activation in no threat trials may signify that on these trials the 
participants engaged in more higher order cognitive appraisal of threat-avoidance, 
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whereas in threat of shock trials the elevated insula and hippocampal activation may 
signify increased emotional reactivity, as would be expect towards threats (Mobbs & Kim, 
2015). 
In the piloting of the JORT as an fMRI task, no main effects of threat were found (Perkins 
et al., Under Submission). The difference between these results and the pilot study in 
healthy controls could be due to our inclusion of a patient group and the resulting 
variability in the included sample in terms of sensitivity to threat (both patients and 
controls were included in main effects analyses). Indeed, the sample included in the 
original pilot scored on average one standard deviation below normal on a neuroticism 
scale (Perkins et al., 2010), suggesting the task is not sensitive to threat in healthy 
individuals due to the mild level of threat the task presents. 
We hypothesised that pursuit trials would activate midbrain regions, for example, the 
PAG, in line with findings from other threat-avoidance tasks (Mobbs et al., 2009, 2007). 
However, we were not able to replicate this finding either at a whole brain or ROI level. 
Additionally, our hippocampal ROI analysis did not show an association with goal-conflict 
conditions unlike previous findings (Abraham et al., 2013; Bach et al., 2014; O’Neil et al., 
2015). Further, we found no association between brain activation and threat imminence. 
This goes against findings from Mobbs et al. (2007, 2009), which found that there is a 
switch from prefrontal to midbrain regions when threats are near, which they postulate 
to represent higher order appraisal of threats when they are far away and a switch to 
hard-wired defensive reactions when threats are close. It may be that our relatively small 
sample size lacked the power to find such effects. Additionally, the tasks used by Mobbs 
et al. (2009) involved the loss of a potential reward if caught and therefore this could 
explain the difference in results, as no reward was at stake in the JORT.  
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6.4.1.2 Patients versus controls 
Although threat avoidance is primarily considered as a key trait of anxiety disorders, it 
has strong links to depressive symptomatology also. For example, Trew (2011) proposed 
a model of aberrant threat sensitivity processes in relation to depression which includes 
increased avoidance and decreased approach of threats which contribute to the 
development and maintenance of depression by the development of negative information 
processing biases and a reduction in exposure to potentially positive situations. There has 
been found to be an important role of both behavioural and cognitive avoidance in the 
maintenance of depression (Moulds et al., 2007; Ottenbreit & Dobson, 2004). 
Additionally, the relationship between neural activation on goal-conflict JORT trials and 
neuroticism in the fMRI piloting suggests a link to threat-related neural processes and 
depressive symptoms (Perkins et al., Under Submission). Therefore, there was 
justification for trialling this task in patients with depression and comorbid anxiety.  
However, we did not find any significant differences in neural activation or behavioural 
measures on the task between our patient group and controls limiting conclusions and 
drawing concerns about the tasks sensitivity despite previous research by Perkins et al. 
(2009, 2013) finding differences in task behavioural measures in those with high versus 
low trait anxiety and fear and sensitivity to psychopharmacotherapy. It is possible that 
comorbid anxiety disorders, or overlapping symptoms between depression and anxiety 
may account for the relationship between threat sensitivity and depression. However, the 
relationship between threat-avoidance and depression has been found to remain after 
controlling for comorbid anxiety (Johnson et al., 2003), suggesting an important 
relationship between threat-sensitivity and depression, beyond that explained by anxiety 
symptoms and comorbidity. It is possible that our relatively small sample size and 
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inclusion of patients with typically mild to moderate depression severity limited our 
ability to find an effect.  
The absence of significant differences in activation between patients and controls suggest 
that major depression is not associated with abnormal function in brain networks involved 
in active avoidance. Perhaps the concepts explored via the JORT are more related to pure 
anxiety disorders. A meta-analysis has shown that trait anxiety and fear of anxiety-related 
situations and threats was most associated with agoraphobia, GAD, panic disorder and 
PTSD compared to depression (Naragon-Gainey, 2010). Future research should trial the 
utility of the JORT in these patient groups where you would expect to see a more clear-
cut elevation in threat avoidance. For example, patients with panic disorder (associated 
with fear and flight behaviours) would be expected to show elevated reactivity in pursuit 
trials, whereas patients with generalised anxiety disorder would be expected to show 
aberrant behaviour and neural activation on goal-conflict trials, associated with anxiety.  
The JORT is an active, signalled avoidance task. It is active due to the requirement of 
action to avoid aversive events (passive/inhibitory avoidance tasks require withholding 
of behaviours to avoid aversive events) and signalled as the consequential threats are 
cued. Future research should investigate the basis of passive avoidance in major 
depression as self-report data comparing patients with depression versus healthy controls 
have shown elevated levels of passive avoidance in MDD (Pinto-Meza et al., 2006). 
Additionally, a study of tryptophan depletion (which allows investigation of the role of 
the serotonin system which is involved in the development and pathophysiology of 
depression (Donkelaar et al., 2011)) in healthy controls found that serotonin depletion 
caused participants to not respond appropriately to punishments in a passive avoidance 
task (Finger et al., 2007). 
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6.4.2 Behavioural results discussion 
Higher scores in the patient group relative to controls were expected on all JORT 
behavioural measures of threat avoidance. Patients did report experiencing more dread 
on the task when being chased by the red dot(s) compared to controls but this did not 
translate to significant differences in the behavioural measures of the JORT between 
groups. This is problematic as a lack of empirical relationship between behavioural 
measures (e.g., speed of movement and oscillations) and the semantic value placed on 
these by participants limits conclusions (LeDoux et al., 2017). Additionally, this lack of 
association with self-report and behavioural measures was also found in the 
neuroimaging sample, limiting our understanding of the involvement of brain regions 
activated in the task. 
We expected to find that all JORT behavioural measures (Flight Intensity, Risk 
Assessment Intensity, average velocity in pursuit and oscillations in goal conflict) and 
dread rating would be positively correlated with neuroticism and depression severity. We 
found significant positive correlations in the patient group between neuroticism and 
dread rating and neuroticism and average oscillations on goal-conflict trials (a measure 
of anxiety behaviour). These correlations were not found with trait anxiety or depression 
severity, suggesting neuroticism is more closely linked to threat sensitivity than other 
measures.   
Positive correlations were expected between FSS fear of tissue damage and Flight 
Intensity, and trait anxiety (STAI) and Risk Assessment Intensity scores due to previous 
findings of this association (Perkins et al., 2011, 2013). These findings were not 
replicated in our sample. Unexpectedly, significant negative correlations in the patient 
group were found between: depression severity and Risk Assessment Intensity and trait 
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anxiety and velocity on pursuit trials. Additionally, in the control group we found a 
negative correlation between dread ratings and oscillations made in goal-conflict trials, 
suggesting that subjective dread did not increase but rather decreased anxiety related 
behaviour on the task. 
Similarly, there was trend for responders to show higher post-therapy average velocity on 
the pursuit trials and significantly elevated oscillations in movement on goal-conflict trials 
compared with non-responders. This is the opposite of what was hypothesised as we 
expected responders to show a reduction in speed of movement (illustrative of a reduction 
in threat sensitivity) and a reduction in Risk Assessment Intensity (illustrative of a 
reduction in anxiety behaviours). In terms of group differences in oscillations, this may 
signify that treatment responders reacted more appropriately to predators post-therapy 
by making small oscillations to avoid getting caught, perhaps a sign of being less anxious 
about being close to approaching threats (rather than the proposition that this measure 
is positively associated with anxiety levels). The negative association between neuroticism 
and oscillations in healthy controls could also be explained by the same process. 
Regarding treatment increasing oscillations in responders, a key therapeutic aim of CBT 
is decreasing patients’ avoidance from threatening stimuli, the increased oscillations in 
movement found in CBT responders post-therapy could be due to patients avoiding the 
red dots less and allowing closer approach of the predators. These results align with the 
findings of Perkins et al. (2013) where lorazepam was found to increase Risk Assessment 
Intensity in those with high trait anxiety scores.  
As with previous studies exploring the effect of psychotropic medication on JORT 
performance, our results suggest that the reinforcement sensitivity theory and 
pathological responses separating anxiety and fear may be less clearly defined in humans 
compared to the animal models upon which the theory was developed. Additionally, the 
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JORT relies on motor precision, especially the goal-conflict trials, i.e., there is a 
relationship between precision and punishment probability. Evidence that anxiety is 
associated with reduced motor accuracy includes sports (Huber et al., 2015; Moore et al., 
2015; Nibbeling et al., 2012), simulated driving (Wilson et al., 2006), and playing music 
(Yoshie et al., 2008). These impairments are found even if they are likely to increase the 
risk of threat (Rigoli et al., 2012). Group difference in motor precision may have led to 
not finding significant group effects and the elevated Risk Assessment in treatment 
responders post-therapy, potentially illustrating increased motor precision with treatment 
response. However, our lack of significant differences between patients and controls in 
the number of times they were captured by the red dot predators suggest this was not the 
case, or if it were, did not impede in overall performance on the task.  
An alternative explanation could be that the JORT is unable to detect group or treatment 
related changes in MDD and comorbid anxiety. Despite evidence showing that threat-
avoidance reduces with therapy (Grupe & Nitschke, 2013; Hadwin & Richards, 2016; 
Maslowsky et al., 2010), and that higher levels of threat avoidance and attentional biases 
are associated with poorer treatment outcomes (Legerstee et al., 2009; Mogg & Bradley, 
2016; Price et al., 2011), research has found that only particularly severe biases in 
avoidance towards threats were associated with poorer treatment outcomes to CBT. 
Patients with an attentional bias towards mildly threatening stimuli pre-treatment (so 
called threat vigilance), responded better to CBT (Price et al., 2011). Similarly, research 
has found a relationship between threat-sensitivity and treatment response only with 
severe threat cues (Legerstee et al., 2010, 2009). Due to the JORT representing low-level 
threats, its ability to determine severe biases in threat avoidance may have been limited, 
and explain why the expected differences between treatment response and differences 
between patients and controls were not found. 
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Additionally, an fMRI study exploring threat orienting before and after CBT and 
antidepressant medication in patients with GAD, found that neural activation, but not 
behavioural changes, occurred with treatment (Maslowsky et al., 2010). Behavioural 
measures may therefore be less sensitive to treatment response.  
6.4.3 Strengths, limitations and suggested refinements to the JORT  
A strength of the JORT task is that unlike most paradigms exploring threat-sensitivity, the 
design of the task allows for the effect of threat imminence to be explored. Most tasks do 
not vary proximity (Buchel & Dolan, 2000). For example, Pavlovian conditioning, the 
most commonly explored paradigms in threat sensitivity research, when a neutral 
stimulus is paired with an aversive stimulus, do not vary imminence, especially in terms 
of distance. Temporally certain conclusions may be drawn about imminence from 
Pavlovian studies in terms of the time of presentation of the conditioned stimulus, but 
this is not amenable to neuroimaging timeframes as the stimuli are typically presented 
for only 2-4 seconds. Mobbs et al.’s work (2007, 2009) has been instrumental in showing 
the effects of threat imminence on human brain activity during pursuit – finding that the 
midbrain takes over from prefrontal activation when threats are near. However, unlike 
the paradigms used by Mobbs and colleagues to explore the effect of threat imminence in 
pursuit, the JORT has the advantage of also exploring goal-conflict, within-task and 
within-subjects (to our knowledge the first task to explore these behaviours within the 
same task).  
As with all threat-avoidance paradigms in humans, the JORT cannot wholly represent 
naturalistic threats, especially when the participant is in a scanner where constraints such 
as the participant remaining motionless are required. In the JORT, as with other 
paradigms in threat-avoidance human research, there is a higher-order nature of the 
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threat of electric shock or burst of aversive noise in relation to the pursuit/goal-conflict 
scenarios presented on the screen, i.e., the threat-avoidance is symbolic rather than 
ecologically natural. Although the JORT is not analogous to real-world threatening 
events, the results show alignment with other threat avoidance and anticipation studies 
in humans and also the animal literature where highly replicable circuits are found, giving 
confidence that threat-avoidance is measured on the task (Gray & McNaughton, 2000; 
McNaughton & Corr, 2004; Mobbs & Kim, 2015). The physical effort required on the 
JORT, unlike many tasks of threat avoidance in humans (e.g., Bach et al., 2014; Mobbs 
et al., 2007, 2009), make the task more ecologically valid.  
In the behavioural version of the JORT, the pressure-sensitive joystick is calibrated to each 
individual participant’s strength. In the fMRI version, the hand-gripper is one size and set 
to one pressure for all participants. Future studies using the JORT should calibrate the 
hand-gripper according to an individual’s hand strength and provide a range of sizes. This 
would control for confounds brought about by variability in hand size and strength which 
could have conceivably led to those with larger and stronger hands (which we did not 
measure) experiencing less anxiety on the trials. Due to an error in data collection, we 
were not able to collect autonomic measures of arousal such as sweating (skin 
conductance) or tachycardia (heart rate) whilst the participant completed the JORT task. 
This would have strengthened the work due to the relation of these measures with threat 
(Epstein & Roupenian, 1970). For example, (Mobbs et al., 2009) found that skin 
conductance levels were associated with the level of threat experienced in their pursuit 
task.  
Additionally, task ability may have influenced results. Other goal-conflict tasks have 
matched the difficulty level to each participant’s skill (Gonen et al., 2016; Mobbs et al., 
2009). A key improvement to the JORT would be to titrate the difficulty of the goal-
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conflict trials according to individual performance, as we found that participants were 
caught in the majority of goal-conflict trials but rarely in simple pursuit trials in the fMRI 
task. This difference was less extreme in the behavioural version of the task but there was 
still a vast difference in the number of times participants were caught between the trial 
types. The practice session could ascertain performance level to set an appropriate level 
of difficulty (e.g., as done by (Mobbs et al., 2007) or even better the difficulty could be 
dynamically adjusted to ensure all participants get ‘caught’ and receive electric shocks the 
same number of times both overall and also in relation to both the goal-conflict and 
pursuit conditions in order to match these conditions more closely in terms of skill and 
demand. This would additionally control for any reductions in motor precision that may 
further confound JORT results in patients with affective disorders (Huber et al., 2015; 
Nibbeling et al., 2012; Rigoli et al., 2012).  
As well as post-task ratings of dread whilst being chased by the digital predators, it would 
have been a good idea to ask participants about their confidence in avoiding the predator, 
as done by Mobbs et al. (2009), which may have affected neural activation and dread 
ratings. A lack of confidence in ability may have led to ‘learned helplessness’ in some 
participants (Maier and Watkins 2005), where depression like symptoms arise if threats 
are perceived as being uncontrollable (Grillon et al., 2003). By asking participants about 
their confidence in controlling the virtual agent, this could have determined whether 
differences between perceived and actual success varied between patients and healthy 
controls, a similar construct as measured in the FIQT (see Chapter 4). 
Further to this when comparing the goal-conflict and pursuit conditions, it is possible that 
the presence of another dot on the screen reflects increased attentional demands and 
increased processing of stimuli required on goal-conflict trials, in addition to the 
measurement of interest. To control for these trial type differences, additional stimuli 
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could be included in the pursuit trial to more closely match the goal-conflict condition, 
but which would not interfere with the subjects’ aim of avoiding the pursuing dot. A 
solution would be to present two preceding red dots, instead of one, in pursuit trials which 
move at different speeds and periodically overtake one another. This would allow for 
greater certainty that the level of difficulty, number of stimuli, and attentional demands 
are not influencing results and adding additional stress to the goal-conflict condition.  
For the aforementioned reasons, there is doubt about the validity of the findings from the 
goal-conflict condition of the JORT task. We did find significant differences between 
pursuit and goal-conflict conditions; however, this could be due to the higher level of skill 
and attention required to negotiate not getting caught by two dots. Due to limitations 
with the goal-conflict condition, and a lack of association with behavioural measures of 
JORT performance and measures relevant to threat sensitivity, we cannot make 
conclusions regarding the differentiation between fear and anxiety as being separable 
emotions controlled by different brain networks.  
Additionally, the task is likely to have been interpreted differently by individual 
participants as experiential fear is subjective and participants are likely to place their own 
meanings and biases onto tasks (LeDoux et al., 2017). The finding of group differences 
(patients scoring significantly higher than controls) and a range of scores on post-task 
dread rating show the task is able to invoke differential levels of fear that are sensitive to 
pathology. However, this subjective experience did not translate into group differences in 
behavioural performance on the task. We therefore conclude that this measure is not 
suitable for patients with MDD. Additionally, the task may not be suitable for all pure 
anxiety disorders. Anxiety is complex and there are likely to be multiple facets of anxiety 
related to different threat-related contexts. In depression threats such as the one posed in 
the Fake IQ test, a threat to self-esteem, may be more relevant. In social anxiety, you may 
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not expect to find elevated threat-sensitivity on a task such as the JORT, but only 
maladaptive levels in social contexts. Therefore, tasks studying treat-processing generally 
may not be suitable across all affective disorders.  
Further, the JORT represents a low-level threat. In the MDTB, of which the JORT is a 
human translation, the rodents were placed in a real-life threatening situation and will 
therefore have experienced high levels of threat – the mice did not know the chasing 
predator was anaesthetised and therefore there was a perceived threat of death. Human 
participants had context to the test and knew that they were engaging in a task which 
involved mild punishments. The rodents on the other hand were threat naïve. 
Additionally, this contextual knowledge may have led to an elevated level of sustained 
apprehension and anxiety throughout the testing session which may have clouded 
differences between threat and anxiety conditions. It is possible that group differences 
would have emerged on a task representing higher threat levels.  
Other fMRI paradigms designed to measure goal-conflict (often called approach-
avoidance behaviour) have involved a conflict between a reward (e.g., a monetary 
incentive) versus punishments (e.g., threat of losing rewards or getting caught by a 
predator) (Bach et al., 2014; Gonen et al., 2016; Mobbs et al., 2013). The 
conceptualisation of goal-conflict therefore differs somewhat in the JORT as the goal-
conflict is created by the need to approach threats in order to not get caught; there is no 
additional reward to successfully negotiate the threat except from successfully completing 
the trial. However, both are valid interpretations of goal—conflict; situations that can 
cause anxiety due to the need to approach threats (Gray & McNaughton, 2000). In 
depression, reduced sensitivity to rewards and an enhanced focus on punishments are a 
common finding (Eshel & Roiser, 2010). A task involving potential rewards may therefore 
provide stronger effects in patients with depression than a task which simply involves 
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avoiding punishments. As well as looking at passive avoidance tasks in depression, active 
avoidance tasks involving rewards should be explored further in this patient group. 
Un-signalled, unpredictable threats have been found to shower greater effects than 
predictable, signalled threats as used in the JORT (Grillon et al., 2004). Also, block 
designs, as opposed to event-related designs, as the JORT is, have been found to produce 
more robust findings (Grillon et al., 2004). This can in part be explained by sustained 
contextual anxiety throughout tasks involving threats. Studies have found exaggerated 
startle and anxious states throughout the durations of experimental studies in: major 
depression (Grillon et al., 2003), PTSD (Grillon & Morgan, 1999; Grillon et al., 1998), 
panic-disorder (Grillon et al., 1994), and those at high risk of developing anxiety 
disorders (Grillon et al., 1998). This may have limited our ability to detect differences 
between the two conditions of the JORT, which were presented in a pseudorandomised 
order. Perhaps hippocampal and PAG differentiations between goal-conflict and pursuit 
conditions and associations with trait self-report measures would have been found in a 
block design, supporting findings from studies which have compared pursuit and goal-
conflict in separate tasks.  
6.4.4 Overall conclusions 
Our results suggest that the JORT was effective in identifying neural regions involved in 
avoidance and anticipation of aversive stimuli, with activation being linked to threat level. 
However, the work presented in this chapter does not support the relevance of the JORT 
in major depression, as no significant differences between patients with depression and 
healthy controls were found neurally or behaviourally on the task. We suggest the 
measure may be relevant to disorders associated with a greater sensitivity to global 
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threats, such as panic disorder and GAD and that passive avoidance should be further 
explored in depression.  
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Chapter 7: Discussion chapter 
 
7.1 Summary of findings 
7.1.1 Aims 
The overall aim of this work was to explore two novel functional neuroimaging tasks and 
a new analysis technique for resting-state data in patients with depression and anxiety. 
Additionally, meta-analyses of the neural correlates and predictors of response to 
psychological therapies in depression and anxiety disorders were conducted to determine 
whether robust results exist currently in this literature. The novel tasks were designed to 
avoid inherent issues with existing measures of threat-avoidance and negative self-
referential processing with the hope they would inform us about pathological neural 
processing of threat-avoidance and self-referential thoughts in patients with depression 
and comorbid anxiety. Additionally, the utility of these novel tasks was piloted 
behaviourally to determine associations with response to CBT.  
7.1.2 Functional neuroimaging and psychological therapy 
Findings from neuroimaging studies of treatment response may not be robust when 
considered independently: studies often have small sample sizes which make it difficult 
to find strong effects after applying multiple comparisons across the whole brain. Meta-
analyses are therefore encouraged to improve statistical power (Button et al., 2013). Our 
meta-analyses present a comprehensive analysis of the evidence-base to date for the 
neural predictors and correlates of psychological therapy in depression and anxiety 
disorders. 
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We were able to demonstrate consistent functional brain changes across psychological 
therapies in depression and anxiety disorders. The most robust findings were significant 
post-therapy decreases in activation in the ACC/paracingulate gyrus, left and right 
inferior frontal gyrus and insula, relative to pre-therapy. The results are largely in 
agreement with neural models of improved self- and emotional-regulation following 
psychological therapy due the observed decreases in limbic activation, areas involved in 
emotional processing. However, our decreased prefrontal activation with therapy runs 
counter to the dual process model of psychotherapeutic action. There was only one 
significant cluster of activation that was predictive of symptom change which met our 
inclusion for robustness, located in the right cuneus, a region not identified by other 
reviews in the field. Previous research has shown that emotional processing activates the 
visual cortex (Mourao-Miranda et al., 2003) and therefore elevated activation in visual 
regions, such as the cuneus, during tasks involving symptoms provocation or emotional 
processing may signify greater emotional processing and threat vigilance, which facilitates 
better treatment outcomes (Price et al., 2011). We expected that elevated ACC activation 
would be predictive of greater symptomatic improvement. This region was significant as 
a predictor, but did not meet our criteria for robustness. More research on predictors of 
psychotherapeutic response is therefore required to provide reliable predictors of 
psychological treatment response across disorders.  
Our work adds to growing evidence suggesting that the dual process model cannot fully 
account for the mechanisms of psychological therapies (Franklin et al., 2016; Messina et 
al., 2016). We propose that a model with greater complexity is required, as suggested by 
Willner et al. (2013) for antidepressant medication mechanisms. The neural activation 
changes associated with psychological therapies appear to be more complex than a linear 
relationship between prefrontal and limbic regions, as the dual process model proposes, 
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and there are likely to be compensatory as well as corrective changes in brain activation 
with psychological treatments. Future models should include decreased prefrontal 
activation following psychological therapies, as we found in our meta-analyses, and which 
have been linked to a reduction in self-reflective cognitions and traumatic memories.  
7.1.3 Self-reflection and the Fake IQ test 
We piloted a novel task to measure implicit self-reflection: the Fake IQ test. We found 
that the measure was sensitive to psychopathology with elevated negative self-
comparison to others, higher self-dissatisfaction, and lower perceived success in patients 
with depression and anxiety relative to controls on the task. Importantly, the ‘fake’ nature 
of the task did not appear to have been perceived by participants in post-task questioning 
and was not revealed quantitatively, which could have been demonstrated by increasing 
or decreasing levels of task satisfaction over the blocks if the participant had guessed they 
were completing an impossible task and altered their responses accordingly. We therefore 
propose the FIQT as an alternative to traditional self-report measures of self-reflection, 
with application to multiple patient groups associated with abnormal self-reflection. As 
we found no significant correlations between FIQT subscales and measures of depression 
severity, self-report self-criticism, rumination or worry, we have not shown evidence of 
construct validity. Further work should explore the task’s relationship to alternative 
measures of self-reflection in order to validate the measure’s construct validity, for 
example self-blame and perfectionism: constructs that are likely to be involved with 
perception of task performance.  
Piloting of the task as an fMRI paradigm revealed that self-reflection on task performance 
invoked activity in brain regions involved in error-processing as hypothesised due to being 
a common finding with tasks of self-reflection. This adds some support to the measures 
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construct validity in measuring self-perception, reflection and error-processing. 
Specifically, we found increased activation on self-reflection versus control conditions 
bilaterally in the inferior cortex, insula, dlPFC, motor cortex and dACC. However, there 
were no significant differences between patients versus controls in neural activation on 
the task, nor correlations between brain activity and self-report measures of self-
reflection.  
7.1.4 Self-reflection and dynamic functional connectivity 
Our study showed that major depression was associated with increased temporal 
variability in connectivity between two key DMN regions, specifically the mPFC and PCC. 
A key strength of this study was that we were able to replicate the finding in a second 
sample of patients with MDD free from comorbidity, suggesting the finding is robust. We 
found a positive correlation between connectivity variability and self-report rumination 
in one sample and therefore speculatively elevated negative self-referential cognitions 
may underlie this elevated temporal instability.  
We believe the result represents an abnormality in network-specific neural properties in 
psychopathology rather than being an effect of global instability or underlying static 
connectivity differences due to our analyses in control regions and static connectivity 
which revealed no group differences. This work highlights the importance of studying 
dynamic functional connectivity to gain a more fine-grained representation of network 
abnormalities than static functional connectivity studies provide in this field.  
Indeed, dynamic functional connectivity is a growing field of interest as, since the 
publication of this chapter (Wise et al., 2017), several studies have been published in 
psychiatric disorders including patients with major depression (Demirtas et al., 2016), 
bipolar disorder (Nguyen et al., 2017) and chronic fatigue (Boissoneault et al., 2016) and 
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those who have experienced childhood trauma (Cisler, 2017). For example, (Demirtaş et 
al., 2016) compared dynamic functional connectivity between patients with MDD (n=27) 
and healthy controls (n=27), as our study did. They found decreased dynamic functional 
connectivity within the DMN and fronto-parietal regions; however, no significant findings 
were found between the mPFC and PCC (the regions we focused our analysis on). Again, 
as with the previous study in MDD by (Kaiser, Whitfield-Gabrieli, et al., 2015), their whole 
brain approach (and additional small sample size) may have lacked the power to detect 
a significant difference between the mPFC and PCC. Additionally, a study (albeit in 
healthy controls) suggests dynamic functional connectivity may be sensitive to 
psychological treatments (Komulainen et al., 2017). A single dose of mirtazapine was 
found to alter dynamic functional connectivity in cortical midline structures and regions 
involved in emotional processing, including the insula, striatum, thalamus and 
hippocampus. A study in euthymic patients with bipolar disorder, compared to controls, 
found alterations between our regions of interest: the mPFC and PCC (Nguyen et al., 
2017). However, they found the opposite direction of results to us; decreased dynamic 
functional connectivity in the patient group. This could be due to their patient group being 
currently euthymic or could represent a differentiation between unipolar and bipolar 
pathology. Further work is warranted to explore the relationship of the findings to 
bipolarity and treatment response.  
7.1.5 Threat-avoidance 
Behavioural and fMRI piloting of the JORT was conducted - a task yet to be piloted in 
patients with anxiety and depression despite abnormal anticipation and avoidance of 
threats being a key feature of affective disorders and the task having been validated in 
healthy controls (Perkins et al., 2009, 2011, 2013, Under Submission). In the behavioural 
piloting of the task, no significant differences were found between patients versus 
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controls, nor were any differences found between responders and non-responders to CBT 
or changes in performance pre- to post-therapy. Despite finding a significantly elevated 
subjective experience of dread in the patient group whilst completing the task, these 
results suggest that this subjective experience did not translate into significantly different 
behaviour on the task thus questioning the measure’s sensitivity and validity to depressive 
pathology or experiential threat. Similarly, fMRI analysis showed no significant 
differences in neural activation on the task’s conditions in patients versus controls. We 
conclude that passive avoidance may be more relevant to depression and warrants further 
investigation. Recommendations for refinements to the JORT task are made in Chapter 6, 
after which exploration should focus on disorders with a greater link to threat-sensitivity, 
such as GAD or panic disorder as we were able to demonstrate that the task conditions 
activated brain regions involved in anticipation and avoidance of threats. 
7.1.6 Threat avoidance and negative self-reflection as distinct forms of threat 
We measured physical threat with an active measure of defensive avoidance behaviours 
(the JORT). However, negative forms of self-reflection can also be considered as defensive 
responses albeit to more abstract perceived threats and generally resulting in more 
submissive defensive responses.  
Self-criticism involves focusing one’s attention on perceived personal faults, mistakes, and 
negative attributes with the consideration that there may be negative consequences, for 
example, punishment or negative social judgement (i.e. a threat to the self or a social 
threat). In affective disorders, high levels of negative self-reflection, for example self-
blame, can be considered as a learnt defensive reaction in response to perceived conflict 
with others (Gilbert & Irons, 2005). High levels are associated with childhood trauma, in 
particular emotional abuse, furthering support that this is a learnt defensive reaction 
(Gilbert & Procter, 2006; Irons et al., 2006). 
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When a highly self-critical individual is asked to be self-reassuring, they have been found 
to respond with threat like responses - such as increased heart rate and skin conductance 
(Epstein & Roupenian, 1970) and patients with depression have been found to have 
deficits in self-soothing even when remitted (Gilbert & Procter, 2006; Rockliff et al., 
2008). For example, in a neuroimaging task which involved hearing maternal criticism 
and being instructed to be self-reassuring, patients who were recovered from depression 
had altered neural activity compared to healthy controls, together with increased heart 
rate (Rockliff et al., 2008). 
Therefore, just as with more physical threats i.e. the threat of an electric shock, self-
criticism has been found to lead to similar bodily reactions and perhaps therefore also to 
brain activation associated with threat processing. We provide some support for this in 
our task of self-reflection as the regions activated in the FIQT aligned to those involved 
in error processing and there is some overlap between these regions and those involved 
in threat-avoidance. For example, on both the JORT (measuring threat-avoidance) and 
FIQT (measuring self-perception) we found insula, ACC and prefrontal brain region 
activation. The type of threat processing involved in self-reflection may be a more trans-
diagnostic concept and therefore suitable to study in a broader range of 
psychopathologies. Indeed, a spectrum based model has been proposed by (Philippi & 
Koenigs, 2014). 
7.2 Methodological considerations 
7.2.1 Methodological approach 
A key strength of the work presented in this thesis is that we looked at behavioural 
performance alongside functional imaging. The development of robust behavioural 
measures to link key aspects of pathological functioning, for example, deficits in 
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emotional processing and cognitive deficits, with specific neural circuitry could be an 
important step in achieving a more evidence-based methodology to psychiatric treatment. 
As a neuroimaging approach is expensive, well-designed behavioural measures that span 
several psychopathologies and that are linked to treatment response could be useful in 
clinical practice in their own right. The tasks we used in this body of work, namely the 
FIQT and JORT, are both implicit in nature and therefore avoid issues with self-report 
measures which may be biased or inaccurate (as discussed in Chapter 4). Neuroimaging 
can potentially help validate the behavioural measures, in terms of understanding their 
neural correlates, as well as providing information on the mechanisms of disease and 
recovery processes, and enabling the prediction of likely response to treatments. 
7.2.2 Clinical Samples 
A key strength of the patient group included in Study 1 is that we controlled for treatment 
effects: all participants were both medication-free and not currently undergoing 
psychological therapy at the time of scanning. Otherwise, we chose to include a 
naturalistic patient sample to pilot our novel methods due to the trans-diagnostic 
relevance of the measures under investigation. Our inclusion of patients with comorbid 
depression and anxiety disorders, nonetheless, limits our ability to determine which 
disorder(s) are responsible for our findings. Limiting to clinically pure populations 
without comorbidities would have allowed us to have greater certainty that the results 
are associated with specific conditions, as mechanisms may vary in those with comorbid 
diagnoses. On the other hand, it is important for neuroscientific research into affective 
disorders to include naturalistic patient samples, as if findings are to have translational 
relevance for clinical practice, effects are required in real-world samples who vary 
markedly in their clinical presentation, degree of severity, and psychiatric history. Indeed, 
MDD most commonly presents as being comorbid with other Axis I disorders (Kessler et 
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al., 2003). Larger sample sizes would allow for the influence of heterogeneity to be 
studied without relying on recruiting highly specific, un-representative clinical samples.  
In line with the study’s naturalistic design, the subset of patients who received CBT was 
selected from local psychological therapy service wait lists. The therapy received by 
participants was therefore representative of real-world therapy as we did not protocolise 
a course of treatment. Indeed, there was variability in the number of sessions that 
participants received: mean 11.61 (+-4.98), range: 6-28. Patients who responded to CBT 
typically received fewer sessions than those who did not respond, suggesting that CBT 
treatment is tailored according to individual need in normal clinical practice. However, 
the naturalistic, uncontrolled nature of the therapy received by participants may mean 
that it was sub-optimally delivered which may have reduced the chance of finding effects 
and have contributed to finding no associations between the tasks and CBT.  
7.2.3 Resting-state versus task-based functional neuroimaging  
The two novel functional imaging tasks we piloted, measuring self-reflection and threat-
avoidance, were not able to demonstrate significant differences in brain activation 
between patients and healthy controls. We were, however, able to demonstrate group 
differences in our resting-state analysis. Resting-state scans have the following advantages 
over task-based paradigms: they avoid task-related confounds such as performance level, 
floor or ceiling effects; issues with practice effects in longitudinal studies involving 
repeated task-based fMRI sessions; and they evade the need for effort which may be an 
important consideration in certain patient groups (Fischer et al., 2016; Fox & Greicius, 
2010; Whitfield-Gabrieli & Ford, 2012).  
Additionally, despite the logical expectation that unconstrained thought during a resting-
state scan may lead to a great diversity in the brain regions engaged, research has shown 
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a consistent neural network to be activated during rest: the DMN (Raichle et al., 2001; 
Shulman et al., 2007). This well-defined and measurable network, which has been found 
to be altered in affective disorders (Whitfield-Gabrieli & Ford, 2012), therefore has some 
advantages in comparison to task based measures which may introduce greater neural 
variability.  
For example, the JORT (see Chapter 6) required a level of skill and between-subject 
variability in how difficult participants found the task will likely have caused confounds. 
We suggest that going forward the difficulty of the JORT should be calibrated to 
individual performance levels to ensure performance effects are controlled for. Regarding 
the FIQT, despite there being no right or wrong answers, the participants did not know 
this and therefore between-participant variability in prior knowledge of how they usually 
perform at these types of tasks could have confounded results. It would be interesting to 
test the task on healthy controls who know from experience that their performance on 
these types of cognitive, IQ-related tasks are poor to see if despite this they score more 
positively in self-referential questioning on task performance compared to patient groups. 
Additionally, a ‘real’ test of visual perception could be gained in addition to the FIQT at 
testing sessions to control for performance, IQ related-confounds in analyses: gaining a 
purer measure of differences in perceptions versus performance. This would help validate 
the task in terms of concurrent validity i.e. its ability to distinguish between patients and 
controls.  
7.2.4 Meta-analyses 
Although the meta-analysis technique used in this thesis is robust, and has numerous 
advantages over alternative neuroimaging meta-analytic techniques (Radua et al., 2012), 
the work relies on the quality of included studies. The analyses illustrated considerable 
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heterogeneity in the methodologies of the existing literature, a lack of replicability and 
small sample sizes. The results of the analyses are therefore likely to have been affected 
by limitations in the original studies.  
Moreover, the meta-analyses in this thesis relied on reported peak co-ordinates in the 
studies, which provide only limited information about the exact results. Valid meta-
analyses can be performed on such data, nevertheless inclusion of statistical parametric 
maps from the original studies can markedly improve sensitivity (Radua & Mataix-Cols, 
2012). These three-dimensional images of results are rarely available, limiting the 
inclusion of studies. Researchers should share statistical parametric maps online via 
repositories such as Neurovault, making it simpler for future meta-analyses to include 
these maps in their analyses. 
This field of research would benefit from studies with larger sample sizes, comparing 
various subtypes and diagnoses with a standardisation of design across research groups 
to allow understanding of the heterogeneity in results. Recommendations of best practice 
have been made for this field of research - the neural correlates and predictors of 
treatment response (Frewen, Dozois, & Lanius, 2008). Frewen et al.’s suggestions to 
improve the methodological rigor of the field include scanning both patients and a non-
psychiatric control group at both baseline and post-therapy, along with a therapy control 
group also scanned at two time points. A therapy control group would allow greater 
confidence that the results illustrate the effects of therapy, by controlling for the passage 
of time and practice effects, similar to placebo arms in pharmacological studies. For 
example, Hölzel et al. (2013) included an active control intervention (the active therapy 
under investigation being mindfulness-based stress reduction). The control therapy was 
called stress management education and was designed to extricate the specific effects of 
mindfulness-based practice from other potentially effective elements of the therapy. They 
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recommend that both resting-state and task-based functional paradigms should be 
utilised and behavioural data collected during and immediately after scanning (as we did 
for all of measures, except resting-state which we acknowledge as a limitation hindering 
conclusions being drawn about the relationship of our findings to self-referential 
thoughts). They add that this behavioural data, including reaction times and physiological 
data, should be correlated with neuroimaging data.  
Frewen et al. 2008 summarise that very few studies meet these criteria. In addition to 
their recommendations, we add the importance of making results available on online 
repositories and reporting whole-brain data as well as ROI results. Additionally, longer 
term follow-up, as well as scans throughout the duration of therapeutic trials, are 
required. This would enable us to more rigorously test the dual process model to 
determine whether there are differential primary effects between pharmacological and 
psychological therapy processes as the theory proposes. Additionally, more complete 
testing of neuroimaging paradigms is required to determine their validity and robustness 
before research teams adopt consistency in their study designs. Studies should also 
measure the quality of psychological therapy received, for example, the quality of patient-
therapist relationships and the patient’s engagement in both treatment sessions and 
homework should be recorded, as these are important predictors of response (Gomes-
Schwartz, 1978; Lambert & Barley, 2001).  
Although not within the scope of our prediction meta-analysis, another way to explore 
prediction of treatment response is to use pattern recognition methods such as support 
vector machine learning or transductive conformal predictors (Costafreda et al., 2009; 
Costafreda et al., 2009; Fu et al., 2008; Marquand et al., 2008; Nouretdinov et al., 2011). 
These methods have been found to have high predictive accuracy for response at the 
individual patient level and may be required in order to translate findings into clinical 
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practice. For example, Fu et al., (2008) found 86% accuracy in classifying patients’ 
treatment response, prior to the initiation of treatment, using patterns of brain activity on 
an implicit emotional processing task.  
 
7.3 Clinical implications 
Many studies have discussed the potential of neuroimaging biomarkers to aid 
understanding of psychopathology and improve clinical decisions. Although 
developments in the field have been made in identifying the neural circuitry associated 
with depression and anxiety, we are a long way from translating this knowledge into 
robust biomarkers for clinical practice to improve treatment interventions and better 
tailor therapies to individuals according to likely response. Diagnosis remains based on 
patient self-report and clinical observation with the aid of DSM and ICD diagnostic 
systems. Transitioning our knowledge into clinical practice could take several 
complementary forms by utilising functional neuroimaging. Resting-state and task-based 
studies could be moved away from a group-based approach to become a tool for clinical 
decision making on an individual patient level. This may provide more accurate diagnoses 
and tailored treatment approaches for patients in the future – with disorders being 
characterised by deficits in neural circuitry, which may give more accurate classification 
than current diagnostic tools and lead to treatments targeting these connectivity and 
activation abnormalities (Fischer et al., 2016).  
The work presented in the meta-analyses in Chapter 6 suggest that there are consistent 
neural activation changes occurring with psychological therapies across both depression 
and anxiety disorders, making these regions an interesting target for future biomarker 
development; although such methods are far from ready for use in clinical practice in 
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their current state. Replication of findings is required in larger and heterogeneous samples 
in order to validate their robustness across and between disorders. Additionally, the 
behavioural measures used in neuroimaging studies could be utilised in clinical settings, 
for example those exploring negative self-referential processing, to better target 
treatments. The work presented in Chapter 4 adds to a growing body of evidence that 
negative self-referential processing is a key feature of psychopathology which is linked to 
treatment response.  
Despite our lack of findings between patients and controls in the fMRI version of the FIQT, 
our elevated dynamic functional connectivity in patients relating to rumination, and 
behavioural data from the FIQT and other self-report measures of self-reflection suggest 
there are abnormalities in negative self-referential processing which can be measured 
behaviourally and are related to a distinct brain network. Due to these concepts being 
relevant to most psychological disorders, targeting treatments more specifically to deficits 
in specific aspects of negative self-referential processing could be a key step towards 
improving treatment response.  
These aspects of self-referential cognition could be measured in patients during clinical 
assessments via self-report and behavioural measures to lead to more targeted and 
personalised therapies. Indeed, in recent years numerous psychological therapies have 
been developed with an emphasis on targeting aberrant self-reflection including 
acceptance and commitment therapy (Hayes et al., 2013), acceptance-based behavioural 
therapy (Roemer et al., 2008), mindfulness-based cognitive therapy (Zindel et al., 2002), 
rumination-focused CBT (Watkins et al., 2011), and emotion regulation therapy (Fresco 
et al., 2013). In this thesis we were able to demonstrate that self-report measures of self-
reflection were able to predict treatment response and showed significantly greater 
reductions in CBT responders compared to non-responders. However, FIQT measures did 
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not show significant reductions post-compared to pre-therapy, nor were there differences 
in responders or non-responders on the FIQT at baseline. Potentially, more targeted 
treatments would change directive task-based measures of self-reflection, such as the 
FIQT.  
As negative self-referential processing often remains post-treatment and is associated with 
poorer response trajectories (Mennin & Fresco, 2013; Nolen-Hoeksema, 1991; Riso et al., 
2003), tasks such as the FIQT which directly measure self-reflection may therefore serve 
a complementary purpose, in addition to self-report measures, in clinical practice. They 
could help to determine whether self-reflective responses to specific events and direct 
measures of performance have changed and not just an experiential reduction as would 
be demonstrated via self-report questionnaires. Rumination-focused CBT and emotion 
regulation therapy in particular directly target negative self-referential processing and 
train individuals to gain awareness of their negative processing (Fresco et al., 2013; 
Watkins et al., 2011). In combination with mindfulness-based meditation, this early cue 
detection can reduce negative self-referential perspectives in actions towards events 
(Mennin & Fresco, 2013). There is evidence that more targeted therapies could help 
prevent relapse and narrow the gap in treatment efficacy for those patients with higher 
levels of negative self-referential processing. Similarly, measures of self-reflection could 
be used to signal whether preventative measures or a longer course of treatment are 
required.  
Additionally, our dynamic functional connectivity analysis in Chapter 4 suggested that 
alteration in functional connectivity in the DMN (related to self-referential processing) in 
depression goes beyond static connectivity differences. Further studies are warranted to 
see if treatments alter this temporal variability and further explore the relationship of 
temporal variability to self-referential processing. The DMN may be a potential target for 
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new treatments, for example, transcranial magnetic stimulation or new drug treatments 
(Fischer et al., 2016).  
 
7.4 Future directions 
7.4.1 The neural basis of psychological treatment response  
The field of research into neural correlates and predictors of treatment response in 
affective disorders would benefit from studies using larger sample sizes, consistent study 
designs and analytic strategies. This would enhance the speed of discovery of clinically 
useful neural biomarkers. A large-scale trial is underway to discover the biomarkers in 
relation to antidepressant medication (Lam et al., 2016); however, a similar study for 
psychological therapies would be beneficial for these comparatively understudied 
treatments in neuroimaging research.  
Additionally, in the work presented in our meta-analyses, causality cannot be inferred. 
Techniques such as dynamic causal modelling of fMRI data or neurostimulation alongside 
functional imaging would allow us to determine the causal direction of results. For 
example, TMS allows for the manipulation of specific brain regions over the duration of 
seconds or weeks, and their connected neural networks. Combined with neuroimaging, 
this would allow interpretation of the effects of manipulation (Etkin, 2017). For example, 
it has been found that the DMN, which is most active during rest, is differentially 
deactivated by different brain regions during attentionally demanding tasks (Chen et al., 
2013). 
Understanding in psychiatry is beginning to develop away from solely descriptive disease 
classification, aided by established diagnostic systems, to a system with greater biological 
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underpinning. However, given the complexity of the neural systems that underlie 
psychopathology, characterising quantifiable and objective psychiatric biomarkers has 
been more protracted than other fields of medicine, with much of the work in this field 
being un-replicated currently. The goal of biological-based, precision psychiatry is to 
understand the mechanisms and recovery processes within and between disorders, to 
identify resilience and risk factors, to accurately predict clinical outcomes and identify 
targets for prevention and treatment (Silbersweig & Loscalzo, 2017), though this is a long 
way from clinical practice currently. Part of the hindrance lies with the heterogeneity 
within current diagnoses and high levels of comorbidities. Due to this, a more 
multidimensional approach may be required for biomarker development (e.g., as 
proposed by (Dunlop, 2015; Silbersweig & Loscalzo, 2017). Future research should aim 
to combine various paths of research, for example, functional brain imaging with 
endocrinological, genomic, neuropsychological, and behavioural measures alongside 
clinical features. This integrated approach may be able to provide enhanced markers 
compared to isolated factors, and enable better stratification and subtyping of disorders, 
a mechanistic understanding of treatment response and improved tailoring of therapies. 
7.4.2 Threat-avoidance in depression and anxiety 
We did not provide support for the JORT measuring pathologically relevant concepts in 
MDD and therefore do not recommend further exploration with this measure in depressed 
individuals. We suggest that piloting of the task should be conducted in patients with 
anxiety disorders such as GAD or panic disorder, where stronger associations have been 
found between threat-avoidance behaviours (Naragon-Gainey, 2010). Improvement (that 
were suggested in Chapter 6) should first be made to the task to hopefully improve the 
reliability, validity and robustness of the measure. Tasks measuring deficits in reward 
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processing via passive avoidance tasks may be more relevant in major depression (Ferster, 
1973; Ottenbreit & Dobson, 2004). 
7.4.3 Future exploration of the Fake IQ task 
Backing up previous findings piloting this measure with patients with anorexia nervosa 
(Corfield, 2014; Patrick et al., Under Submission), we were able to show that patients 
with depression and comorbid anxiety showed elevated negative perceived versus actual 
success on the FIQT compared to controls adding to evidence of concurrent validity of the 
task. Our neural main effects comparing self-reflection versus control conditions in brain 
regions relevant to self-reflection and relatedly error processing give us certainty that this 
measure is tapping psychologically relevant constructs. However, we propose that future 
use of the FIQT should initially explore the relationship of FIQT performance with 
alternate measures of self-reflection including self-blame, self-punitiveness, and 
perfectionism, which seem likely to have associations with FIQT rating. We propose that 
the measure should be tested within and between different disorders, in particular 
patients with depression or anxiety (i.e. a non-comorbid patient sample unlike ours – to 
give certainty that the results are found in specific disorders and not due to comorbidity) 
and also disorders associated with reduced self-reflections, for example, autism spectrum 
disorders or schizophrenia (Philippi & Koenigs, 2014). Comparison between different 
patient groups may highlight distinctions between disorders.  
The lack of association between task subscales and treatment response may mean the task 
measures trait aspects of self-reflection that are unamenable to change. Indeed, low 
confidence in one’s abilities has been found to be a relatively stable trait in individuals 
generalising across tasks (Ais et al., 2016; Rahnev et al., 2015; Stankov & Crawford, 
1997), and having an inherited component (Cesarini et al., 2010) suggesting self-
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perception may be a trait level predictor of vulnerability to psychopathology. Our findings 
of no significant changes in scores over time may therefore show evidence that the task 
is reliable in measuring this trait disposition. However, further exploration is warranted 
to substantiate this, especially due to our small sample size. It may be that therapies 
specifically targeted towards reducing negative self-reflection could lead to more positive 
reflection on FIQT performance post-therapy. This could be supplemented by testing the 
measure in at risk and remitted populations to explore if findings in these populations 
display no significant differences with patient groups, as would be expected if it is a purely 
trait measure. Similarly testing the measure in healthy controls with knowledge that they 
perform poorly at cognitive, IQ based tasks and patients who know they perform well 
could determine the measure’s reliability. 
Recommendations were made for refinements to the task design in Chapter 4, especially 
in relation to suitability as a neuroimaging paradigm. We would urge future researchers 
using this task during scanning to develop an alternative control condition which 
minimises the possibility for self-reflection; for example, a distractor condition, and refine 
the timing of reflection conditions. Future work should study the fMRI task in a variety of 
psychiatric disorders associated with aberrant self-reflection, using larger sample sizes 
and alternative measures of self-reflection. For example, there is evidence that self-critical 
behaviours have a separate and independent contribution to anorexia nervosa, beyond 
that of related depressive symptoms (Dunkley & Grilo, 2007; Starrs et al., 2015), and 
therefore neural group differences may be displayed in this patient group. 
7.4.4 Dynamic functional connectivity in psychopathology 
Our work adds to a growing body of evidence that dynamic functional connectivity is 
altered in various psychopathologies. However, a key barrier to bring this research into 
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clinical practice is a lack of understanding surrounding what the time-varying property of 
connectivity means. Future studies should try to clarify the causes of variability and its 
relationship to static connectivity. Our approach of correlating variability with global self-
report measures suggests further exploration of variability and psychological constructs 
is warranted. Post-scan questioning about the level and quality of self-reflective cognitions 
engaged in during scanning could help determine links between psychological state and 
cognitions with connectivity variability, as utilised by Kucyi & Davis (2014) who found a 
positive correlation between daydreaming during scanning and variability.  
The patients included in our work were currently depressed; however, it cannot be 
concluded that this variability is specific to the depressive state. Future work should 
investigate dynamic functional connectivity in alternate groups, for example, remitted 
and at risk populations and those with other disorders relating to aberrant self-reflection 
to determine whether altered dynamic functional connectivity in the DMN is a 
vulnerability marker of depression or specific to the depressed state. The findings by 
Komulainen et al. (2017), which showed that a single dose of mirtazapine altered 
variability in emotional processing regions, suggest that altered connectivity is a state, 
rather than trait marker, amenable to change.  
 
7.5 Overall conclusions 
The main aim of this work was to examine novel tasks and new analysis techniques to 
measure threat-avoidance and self-reflection in patients with depression and varying 
levels of comorbid anxiety. The results suggest further exploration of the Fake IQ test, an 
implicit measure designed to explore differences between perceived versus actual success, 
is warranted due to our observed pathological sensitivity and the measure invoking 
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activation of brain regions involved in error processing and self-reflection. Additionally, 
we found dynamic functional connectivity abnormalities in regions of the default mode 
network thought to be crucially involved in the generation of self-reflective cognitions in 
patients with depression versus controls. We replicated this finding in a second sample of 
patients with depression, free from comorbidities, suggesting the finding is robust. This 
is a relatively understudied technique and therefore our work adds to a small body of 
growing evidence suggesting that psychiatric conditions are associated with aberrant 
temporal fluctuations in disorder-relevant networks. Meta-analyses showed evidence of 
consistent neural correlates of psychological therapies across depression and anxiety 
disorders; however, robust neural predictors of treatment response were not found in the 
current evidence base. We conclude that the novel task utilised in this thesis to measure 
pathological threat-avoidance and anticipation is not related to depression, but deserves 
exploration in pure anxiety disorders due to previous findings that anxiolytic medication 
altered behaviour on the task (Perkins et al., 2013, 2009). The clinical implications of the 
findings have been described in relation to the importance of negative self-reflective 
cognitions in affective disorders and future recommendations made regarding 
improvements to neuroimaging studies of treatment response and how this could enhance 
the speed of robust biomarker development for use in clinical practice.   
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Appendix 1: Search terms for meta-analyses 
The title, abstract and keywords of Scopus (Elsevier, Amsterdam, Netherlands, 
http://www.scopus.com) and Medline (Ovid Technologies, Inc., 
http://ovidsp.uk.ovid.com were searched for the following words:  
 (("psychotherapy" OR ("psychological" AND "therapy") OR "CBT" OR ("cognitive" AND 
"therapy") OR ("behavio*" AND "therapy") OR ("interpersonal" AND "therapy") OR 
"psychoeducation*" OR ("exposure" AND "therapy") OR "psychodynamic" OR "mindful*") 
AND ("*MRI" OR "SPECT" OR "magnetic resonance imaging" OR "tomography" OR "PET" 
OR "positron emission") AND ("anxi*" OR "depress*" OR "anxious" OR "traumatic" OR 
("obsess" AND "compul*") OR "phobia" OR "panic" OR "bipolar" OR "manic" OR 
"dysthymi*" OR "melancholi*" OR "cyclothymi*" OR "seasonal affect*"))  
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Appendix 2: Funnel plots from meta-analyses 
Funnel plots from regions of significant difference in brain activation change pre-to 
post-treatment (both task and resting state studies included): 
1) Right inferior network, inferior longitudinal fasciculus 
 
Egger test: Bias = -0.83, t = 1.38, df = 21, p = 0.182 
2) Right arcuate network, posterior segment 
 
Egger test: Bias = -0.86, t = -1.44, df = 21, p = 0.164 
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3) Left anterior cingulate/paracingulate gyri 
 
Egger test: Bias = 0.36, t = 0.72, df = 21, p = 0.479 
 
4) Left inferior frontal gyrus, opercular part, left insula 
 




5) Right inferior frontal gyrus, triangular part 
 
Egger test: Bias = 1.06, t = 1.57, df = 21, p = 0.131 
 
6) Left middle frontal gyrus 
 




7) Right temporal pole, middle temporal gyrus 
 
Egger test: Bias = 1.03, t = 1.64, df = 21, p = 0.115 
 
8) Right middle frontal gyrus, orbital part 
 




Funnel plots from regions of significant difference in brain activation change 
pre-to post-treatment– task-based studies only 
1) Right and left precuneus/corpus callosum 
 
Egger test: Bias = -0.19, t = -0.34, df = 16, p = 0.739 
 
2) Left inferior frontal gyrus, opercular part 
 
Egger test: Bias = 1.37, t = 2.14, df = 16, p = 0.048 
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3) Left anterior cingulate / paracingulate gyri / right anterior cingulate 
 
Egger test: Bias = 1.22, t = 1.80, df = 16, p = 0.091 
 
4) Left insula 
 
Egger test: Bias = 2.13, t = 3.44, df = 16, p: 0.003 
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5) Right temporal pole, middle temporal gyrus 
 
Egger test: Bias = 1.21, t = 1.32, df = 16, p = 0.206 
 
Funnel plots from regions of significant difference in brain activation change 
pre-to post-treatment – resting-state studies only 
1) Right lingual gyrus / right inferior network, right fusiform gyrus 
 
Egger test: Bias = -2.75, t = -2.59, df = 3, p = 0.081 
264 
2) Right arcuate network, posterior segment 
 
Egger test: Bias = -2.77, t = -2.58, df = 3, p = 0.082 
 
3) Corpus callosum 
 
Egger test: Bias = -2.11, t = -2.71, df = 3, p = 0.073 
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4) Right middle frontal gyrus, right inferior frontal gyrus 
 
Egger test: Bias = 1.19, t = 0.92, df = 3, p = 0.427 
 
5) Left middle frontal gyrus 
 




6) Right middle frontal gyrus, orbital part 
 
Egger test: Bias = 1.66, t = 1.17, df = 3, p = 0.326 
 
7) Right anterior cingulate / paracingulate gyri / left anterior cingulate 
 




Funnel plots for regions significantly predicting symptomatic improvement  
1) Right cuneus cortex 
 
Egger test: Bias = 0.65, t = 0.50, df = 10, p = 0.631 
2) Left medial cingulate / paracingulate gyri / left anterior cingulate 
 




3) Right frontal orbitopolar tract 
 
Egger test: Bias = -1.34, t = -1.09, df = 10, p = 0.300 
 
4) Left precentral / postcentral gyrus 
 




Appendix 3: Standardised participant instructions for the Fake IQ test 
In this experiment, we will test your visual perception ability.  This is a property of your brain 
which is thought to be linked to intelligence. In order to accomplish this, we will ask you 
briefly to look at some images and make quick, accurate assessments of their properties. 
You will be shown two images side by side and asked to select one of them according to a 
previously specified criterion, for example, which shape has the largest surface area or volume 
or contains the most elements. Some of the differences between the images may be very subtle 
and difficult to perceive but please do your best to make a judgement.  You select an image 
by pressing either the left- or right-hand key of your button box. 
After each image, you will be asked either to think about how satisfied you were with your 
performance or to relax and wait for the next trial. When presented with the word 
“SATISFIED” please think carefully about how satisfied you were with your performance on 
that last trial.  This is an important test of your analytical ability. If you are presented with 
the word “WAIT” please wait for the next trial, relax and clear your mind. Try not to think 
about your performance on the previous trials. 
In between trials you will see a cross. Look at the cross and wait for the next two images to 
appear on the screen. 
After every 10 trials you will be asked 3 questions about your performance on the previous 
10 images presented. This part of the experiment is an important test of your analytical 
ability so please think carefully about your ratings of your performance. Please click on the 
appropriate answer on a scale by pressing down on either the left or right-hand side of the 
button box to move the pointer on the response box. 
 
